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1 ZUSAMMENFASSUNG 
 
Neisseria meningitidis ist ein fakultatives Humanpathogen, welches mitunter sehr 
resistant gegenüber Serumkomplement-Exposition ist. Bereits beschriebene Faktoren, 
welche die Serumresistenz von Meningokokken fördern, sind beispielsweise die Kapsel, 
LPS-Sialylierung und Expression des fH-bindenden Proteins. Das Ziel dieser Arbeit war 
die Identifikation neuartiger Serumresistenzfaktoren, wobei ich zwei Ansätzen verfolgte:  
i) Die Analyse des Einflusses von globalen Regulatoren der Genexpression auf die 
Serumresistenz; und ii) eine vergleichenden Analyse von eng verwandten Stämmen, die 
sich hinsichtlich ihrer Serumresistanz unterschieden. 
i) Von sechs untersuchten globalen Regulatoren der Genexpression, war die 
Komplementdeposition auf Meningokokken nur nach Mutation des Regulators der 
Zinkaufnahme, Zur, reduziert. Über Zur selbst und die regulatorischen Prozesse in 
Reaktion auf Zink war in Meningokokken wenig bekannt. Ich habe daher das bisher nicht 
bestimmte Zur-Regulon von Meningokokken aufgeklärt, wofür ich mittels Mikroarrays die 
transkriptionelle Antwort des N. meningitidis-Stammes MC58 unter Zink-Überfluss und 
Zink-Mangel zu vergleichen. Das Zur-Regulon von Meningokokken umfasst 17 Gene, von 
denen unter Zinküberfluss 15 reprimiert und zwei aktiviert wurden. Unter den Zur-
reprimierten Genen fanden sich Gene, die in die Aufnahme von Zink, die Modikation von 
tRNAs und den Zusammenbau des Ribosoms involviert sind. Ein 23 bp langes Binde-
Konsensusmotiv für Meningokokken-Zur (Zur-Box) mit einem konservierten zentralen 
Palindrom wurde ermittelt (TGTTATDNHATAACA) und in der Promotorregion aller 
regulierten Transkriptionseinheiten (Gene/Operons) detektiert. In vitro-Bindung des 
N. meningitidis Zur an die Zur-Box dreier ausgewählter Genen konnte mittels EMSAs 
erstmals gezeigt werden. Die Bindung von Zur an DNA war spezifisch abhängig von Zink, 
und Mutationen in der palindromischen Sequenz hemmten die Zur-Bindung an das DNA-
Motiv. 
ii) Drei eng verwandte Stämme des ST-41/44-Komplexes aus invasiver Erkrankung und 
Trägertum, die sich in ihrer Resistenz gegenüber Serumkomplement-Exposition 
unterschieden, wurden analysiert um neuartige Mediatoren der Serumresistenz zu 
identifizieren. Der Gengehalt der Stämme wurde mittels Mikroarray-Analyse verglichen. 
Dies offenbarte sechs Gene, die in den beiden Trägerstämmen vorhanden, aber in dem 
invasiven Isolat abwesend waren. Vier dieser Gene liegen innerhalb zweier Inseln 
horizontal transferierter DNA, d.h. IHT-B und –C. Weiterhin führte die Arbeitsgruppe eine 
Transkriptom- und Proteom-Analyse der drei Stämme sowie einen umfangsreichen 
Screening-Assay durch. Diese Ansätze führten zur Identifikation dreier Kandidaten-
Proteine für die weitere Analyse. Ich wirkte daran mit, die Rolle dieser Proteine für die 
Serumresistenz von Meningokokken zu ermitteln: Das Adhäsin Opc vermittelt 
ZUSAMMENFASSUNG 
 
2 
Serumresistenz durch Bindung von Vitronektin, einem negativen Regulator des 
Komplementsystems; das hypothetische Protein NMB0865 trägt über einen bisher 
unbekannten Mechanismus geringfügig zur Serumresistanz bei; und NspA, für welches 
vor Kurzem erkannt wurde, dass es den negativen Komplementregulator Faktor H bindet, 
führte zu beträchtlich reduzierter Abtötung durch Komplement. 
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2 SUMMARY 
 
Neisseria meningitidis is a facultative human pathogen that occasionally shows strong 
resistance against serum complement exposure. Previously described factors that 
mediate meningococcal serum resistance are for example the capsule, LPS sialylation, 
and expression of the factor H binding protein. I aimed for identification of novel serum 
resistance factors, thereby following two approaches, i) the analysis of the impact of 
global regulators of gene expression on serum resistance; and ii) a comparative analysis 
of closely related strains differing in serum resistance. 
(i) Of six meningococcal global regulators of gene expression studied, only mutation of 
the zinc uptake regulator Zur reduced complement deposition on meningococci. Little 
was known about meningococcal Zur and regulatory processes in response to zinc. I 
therefore elucidated the yet unidentified meningococcal Zur regulon comparing the 
transcriptional response of the N. meningitidis strain MC58 under zinc-rich and zinc-
deficient conditions using a common reference design of microarray analysis. The 
meningococcal Zur regulon comprises 17 genes, of which 15 genes were repressed and 
two genes were activated at high zinc condition. Amongst the Zur-repressed genes were 
genes involved in zinc uptake, tRNA modification, and ribosomal assembly. A 23 bp 
meningococcal consensus Zur binding motif (Zur box) with a conserved central 
palindrome was established (TGTTATDNHATAACA) and detected in the promoter region 
of all regulated transcriptional units (genes/operons). In vitro binding of meningococcal 
Zur to the Zur box of three selected genes was shown for the first time using EMSAs. 
Binding of meningococcal Zur to DNA depended specifically on zinc, and mutations in the 
palindromic sequence constrained Zur binding to the DNA motif. 
ii) Three closely related strains of ST-41/44 cc from invasive disease and carriage which 
differed in their resistance to serum complement exposure were analysed to identify 
novel mediators of serum resistance. I compared the strains’ gene content by microarray 
analysis which revealed six genes being present in both carrier isolates, but absent in the 
invasive isolate. Four of them are part of two Islands of horizontally transferred DNA, i.e. 
IHT-B and –C. The working group furthermore applied a comprehensive screening assay, 
a transcriptome and a proteome analysis leading to identification of three target proteins. 
I contributed to establish the role of these three proteins in serum resistance: The 
adhesin Opc mediates serum resistance by binding of vitronectin, a negative regulator of 
the complement system; the hypothetical protein NMB0865 slightly contributes to serum 
resistance by a yet unknown mechanism; and NspA, recently identified to bind the 
negative complement regulator factor H, led to considerable reduced complement-
mediated killing. 
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3 INTRODUCTION 
 
3.1 The pathogen Neisseria meningitidis 
 
The gram negative β-proteobacterium Neisseria meningitidis was first discovered in 1887 
by the Austrian physician Anton Weichselbaum in the cerebrospinal fluid of a meningitis 
patient (Weichselbaum, 1887). The prokaryote is pathogenic only in humans and is the 
major cause of bacteraemia and meningitis worldwide (Tan et al, 2010). 
 
Meningococci are transmitted by direct contact with or inhalation of respiratory droplets. 
Asymptomatic colonisation (carriage) of the human nasopharynx by N. meningitidis may 
only be transient, or last days or even months; ending by natural clearing of the 
organism (Christensen et al, 2010; Stephens, 2007). However, carriage forms a reservoir 
for transmission (Claus et al, 2005). It furthermore can lead to invasive disease, for 
which an interplay of bacterial virulence factors (e.g. LPS), host susceptibility (e.g. due to 
absence of protective antibodies) and environmental factors (crowded living conditions, 
smoking, social gathering and intimate kissing) is thought to be responsible (Pace & 
Pollard, 2012; Stephens et al, 2007). Upon infection, meningococci penetrate the 
nasopharyngeal mucosal epithelium and invade the blood stream. Their massive 
proliferation and dissemination can cause septicaemia. When the diplococci eventually 
pass the blood-brain barrier, meningitis develops (Rouphael & Stephens, 2012). 
 
 
 
3.2 Meningococcal population structure & epidemiology 
 
The meningococcal population displays high variability due to extensive genomic 
recombination. Despite that, lineages have evolved which persist on a world-wide scale 
over decades (Budroni et al, 2011). For tracing transmission and detection of disease 
clusters, genetic typing of isolates is important (Elias et al, 2010). This is achieved by 
determination of the capsular serogroups, and antigen sequence typing of the major 
outer membrane porin PorA and the iron-regulated outer-membrane protein ferric 
enterochelin A (FetA). Furthermore, multilocus sequence typing (MLST), based on seven 
housekeeping genes, helps to assign the lineage by defining the sequence type (ST) and 
the clonal complex (cc). These classification systems ease epidemiological analysis and 
the surveillance of meningococcal disease (Jolley et al, 2007) and will in future be 
conducted by next generation sequencing approaches (Vogel et al, 2012a). 
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Carriage of N. meningitidis varies depending on setting and age. High rates of carriage 
for example have been reported in close contact persons of IMD patients (Kristiansen et 
al, 1998), military personnel (Pether et al, 1988) or Hajj pilgrims (Hahne et al, 2002). 
Prevalence of carriage is low in infants with 4.5%, increases during childhood and 
adolescence reaching a peak with 23.7% in 19-year olds, and decreases again during 
adulthood, e.g. 13.1% and 7.8% in 30- and 50-year olds, respectively (Christensen et al, 
2010).  
In contrast, invasive meningococcal disease (IMD) is most prevalent in infants and 
adolescents (Goldschneider et al, 1969a; Goldschneider et al, 1969b). IMD is of 
particular interest for public health due to the fast progress of infection, that may lead to 
death within 12 to 24 hours, and a high mortality of 10-15%, despite of the 
administration of suitable antibiotics (Brandtzaeg & van Deuren, 2012; Pace & Pollard, 
2012). Furthermore, up to 20% of patients that survive the infection suffer from long-
term sequelae as amputations, hearing loss, impaired motor skills and neuronal 
dysfunction (Bilukha & Rosenstein, 2005; Pace & Pollard, 2012). 
IMD is sporadic in industrialised countries IMD with an average incidence in Europe of 
approximately 1/100,000 (Tan et al, 2010). In contrast, it is of special concern in non-
industrialised regions like Africa. Especially serogroup A meningococci (MenA) periodically 
cause epidemics in the so called “African meningitis belt”, a term first employed by 
Lapeyssonnie for the sub-Saharan region spanning from Ethiopia to Senegal, where large 
epidemics occur annually during the dry season, and devastating outbreaks caused 
thousands of deaths (Lapeyssonnie, 1963; Stephens et al, 2007). Additionally, MenW-
135 and recently MenX caused local outbreaks in the meningitis belt, e.g. in Burkina Faso 
(Bertherat et al, 2002; Delrieu et al, 2011). MenW-135 also was associated with 
outbreaks among pilgrims during the Hajj (Decosas & Koama, 2002). MenY emerged as 
an IMD-causing group relatively recently in Northern America, for example in the USA 
(McEllistrem et al, 2004). 
However, most cases of IMD in North and South America, Europe, Australia and Asia are 
caused by MenB and MenC (Bettinger et al, 2012; Gorla et al, 2012; Racloz & Luiz, 2010; 
Russell et al, 2008; Tribe et al, 2002; Xu et al, 2012). MenB thereby is associated with 
larger outbreaks and substantial morbidity and mortality, causing up to 80% of IMD in 
Europe (Rouphael & Stephens, 2012). In Germany, incidences of IMD in persons below 
25 years were 0.32 and 0.10 per 100,000 due to MenB and MenC, respectively 
(Hellenbrand et al, 2013). More than half of MenB cases are caused by the clonal 
complexes ST-41/44 and ST-32. The large hypervirulent complex ST-41/44 cc is the 
most diverse one with more than 1000 STs, among these the geographically widespread 
and most common ST-41 and ST-42 (Racloz & Luiz, 2010). ST-41/44 cc caused 
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epidemics in The Netherlands and New Zealand (Dyet & Martin, 2006; Scholten et al, 
1994) and was most prevalent in cases of IMD in Belgium, Italy and Ireland (Harrison et 
al, 2009; Racloz & Luiz, 2010). In Germany, ST-41/44 cc was responsible for a 
community outbreak in the Greater Aachen region (Elias et al, 2010). 
 
 
 
3.3 Vaccine development against meningococcal 
disease 
 
Extensive research regarding the immunogenicity of the meningococcal capsule led to 
development of quadrivalent meningococcal vaccines composed of MenA, C, W-135, and 
Y capsular polysaccharides already in the 1970s (Artenstein et al, 1970; Gold et al, 1975; 
Goldschneider et al, 1969a; Goldschneider et al, 1969b). However, polysaccharides only 
elicit a weak T cell-independent immune response with no immune memory in infants 
(Gold et al, 1975; Stein, 1992). Therefore, monovalent MenC meningococcal glyco-
conjugate vaccines, in which the capsule polysaccharide was conjugated to a carrier 
protein, were introduced in the late 1990s that led to a robust T-cell dependent response 
and induction of immune memory (MacDonald et al, 1998). These vaccines reduced 
MenC infection rates and also asymptomatic carriage rates, thereby contributing to herd 
immunity (Maiden et al, 2008). This success also prompted development of quadrivalent 
meningococcal glycoconjugate vaccines against MenA, C, W-135 and Y, in which the 
MenACWY capsule polysaccharides are conjugated to diphtheria or tetanus toxoid (Dull & 
McIntosh, 2012). 
In the sub-Saharan meningitis belt, 85% of IMD are caused by MenA (Burki, 2011). 
Therefore, in 2001 the Meningitis Vaccine Project was set up by the World Health 
Organisation (WHO) and the Program for Appropriate Technology for Health (PATH) to 
develop a low-priced vaccine against MenA (LaForce & Okwo-Bele, 2011). MenAfriVac, a 
monovalent MenA-tetanus toxoid conjugated vaccine, was introduced in three 
hyperendemic countries in December 2010, and vaccination is ongoing in the other 23 
countries within the meningitis belt (Burki, 2011; Djingarey et al, 2012). 
Development of protective vaccines against MenB was lagged, because the MenB capsule 
polysaccharide constitutes a molecular mimicry of human fetal NCAM (3.5.1) which 
results in poor immunogenicity and might cause autoimmune reactions (Finne et al, 
1987). As a first suitable approach, vaccines comprising outer membrane vesicles 
(OMVs) of a particular IMD-causing strain were effective against MenB outbreaks, e.g. in 
Norway, Cuba and New Zealand (Bjune et al, 1991; Oster et al, 2005; Sierra et al, 
1991). However, they could only induce a strain-specific immune response and short-
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term protection. Using the novel approach of reverse vaccinology (Rappuoli, 2000), 
various surface-exposed proteins and secreted antigens were predicted as putative novel 
MenB vaccine targets [3.6.2.1] (Pizza et al, 2000). Based on this, the company Novartis 
designed the multi-component MenB vaccine Bexsero® (4CMenB) which contains the 
protein components Neisserial adhesin A (NadA), factor H binding protein (fHBP) and 
Neisserial heparin-binding antigen [NhbA, NMB2132; Welsch et al (2003)] that are fused 
to carrier proteins; and additionally OMVs (PorA P1.4) used in the New Zealand vaccine 
(Dull & McIntosh, 2012). All four main components are involved in immune evasion - 
whereas NhbA binds heparin leading to enhanced bacterial serum resistance (Gasparini 
et al, 2012), the actions of NadA, fhBP and PorA are discussed in more detail in chapter 
3.5. This January, Bexsero® received EU approval by the European medicines agency 
(EMA) for use in persons from two months age and older (Novartis, 2013). The vaccine is 
predicted to cover 78% of MenB strains based on collections from five European 
countries (Vogel et al, 2013).  
 
 
 
3.4 Meningococci and the human complement system 
 
Meningococci evolved several mechanisms to avoid killing by human complement 
(Schneider et al, 2007), and serum resistance contributes invasive disease (Vogel & 
Frosch, 1999). 
The complement system consists of more than 30 antimicrobial proteins and is an 
important component of the innate (unspecific) and the adapted (specific) immunity. The 
name derived from its function to ‘complement’ further mechanisms of defence by 
recognition and elimination of invading microorganisms [for review see Zipfel and Skerka 
(2009)]. 
 
3.4.1 The complement cascade 
 
Activation of complement leads to a cascade of enzymatic reactions that can occur via 
three different pathways: The i) classical pathway (CP); ii) alternative pathway (AP); and 
ii) lectin pathway (LP) (Sarma & Ward, 2011). These pathways and their components are 
depicted in Figure 1. The activation cascade is summarised below according to various 
review articles (DiScipio, 1997; Sarma & Ward, 2011; Schneider et al, 2007; Zipfel & 
Skerka, 2009). 
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The CP is initiated by binding of the complement protein C1q to the bacterial surface, i.e. 
directly on lipid A or lipoteichoic acids (LTA) or indirectly on surface-bound antibodies 
(IgG, IgM). Binding of C1q activates C1r and C1s which leads to formation of the C1 
complex. The products of C1s-mediated cleavage of C4 and C2 then form the C3 
convertase of the CP (C4b2a). Likewise, the LP is initiated by binding of mannose-binding 
lectin (MBL) or ficolin to carbohydrates on the pathogen’s surface. This induces 
autoactivation of MBL-associated proteins (Masp1/2) that then cleave C4 and C2 which 
leads to formation of the C3 convertase C4b2a. The C3 convertase cleaves C3 into C3a, a 
potent anaphylatoxin, and C3b. C3b can directly bind to bacterial surfaces leading to an 
amplification loop of complement activation via the AP. Upon binding, factor B is 
recruited and cleaved by factor D which results in the formation of a C3bBb complex, the 
C3 convertase of the AP. Furthermore, C3b interacts with the C3 convertases of CP/LP 
and AP to form the C5 convertases, C4b2a3b and C3bBbC3b, respectively. The C5 
convertases cleave C5 into C5a, another anaphylatoxin, and C5b. C5b is the start point 
for the terminal pathway, initiating the assembly of the membrane attack complex 
(MAC). It first associates with C6 and C7 leading to the C5b-7 complex. If close to a 
phospholipid bilayer, this complex embeds to the outer leaflet. Upon binding of C8, the 
formed C5b-8 complex pierces the membrane, creating an initial pore. The C5b-8 
complex initiates and accelerates polymerisation of C9n. Eventually, the C5b-9 complex 
(MAC) forms a pore in the bacterial membrane which leads to cell lysis. Mature MAC can 
be detected by monoclonal antibodies specific to a neoepitope which is only exposed in 
this terminal complement complex (Mollnes & Harboe, 1987). 
 
Besides MAC-mediated cell lysis, the complement system has two more important 
functions: Firstly, by binding to bacterial surfaces, C3b and its inactivated form iC3b also 
act as opsonins leading to phagocytosis of the respective bacterial cell. Secondly, 
anaphylatoxins derived from factors C3, C4 and C5 (i.e. C3a, C4a and C5a) are chemo-
attractants for phagocytic cells (neutrophils, monocytes) to sites of injury or 
inflammation, induce release of histamines by mast cells and reactive oxygen species by 
neutrophils (oxidative burst), and cause vasodilation leading to increased blood flow. 
High levels of anaphylatoxins therefore contribute to an overshooting immune reaction 
upon meningococcal septic shock that might lead to multiorgan failure and death 
(Brandtzaeg & van Deuren, 2012). 
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Figure 1. Schematic overview of the three pathways of the complement system and the 
points of action of important negative regulators. Binding of complement component C1q and 
MBL on bacterial surface structures (lipid A, IgA/IgM, LTA; Carbohydrates) initiates activation of 
complement via the classical (CP) and the lectin pathway (LP), respectively, leading to formation of 
the C3 convertase C4b2a. Cleavage of C3 into C3a and C3b induces an amplification loop of 
complement activation via the alternative pathway (AP) leading to formation of the C3 convertase 
C3bBb. C3b also interacts with each C3 convertase to form the C5 convertases of CP/LP and AP 
which cleave C5 into C5a and C5b. C5b associates with C6, C7, C8 and polymerised C9n to form of 
the MAC which causes pore formation and cell lysis. The negative regulators of complement, i.e. 
C1-INH, C4BP and fH (together with fI), downregulate complement activation. They inhibit C3 
convertase formation and C3 cleavage, thereby interfering with the amplification loop and 
formation of the C5 convertases. The size of the components does not correspond to their actual 
size. 
 
 
3.4.2 Negative regulators of complement 
 
To prevent destruction of the body’s own cells as well as overshooting reactions, 
complement activation is limited by various regulatory proteins that are either 
membrane-bound or soluble. Host membrane-bound regulators such as the membrane-
cofactor protein (MCP or CD46) and the decay-accelerated factor (DAF or CD55) more 
generally regulate the three complement activation pathways, leading to inactivation of 
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C3 and accelerated decay of the C3 convertase, respectively. Soluble regulatory proteins 
such as C1 inhibitor (C1-INH), factor H (fH), factor I (fI) and C4 binding protein (C4BP) 
act more specifically on one component or pathway (Zipfel & Skerka, 2009). C1-INH 
inactivates C1r, C1s and a MBL-associated protein, thereby hampering cleavage of C2 
and C4 and thus formation of the C3 convertase of the CP/LP (Davis et al, 2008). fH and 
C4BP have similar functions in the AP and CP/LP, respectively: fH inhibits the 
amplification loop of the AP at several steps. It binds C3b, thereby preventing the 
formation of the C3 convertase C3bBb; and furthermore causes dissociation of that 
complex. It also hinders spontaneous C3 activation in fluid phase or on cell surface by 
acting as cofactor for fI in the inactivation of C3b to iC3b (Ferreira et al, 2010). iC3b is 
then further proteolysed by fI into C3c and C3dg, which is finally cleaved by trypsin into 
C3d and C3g (Nilsson & Nilsson Ekdahl, 1997). Likewise, C4BP binds C4b, thereby 
preventing formation of the C3 convertase C4b2b of CP and LP, and also accelerates 
decay of this complex (Jarva et al, 2005). Additionally, C4BP co-acts with fI in cleavage 
of C4b into C4c and C4d (Blom, 2002; Sarma & Ward, 2011). The steps of the terminal 
pathway leading to MAC assembly are negatively regulated by the soluble proteins 
vitronectin and clusterin (Zipfel & Skerka, 2009). They block MAC assembly by binding to 
the C5b-7 complex, and furthermore inhibit C9 polymerisation and pore formation (Milis 
et al, 1993; Tschopp et al, 1993). 
 
 
 
3.5 Meningococcal virulence factors and serum 
resistance 
 
The meningococcal genome encodes an array of virulence factors that contribute to 
survival during infection, enable the bacteria to cope with complement proteins in saliva 
and normal human serum (NHS) (Andoh et al, 1997; Vogel & Frosch, 1999). 
Meningococcal factors most important for complement evasion and serum resistance are 
discussed in the following and a summarising overview is given in Figure 2. 
 
3.5.1 Capsule 
 
The most important virulence factor of meningococci is the polysaccharide capsule. It is 
essential for protection of the bacteria against complement-mediated killing and 
phagocytosis (Vogel et al, 1996). Hence, almost all isolates obtained from patient blood 
are encapsulated (Schneider et al, 2007). Thirteen capsular serogroups have been 
described. However, only six of them, namely A, B, C, W-135, Y and X, account for 
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almost all cases of disease (Tan et al, 2010). The capsule structures of these disease-
associated serogroups have been extensively studied in the 1970s. Whereas capsules of 
serogroups A and X are built up of N-acetyl-mannosamine-phosphate and N-acetyl-
glucosamine-phosphate, respectively, those of serogroups B, C, W-135 and Y are 
composed of derivatives of sialic acids (Bhattacharjee et al, 1975; Bhattacharjee et al, 
1976; Bundle et al, 1973; Bundle et al, 1974; Liu et al, 1971a; Liu et al, 1971b). As 
mammalian cells also harbour sialic acid, these serogroups established a molecular 
mimicry. Especially the capsule of meningococci of serogroup B (MenB) is poorly 
immunogenic (Finne et al, 1987), because it consists of a (α2-8)-N-acetylneuraminic acid 
[NeuNAc] polymer which is also carried by the neural cell adhesion molecule (N-CAM) of 
mammals (Bitter-Suermann & Roth, 1987). Expression of the capsule prevents 
complement-mediated lysis and is essential for serum resistance of MenB (Kahler et al, 
1998). Moreover, capsules of MenB and C were indirectly shown to limit C3 deposition 
(Jarvis & Vedros, 1987; Uria et al, 2008). Furthermore, sialic acid-containing cell surfaces 
have an increased affinity of fH, the negative regulator of the AP, to C3b (Pilatte et al, 
1993). Both mechanisms protect the bacteria from complement attack. 
 
3.5.2 Lipopolysaccharide 
 
In an analysis of a mutant collection, all mutants with reduced serum resistance showed 
mutations in genes responsible for capsule or LPS synthesis which confirms the capsule 
and the lipopolysaccharide (LPS) being the most important meningococcal factors 
mediating serum resistance (Geoffroy et al, 2003). 
 
The Lipopolysaccharide (LPS) is composed of: i) lipid A, which is anchored to the outer 
membrane; ii) an inner core of two heptose and two 2-Keto-3-Deoxy-D-manno-octonate 
(KDO) residues bound to the lipid A; and iii) variable oligosaccharide chains (α, β, γ) 
bound to the heptoses (Plant et al, 2006). Upon infection, lipid A and KDOs act as 
endotoxin up-regulating the immune response (Zughaier et al, 2006). LPS also is a target 
for complement component C4b which binds to phosphoethanolamine (PEA) residues on 
the second heptose of the inner core (Ram et al, 2003). Meningococci show a large 
variety in LPS structure and until now 12 different LPS immunotypes (designated L1 to 
L12) have been described (Mistretta et al, 2010). Types L1-L8 are found in MenB and C 
strains, L9 in MenA, B and C isolates, and L10-L12 only in MenA strains (Mandrell & 
Zollinger, 1977; Zollinger & Mandrell, 1980). However, several of these immunotypes can 
be expressed at the same time, resulting in e.g. the L3,7,9 immunotypes that prevails 
among invasive isolates (Jones et al, 1992; Vogel & Frosch, 1999). The IMD-associated 
LPS immunotypes L2, L3, L5, L7 and L9 contain a Lacto-N-neotetraose (LNT) epitope in 
the α-chain (Tsai & Civin, 1991). This LNT moiety constitutes a molecular mimicry as it is 
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identical to a human blood group antigen (Schneider et al, 2007). Furthermore, LNT can 
be terminally sialylated (Mandrell et al, 1991; Tsai et al, 2002). Sialylation of LPS was 
shown to block phagocytosis, possibly by disguising bacterial surface proteins involved in 
the process (Kurzai et al, 2005; Unkmeir et al, 2002a). Its effect on serum resistance, 
however, remains controversial: On the one hand, Vogel et al. only found a minor 
influence of sialylation on serum resistance and survival in an infant rat model (Vogel et 
al, 1997a; Vogel et al, 1999). On the other hand, LPS sialylation was shown to raise 
resistance to serum when testing strains with naturally occurring sialylation differences 
(Estabrook et al, 1997; Kahler et al, 1998). 
 
3.5.3 Adhesins, OMPs and their role in complement defense 
 
Meningococci express a variety of adhesins that besides their importance for adherence 
also support evasion of the immune response by interaction with immune cells or 
recruiting of regulators of complement (Hill & Virji, 2012; Schneider et al, 2007). 
Pili are filamentous appendages sticking out of the bacterial surface (Soto & Hultgren, 
1999). They enhance the meningococcal attachment to and invasion in nasopharyngeal 
cells and erythrocytes (Takahashi et al, 2012), and furthermore facilitate the selective 
uptake of DNA (Cehovin et al, 2013; Proft & Baker, 2009). Pili can be posttranslational 
modified at their pilin subunits, e.g. by O-linked glycosylation (Chen & Seifert, 2011). 
Some of these modifications are associated with reduced adherence or bacterial 
aggregation which in turn supports dissemination of N. meningitidis within or between 
hosts (Chamot-Rooke et al, 2011; Chen & Seifert, 2011; Marceau et al, 1998). Hubert el 
al recently discovered that enhanced serum resistance was associated with pilin 
conversion leading to increased autoaggregation, which most likely constitutes a physical 
barrier to complement (Hubert et al, 2012). Furthermore, binding of naturally occurring 
anti-Gal serum antibodies to terminal α-galactosyl residues of meningococcal pili was 
shown to interfere with complement-mediated lysis via the AP (Hamadeh et al, 1995). 
However, a direct interaction of type IV pili with complement components until date was 
only shown for gonococci: C4BP, an inhibitor of CP/LP, binds to the pilus-associated 
protein PilC which is assumed to interfere with complement activation (Blom et al, 2001). 
 
Furthermore, integral outer-membrane proteins (OMPs), i.e. porins (PorA and PorB) and 
opacity proteins (Opa and Opc), are involved in meningococcal virulence. PorA interacts 
with the laminin receptor on human brain microvascular endothelial cells which may 
cause a tropism to the central nervous system (Orihuela et al, 2009). It furthermore 
binds C4BP, the negative regulator of the CP/LP, which leads to evasion of complement-
mediated killing and thus enhanced serum resistance (Jarva et al, 2005). PorB interacts 
with immune cells (e.g. B cells) and upregulates the immune response (Massari et al, 
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2003). Moreover, gonococcal PorB has been shown to mediate bacterial invasion and 
dissemination (Bauer et al, 1999; Zeth et al, 2013). The various Opa proteins mainly 
interact with host cell receptors of the CEACAM family, molecules that mediate cell-cell-
adhesion, leading to adhesion to and invasion of endothelial cells and immune cells 
(neutrophils, T and B lymphocytes). On the one hand, they interfere with the immune 
response and confer enhanced resistance to complement-mediated killing (Sadarangani 
et al, 2011). On the other hand, they are a target structure for binding of complement 
proteins C3b and C4b on the bacterial surface that opsonise the cell for killing (Lewis et 
al, 2008). Opa proteins moreover interact with heparan-sulfate proteoglycans (HSPGs) 
on the cell surface (Chen et al, 1995). This was also shown for Opc, mediating invasion 
to epithelial cells (de Vries et al, 1998). Opc furthermore binds to the extracellular matrix 
proteins fibronectin and vitronectin to mediate invasion of endothelial cells (Sa et al, 
2010; Unkmeir et al, 2002b; Virji et al, 1994).  
Vitronectin is also bound by the meningococcal surface fibril (Msf, NhhA), an OMP and 
autotransporter, although binding occurs at different sites of the vitronectin molecule 
(Griffiths et al, 2011). Recruiting of vitronectin by Msf interferes with the terminal 
pathway of complement system, therefore enhancing meningococcal serum resistance 
(Griffiths et al, 2011; Singh et al, 2010). Another autotransporter, the Neisseria 
meningitidis adhesin A (NadA), promotes invasion of epithelial cells and stimulates 
immune cells, i.e. monocytes, macrophages and dendritic cells (Capecchi et al, 2005; 
Franzoso et al, 2008). 
 
3.5.4 Recruitment of negative regulators of the host immune response 
 
Meningococci are able to recruit negative regulators of the complement system (3.4.2) 
onto their surface (Schneider et al, 2007). Examples already mentioned are recruitment 
of C4BP, the key soluble regulator of CP/LP, by PorA, as well as binding of vitronectin, a 
soluble regulator of the terminal complement pathway, by Opc and Msf (3.5.3). 
Furthermore, the key soluble regulator of the AP, fH, is recruited to the meningococcal 
surface. In comparison to gonococci, where fH is bound by porins (Welsch & Ram, 2008), 
meningococci employ two membrane proteins, i.e. factor H binding protein (fHBP) 
(Madico et al, 2006) and Neisserial surface protein A (NspA) (Lewis et al, 2010). 
The meningococcal outer membrane lipoprotein fHBP (NMB1870) was first identified 
through reverse vaccinology (Masignani et al, 2003). It was surface-exposed on all 
strains tested, and verified to act as a ligand for the complement protein fH, thereby 
enhancing meningococcal serum resistance (Fletcher et al, 2004; Madico et al, 2006). 
NspA was identified as a second fH-binding surface protein whose deletion leads to 
enhanced C3 deposition and hence complement-mediated killing (Lewis et al, 2010). 
Expression levels of each protein, fHBP and NspA, differ among meningococcal isolates 
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(Vogel et al, 2013) and correlate with the amount of bound fH (Lewis et al, 2010; 
Masignani et al, 2003). Furthermore, both proteins bind fH at the same site, i.e. the 
domains 6-7 (Lewis et al, 2010; Schneider et al, 2009). However, fHBP and NspA were 
found to cooperatively contribute to fH binding (Lewis et al, 2012). This is also supported 
by a recent study, where fHbp and nspA both were upregulated in MC58 after four-hour 
growth in human blood (Hedman et al, 2012). 
 
 
 
Figure 2. Meningococcal virulence factors contributing to serum resistance and 
complement evasion. Meningococcal structures and the host components they bind (anti-Gal 
antibodies in serum, complement component C4b) and negative regulators of complement they 
recruit (fH, factor h; Vn, vitronectin; C4BP, C4 binding protein). The polysaccharide capsule 
prevents MAC insertion and C3b deposition, and attracts binding of fH. NspA, neisserial surface 
protein A, and fHBP, factor H binding protein, recruit fH. The type IV pilus binds anti-Gal 
antibodies. Opc, Opacity protein C, and Msf, meningococcal surface fibril, recruit vitronectin. LPS, 
lipopolysaccharide binds C4b, and PorA, porin A, recruits C4BP. The illustration of the shown 
components is adapted from (Feavers & Pizza, 2009; Griffiths et al, 2011; Sa et al, 2010; 
Schneider et al, 2007; Serruto et al, 2012; Tan et al, 2010). 
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3.6 Genomic methods for the analysis of meningococcal 
serum resistance factors and vaccine candidates 
 
A variety of genomic methods have been developed and applied to identify 
meningococcal serum resistance factors and screen for putative vaccine candidates. 
Basically, there are two approaches to investigate bacterial pathogenicity factors: Firstly, 
going from an occuring phenotype backwards to the genotype responsible; and secondly, 
analysing the genome to identify putative virulence genes. 
 
3.6.1 From phenotype to genotype 
 
Hereby, mutants derived from natural or artificial mutagenesis are screened for a 
phenotype that increases bacterial survival. Signature tagged mutagenesis (STM) for 
example uses transposons that carry each a unique DNA sequence for gene disruption 
(Hensel et al, 1995). Using STM, Sun et al constructed insertion mutants of 
N. meningitidis and analysed them in an infant rat model to identify genes essential for 
bacteraemic infection. Mutants attenuated in survival showed insertions within the genes 
coding for capsule, LPS, iron acquisition molecules as well as further genes involved e.g. 
in transport and metabolism (Sun et al, 2000). A genome-wide screen of a STM-derived 
mutant library for resistance to complement-mediated lysis again highlighted the 
importance of capsule and LPS for serum resistance of meningococci (Geoffroy et al, 
2003). A colorimetric serum bactericidal assay developed by Perez and co-workers based 
on the visualisation of metabolic end products of surviving bacteria, made high 
throughput screening possible (Rodriguez et al, 2002; Rodriguez et al, 2003). An 
adaptation of this assay was used in our work group to screen for colonies with enhanced 
serum resistance, which led to identification of three classes of mutants with changes in 
opc expression, the LPS and the pilus in which I was partially involved (Hubert et al, 
2012). 
 
3.6.2 From genotype to phenotype 
 
This approach to analyse meningococcal virulence factors became possible through the 
sequencing of genomes of various N. meningitidis strains within the last twelve years 
(Bentley et al, 2007; Parkhill et al, 2000; Tettelin et al, 2000). Comparing meningococcal 
strains of different serogroup and source, Schoen and colleagues defined genes that are 
present in all strains analysed. This so called meningococcal core genome comprised 
1139 genes (~68%) which show a higher GC content in contrast to accessory genes that 
vary between different strains, and mainly encode housekeeping functions as the 
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metabolism (Joseph et al, 2011). Five large regions of atypical nucleotide composition 
were identified and designated islands of horizontally transferred DNA (IHT): IHT-A 
harbours the genes for capsule synthesis, IHT-B contains hypothetical proteins; IHT-C 
comprises homologues of toxins, putative virulence factors and mobile elements; IHT-D 
and IHT-E encode prophage elements and a transposon (Dunning Hotopp et al, 2006; 
Tettelin et al, 2000). 
Genome-based methods that were used to search for pathogenicity factors and vaccine 
candidates include: i) in silico prediction of phase-variable genes or putative vaccine 
targets (reverse vaccinology); ii) functional genomics and iii) proteomics (Pajon et al, 
2009). 
 
3.6.2.1 In silico prediction 
 
Meningococci optimise adaptation to new host environments by variable expression of 
virulence factors due to phase variation, a reversible mutation altering the length of DNA 
repeats which interferes with transcription or translation (Saunders et al, 2000). Moxon 
and colleagues identified 65 putative phase variable genes in the MC58 genome, several 
of whom were associated with known phase-variable structures, i.e. the capsule, LPS, pili 
and surface proteins (Parkhill et al, 2000; Tettelin et al, 2000). However novel phase-
variable genes coded for e.g. LPS glycosyltransferases, restriction-modification systems 
and NadA (Martin et al, 2003; Saunders et al, 2000). 
 
The availability of the MC58 genome sequence furthermore enabled in silico prediction of 
potentially surface-exposed proteins in an approach starting from the genome instead of 
the microorganism which became known as reverse vaccinology (Rappuoli, 2000; Serruto 
et al, 2009). Based on the genome sequence of the MenB strain MC58, ORFs coding for 
putative surface-exposed or exported proteins were predicted bioinformatically. Target 
genes were recombinantly expressed in E. coli, and surface exposure and bactericidal 
activity of these proteins were tested in mice. Accessibility to antibodies and conservation 
of the molecules were analysed using a representative collection of IMD-associated MenB 
isolates (Pizza et al, 2000). Gorringe and colleagues extended this reverse vaccinology 
approach in a pan-genome analysis of the genome sequences of strains Z2491 (MenA), 
MC58 (MenB) and FAM18 (MenC), and identified five additional novel surface antigens 
with vaccine potential (Pajon et al, 2009). 
 
3.6.2.2 Functional genomics 
 
Extensive research to determine virulence factors was achieved by means of whole-
genome microarrays that were used for gene content comparisons of different neisserial 
strains and the analysis of transcriptional responses to different stimuli (Claus et al, 
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2007). Various microarray-based genome studies were conducted to define putative 
virulence genes that are specific for i) pathogenic Neisseria (N. meningitidis and 
N. gomorrhoeae) in comparison to commensal Neisseria (mainly N. lactamica); ii) 
meningococci compared to other Neisseria spp.; and iii) invasive meningococcal isolates 
versus carrier isolates. These studies concluded: 
i) Pathogen-specific sequences resemble 3% of the Z2491 genome and are scattered in 
small islands within the genome (Perrin et al, 2002). 55 meningococcal pathogen-specific 
genes were identified when comparing MenB strains to various commensal species 
(Stabler et al, 2005), whereas 60 putative core pathogen-specific genes were found in a 
comparison of meningo- and gonococci to N. lactamica (Dunning Hotopp et al, 2006). 
However, only six of 127 putative virulence genes of Neisseria spp. were found in none of 
13 N. lactamica strains analysed (Snyder & Saunders, 2006). 
ii) Only 2% of Z2491 genes are meningococcus-specific (Perrin et al, 2002). Moreover, 
only 18 potential N. meningitidis-specific genes were present in all 48 meningococcal 
strains examined (Dunning Hotopp et al, 2006). 
iii) A whole-genome comparison of strains of hyper- and non-invasive STs identified a 
chromosomally integrated bacteriophage designated meningococcal disease associated 
island (MDA) associated with disease-causing strains (Bille et al, 2005). However, 
Tettelin and co-workers did not find any genetic differences between invasive and 
carriage meningococcal isolates, and detected the MDA in only 60% of the invasive but 
42% of the carriage strains tested (Dunning Hotopp et al, 2006). A whole-genome 
comparison of meningococcal strains confirmed this finding as only eleven genes were 
present in all disease and absent in all carriage isolates analysed. When only comparing 
listed candidate virulence genes, just one gene was elusively present in all disease 
strains, which had paralogues in the carriage strains (Schoen et al, 2008). 
 
These studies highlight the similar genetic pool of different neisserial species and the 
extensive variability even between meningococcal strains. Virulence genes may have 
been transferred horizontally within genetic islands within meningococci, neisseria or 
even different respiratory colonizers (Dunning Hotopp et al, 2006). However, in silico 
predictions and whole-genome comparisons do not provide any information about 
expression levels of antigens during infection, which is of importance in light of extensive 
variation of protein expression levels due to phase variation, mutation, and DNA uptake 
(Frosch & Meyer, 1992; Hammerschmidt et al, 1996). Therefore, comparing gene 
expression levels by transcriptome analysis using DNA microarrays is crucial to identify 
genes essential for virulence and pathogenesis. First studies analysed transcriptional 
changes upon meningococcal interaction with epithelial or endothelial cells as a model of 
invasion (Dietrich et al, 2003; Grifantini et al, 2002a; Grifantini et al, 2002b). Two 
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hundred and seventy nine differentially regulated genes, e.g. encoding membrane 
proteins and transporters, were differentially expressed during meningococcal exposure 
to human serum as a model system for infection (Kurz et al, 2003). Upregulation of 
transcriptional regulators, transport and binding proteins, detoxifying enzymes and 
surface-exposed virulence factors [e.g. fHbp and nspA] was shown upon ex vivo growth 
of N. meningitidis in human blood (Echenique-Rivera et al, 2011). Moreover, due to the 
importance of iron during infection, the transcriptional regulation by the ferric uptake 
regulator Fur was studied in meningococci (Delany et al, 2006; Grifantini et al, 2003), 
which will be discussed in more detail in section 3.7.  
 
3.6.2.3 Proteomics 
 
The first systematically annotated meningococcal proteome map of a MenA strain Z4970 
consisting of 273 proteins was the basis for a meningococcal proteome database 
(Bernardini et al, 2004). A subsequent protein inventory of MC58 comprised 238 proteins 
of which 83 had counterparts in the MenA proteome and 33 were previously unidentified 
(Mignogna et al, 2005). Only 1% of Men A/B proteins were classified having a function in 
pathogenicity, although also 7% and 6% of Z4970 and MC58 proteins, respectively, were 
hypotheticals (Bernardini et al, 2007). The development of outer membrane vesicle 
(OMV)-based vaccines (see 3.3) led to several proteome studies analysing the proteins in 
OMVs (Ferrari et al, 2006; Sanchez et al, 2005; Uli et al, 2006; Vaughan et al, 2006). 
Moreover, the immunoproteome of N. meningitidis was studied, i.e. proteins that are 
recognised by the host immmune response, leading to identification of novel antigens 
that are potential vaccine candidates (Mendum et al, 2009; Williams et al, 2009). 
Furthermore, comparative proteomics analyse differential protein expression at particular 
conditions, e.g. upon growth in a biofilm [as a model of carriage] compared to planktonic 
cells, 2% of meningococcal proteins were differentially expressed (van Alen et al, 2010). 
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3.7 Regulation of gene expression in meningococci 
 
Regulators of gene expression in prokaryotes in principle are alternative sigma factors, 
two-component regulatory systems (TCS), and transcriptional regulators. These 
regulation mechanisms enable bacterial adaptation to changing environmental conditions 
(e.g. nutrients, oxygen level, pH, temperature), and also are often involved in expression 
of virulence genes (Finlay & Falkow, 1997). 
Alternative sigma factors are initiation factors of transcription, mediating specific binding 
of the RNA polymerase to a promoter in response to stress (Gruber & Gross, 2003). In 
the meningococcal genome, three alternative sigma factors have been annotated, i.e. 
RpoH (σ32), RpoN (σ54) and RpoE (σE) (Gunesekere et al, 2006). The RpoE regulon was 
described in detail (Hopman et al, 2010; Huis in 't Veld et al, 2011), RpoN seems to be 
not functional (Laskos et al, 1998), and RpoH has been investigated more closely only in 
gonococci (Gunesekere et al, 2006). Two-component systems (TCS) consist of an histidin 
kinase sensing environmental stimuli and a transcriptional response regulator 
(Stephenson & Hoch, 2002). The magnesium-dependent MisR/MisS (PhoPQ) TCS seems 
to be the only functional in the meningococcal genome, mediating virulence control and 
modulation of the outer membrane structure (Newcombe et al, 2005; Tzeng et al, 2008). 
 
According to current genome annotations, meningococci only express 35 global 
regulators in their genome - compared to 200 in E. coli (Pareja et al, 2006). Of these 
transcriptional regulators, until now only AsnC, CrgA, FNR, Fur (and NrrF), Hfq, NadR 
(FarR), NsrR, OxyR and Zur have been experimentally verified. The contact-regulated 
gene A (crgA) is expressed upon contact with epithelial cells and represses genes 
involved in biosynthesis of pilin, adhesin and capsule triggering adhesion (Deghmane et 
al, 2004; Deghmane et al, 2000). OxyR, the regulator of oxidative stress, tightly controls 
expression of genes for detoxification in response to intracellular hydrogen peroxide 
(Ieva et al, 2008; Sainsbury et al, 2010). The nitric oxide-sensitive repressor NsrR 
regulates an array of genes involved in synthesis and detoxification of nitric oxide 
(Heurlier et al, 2008; Rock et al, 2007). NadR very specifically represses expression of 
the meningococcal adhesin NadA which is one component of the 4CMenB vaccine (3.3) 
(Schielke et al, 2009; Schielke et al, 2011). Recently, the saliva metabolite 4-
hydroxyphenylacetic acid (4HPA) was shown to attenuate NadR DNA-binding activity 
leading to derepression of NadA, yet corepression of MafA adhesins. Therefore, NadR is 
now supposed to more globally regulate the transcriptional response to signals sensed 
within human saliva (Fagnocchi et al, 2012; Montanari et al, 2012). 
 
The ferric uptake regulator Fur acts as a global regulator in response to differing iron 
concentrations in the environment (Andrews et al, 2003). Its role in iron homoeostasis, 
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survival and pathogenesis has been extensively studied in meningococci (Delany et al, 
2006; Delany et al, 2003; Delany et al, 2004; Grifantini et al, 2004; Grifantini et al, 
2003). Binding of its cofactor Fe2+ activates Fur to bind to its specific target DNA 
sequence, designated Fur binding motif or Fur box (Escolar et al, 1999). Fur mainly acts 
as a repressor, but can also activate transcription (Delany et al, 2004; Grifantini et al, 
2003). Repression of gene transcription is achieved by direct binding of Fur to the 
promoter of regulated genes, thereby blocking the entry of the RNA-Polymerase (Escolar 
et al, 1999; Lee & Helmann, 2007). Activation of gene transcription was shown to occur 
either i) directly, by binding to the promoter of the regulated gene as studied for e.g. 
norB and nspA (Delany et al, 2004; Shaik et al, 2007); or ii) indirectly, by repression of 
the small regulatory RNA (sRNA) NrrF, i.e. neisserial regulatory RNA responsive to iron, 
that otherwise binds to the sdhA and sdhC transcripts (Mellin et al, 2007). Genco and co-
workers identified the meningococcal Fur binding motif (Fur box) and the iron-dependent 
Fur regulon by transcriptome comparison of iron-repleted and -depleted conditions in 
MC58, showing that several virulence-associated genes were upregulated under iron 
depletion (Grifantini et al, 2003). In a follow-up study, they analysed the MC58 Fur 
modulon comparing transcriptional changes in response to iron using the wild type as 
well as its fur deletion and fur-complemented mutant. The transcriptional regulators 
AsnC, FNR, Hfq and Zur; the sigma factor RpoH the small regulatory RNA NrrF were of 
stronger interest for this work, because their regulation of versatile targets may also 
influence bacterial serum resistance. An overview of the current knowledge about these 
global meningococcal regulators and their target structures is given in Table 1. 
INTRODUCTION 
 
21 
Table 1. Meningococcal regulators that might influence serum resistance. 
Regulator (ID) Description Source 
Transcriptional activator 
Adaptive response to nutrient poor conditions  
AsnC 
(NMB0573) 
Targets cell surface proteins & components of aerobic 
metabolism 
Ren et al 
(2007) 
   
Neisserial regulatory RNA responsive to iron [Fe], Fur 
regulated 
NrrF 
(between 
NMB2073 & 
NMB2074) 
Targets e.g. succinate dehydrogenase genes (sdhA, 
sdhC)  
Mellin et al 
(2007) 
   
Zinc Uptake Repressor Panina et al 
(2003) 
Zur 
(NMB1266) 
Regulator of a Zn2+ uptake system  
Stork et al 
(2010) 
   
Fumarate and nitrate reduction regulator  
Oxygen-sensitive activator, adaptation to oxygen 
restrictive conditions 
FNR 
(NMB0380) 
Targets e.g. aniA (nitrate reductase), galM (sugar 
transporter), mapA (maltose phosphorylase); fHbp 
Bartolini et 
al (2006) 
   
RNA chaperone, regulates sRNA stability Fantappie et 
al (2009) 
Involved in post-transcriptional gene regulation of 
many stress-responsive genes by sRNAs  
Mellin et al 
(2010) 
Hfq 
(NMB0748) 
Involved in iron-dependent and –independent gene 
regulation of general metabolism, iron 
metabolism and virulence 
Pannekoek 
et al (2009) 
   
RNA polymerase sigma factor  
Major regulator of stress response (e.g. heat shock) 
in γ-proteobacteria 
RpoH 
(NMB0712) 
Targets in N. gonorrhoeae are e.g. chaperones as 
groES, dnaK/J and the transcriptional regulator marR 
Gunesekere 
et al (2006) 
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3.8 Zinc homoeostasis and the Zinc-uptake regulator 
 
Trace metals like zinc are essential cofactors of many enzymes and DNA-binding proteins 
(O'Halloran, 1993). Upon infection of the host, availability of transition metals like zinc is 
decreased for a pathogen, and its deprivation poses a challenge for a pathogen (Kehl-Fie 
& Skaar, 2010). On the contrary, at high concentrations, zinc can lead to production of 
toxic reactive oxygen species (Reyes-Caballero et al, 2011). Therefore, bacteria have to 
tightly regulate metal homeostasis by specialised metal-sensing transcriptional 
regulators. These so called metalloregulatory proteins undergo conformation changes 
upon binding of the specific ions (Chen & He, 2008). This induces either i) metal-
mediated repression by binding to the activated regulator to the promoter of regulated 
genes, or ii) metal-mediated transcriptional derepression by regulator detachment 
(Reyes-Caballero et al, 2011). 
Zinc uptake regulators (Zur) belong to a family of transcriptional regulators that also 
includes Fur, Mur and Nur which are sensors of iron, manganese and nickel, respectively 
(Lee & Helmann, 2007). Zinc-uptake systems and their regulation by Zur were 
investigated for various bacteria such as Escherichia coli (Patzer & Hantke, 1998), 
Bacillus subtilis (Gaballa & Helmann, 1998), Listeria monocytogenes (Dalet et al, 1999) 
and Staphylococcus aureus (Lindsay & Foster, 2001). Furthermore, the Zur regulons of 
B. subtilis (Gaballa et al, 2002), Mycobacterium tuberculosis (11), Yersinia pestis (Li et 
al, 2009) and Corynebacterium glutamicum (Schröder et al, 2010) were characterised in 
the last ten years. Using comparative computational analysis, the promoter binding 
motifs for Zur were identified for γ-Proteobacteria, the Agrobacteria group, the 
Rhodococcus group, and Gram-positive bacteria, as well as for the streptococcal zinc 
repressor AdcR (Panina et al, 2003). 
Over the last years, several genomes of N. meningitidis strains of different serogroups 
have been sequenced (Bentley et al, 2007; Parkhill et al, 2000; Tettelin et al, 2000), 
which was the basis for bioinformatic prediction of a Zur binding motif for β-
Proteobacteria in the RegPrecise database (Novichkov et al, 2010). Recently, Tommassen 
and co-workers identified ZnuD, a meningococcal TonB-dependent outer membrane 
receptor involved in zinc acquisition upon zinc limitation (Stork et al, 2010), which gave 
the only experimental evidence for regulation by meningococcal Zur to date. They also 
discovered that expression of znuC and znuD is enhanced in a zur deletion mutant, and 
predicted Zur binding motifs upstream of both genes based on the E. coli Zur binding 
sequence (Stork et al, 2010). Subsequently, meningococcal znuD was observed being 
also regulated by Fur, and mediating heme capture on cell surface upon expression in 
E. coli (Kumar et al, 2012). However, so far binding of Zur to the promoter of any Zur-
regulated gene (incl. znuD) has not been demonstrated by in vitro experiments. 
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3.9 Objectives 
 
Within an ERA-NET PathoGenoMics project, the aim of this work was the identification of 
MenB factors involved in resistance to serum complement that could be useful as vaccine 
targets. The MenB genome contains over 2000 open reading frames (ORFs), a high 
percentage of which have not been assigned a biological function to date. It was 
therefore considered very likely that there exist further proteins besides the already 
known ones which mediate serum resistance. The development of vaccines against MenB 
is still ongoing and strain coverage of current vaccine formulations is predicted to be only 
78% (Vogel et al, 2013). Hence, newly discovered proteins mediating serum resistance 
could have a valuable potential as vaccine targets and amend already existing vaccine 
formulations. 
During my dissertation, I therefore followed three genomic approaches to unravel novel 
proteins mediating serum resistance of serogroup B meningococci: 
 
(A) Impact of global regulators of gene expression on serum resistance 
 Analysis of the serum resistance of global regulator mutants 
 Analysis of the zinc-responsive regulon of Neisseria meningitidis MC58 
o Validation of growth conditions for differential expression of zinc-dependent genes 
o Microarray transcriptome analysis of the zinc-dependent genes leading to elucidation 
of the Zur regulon 
o In silico prediction of the promoter organisation of Zur-regulated genes and the 
meningococcal Zur binding motif 
o Establishment of electrophoretic mobility shift assays (EMSAs) to confirm binding of 
Zur to the predicted meningococcal Zur binding motif of selected Zur-regulated 
genes 
 
(B) Analysis of genetically closely related strains with differing serum 
resistance 
 Characterisation and analysis of serum resistance of strains from carriage and 
disease 
 Gene content analysis of selected strains to unravel genetic differences leading 
to differed serum resistance of the strains 
 Analysis of the contribution of identified target proteins to serum resistance 
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4 MATERIALS 
 
4.1 Laboratory equipment 
 
 
Table 2. Laboratory equipment used. 
Laboratory Equipment Manufacturer (Type) 
Agarose gel electrophoresis 
chamber Bio-Rad (SubCell GT) 
Analytical balance Sartorius (R 160 P) 
Cell Density Meter Biochrom (WPA CO8000) 
Cell Disrupter Thermo Savant (FastPrep FP120) 
Centrifuges with refrigeration 
system 
Sorvall (RC5B Plus); 
Heraeus (Megafuge 1.0 R) 
Colony counter Synoptics (PhotoCOL SR 92000) 
Electrophoresis power supply Bio-Rad (3000Xi) 
Electroporation system Fischer (EPI 2500) 
ELISA reader 
Thermo Labsystems (Multi Scan 
Ex) 
Flow cytometer BD (FACS Calibur™) 
Gel documentation system Herolab (UVT 28 MP) 
Gel scanner Bio-Rad (GS-800) 
Heating block VLM (1Q) 
Hybridisation oven Biometra (OV5) 
Microarray hybstation Tecan (HS4800 Pro) 
Microarray scanner 
Molecular Devices (Genepix 
4200A) 
Incubator Thermo Scientific (Heraeus) 
Incubator shaker 
New Brunswick Scientific (G25); 
B. Braun Biotech (Certomat 
H/R/U); 
Edmund Bühler Labtech (TH30) 
Magnetic stirrer IKA (RH IKAMAG) 
Microwave Bauknecht (MW 1820 Duo) 
PCR Thermocycler 
MWG-Biotech (Primus 96 plus); 
Biometra (T3000) 
pH meter WTW (pH530) 
Processor (X-ray films) AGFA (Curix 60) 
Real-Time PCR system Applied Biosystems (StepOne Plus) 
RNA electrophoresis system Agilent (2100 Bioanalyzer) 
SDS-PAGE chamber Biometra (Mini Gel Twin) 
Sequencer (DNA) Applied Biosystems (3130) 
Shaker Biotech Fischer (Phero Shaker) 
Table centrifuge Heraeus (Biofuge 15) 
Thermo shaker Eppendorf (Thermomixer 5436) 
Ultrasonic system HTU (Soni 130) 
UV Crosslinker Stratagene (Stratalinker 1800) 
UV-Vis spectrophotometer Peqlab (NanoDrop 1000) 
Vortex mixer Stuart (SA8) 
Water bath (shaker) Julabo (SW20) 
Western Blot module Bio-Rad (Mini Trans Blot Cell) 
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4.2 Chemicals & consumables 
 
Standard chemicals used were purchased from AppliChem, Merck, Roth, Roche, Sigma-
Aldrich in p.a. quality. Standard consumables were supplied from Ambion, Biozym, 
Eppendorf, Greiner bio-one, Hartenstein, Nunc, Schleicher & Schuell and Sarstedt. All 
specific reagents and consumables used are listed in Table 3 and Table 4, respectively. 
 
Table 3. Specific chemicals used and sources of supply. 
Specific chemicals Source 
ABTS tablets and buffer Roche 
Acrylamide Roth 
Ammonium persulfate (APS) Roth 
Anti-Digoxigenin-AP Fab fragments 
(Anti-DIG-AP) 
Roche 
Bacteria Protect reagent Qiagen 
Barbital Serva 
β-mercaptoethanol (β-ME) Roth 
Bovine serum albumine (BSA) AppliChem 
Cytidine-5′-monophospho-N-acetylneuraminic 
acid (CMP-NANA) Sigma 
Coomassie Brilliant Blue G-250 Merck 
CSPD Roche 
Cy3 dCTP/ Cy5-dCTP, 25 nM GE Healthcare 
DIG DNA Labeling Mix (10x) Roche 
Dithioerythritol (DTE) Applichem 
Dithiothreitol (DTT) Sigma-Aldrich 
dNTPs Invitrogen 
Ethanol absolute AppliChem 
Hank's Balanced Salt Solution (HBSS--, 1x) Invitrogen 
Hexanucleotide Mix (10x) Roche 
Nona primer Sigma 
Nuclease-free water Ambion 
PerfectHyb Plus Hybridization Buffer Sigma 
Phenol/Chloroform/Isoamylalcohol (25:24:1) AppliChem 
Phosphate-buffered saline (PBS Dulbecco, 10x) Invitrogen 
Pooled human complement preserved serum 
(Order no.: IPLA_CSER0; LOT: C10562) Dunn Labortechnik 
Polyacrylamid (PAA): Rotiphorese Gel 30 Roth 
Power SYBR Green PCR Master Mix Applied Biosystems 
Poly-D-lysine hydrobromide Sigma 
RNA Protect Bacteria Reagent Qiagen 
RNase Zap Ambion 
Salmon sperm ssDNA Sigma 
Sequencing buffer (5x) Applied Biosystems 
Silver nitrate AppliChem 
Skim milk powder Heirler Cenovis 
Sodium dodecyl sulfate (SDS), ultra pure AppliChem 
Tetramethylethylendiamine (TEMED) Merck 
Triton-X 100% Sigma 
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Table 4. Specific consumables used and sources of supply. 
Specific consumables Source 
96 Well ELISA Microplates Greiner bio-one 
Chromatography paper (3 mm) Whatman 
Electroporation cuvettes (2 mm) Eurogentec 
Epoxy-coated microarray slides Nexterion E Schott 
Nitrocellulose transfer membrane (Protran, 0.45 µM) Whatman 
Nylon membrane (porablot NY plus, 0.45 µM) Macherey-Nagel 
Optical 96-well reaction plate (for qRT-PCR) Applied Biosystems 
RNA Nano Chips Agilent Technologies 
X-ray film (Super RX) Fujifilm 
 
 
4.3 Kits, antibodies, enzymes, protein & DNA ladders 
 
Table 5. Laboratory kits, antibodies, enzymes and protein/DNA ladders 
used and sources of supply. 
Kits Source 
Agilent RNA 6000 Nano Reagents Agilent Technologies 
DIG Gel Shift Kit, 2nd generation Roche 
Genomic-tip 100/G Qiagen 
illustra AutoSeq G-50 dye terminator removal kit GE Healthcare 
Pierce BCA Protein Assay Kit Thermo Scientific 
Pierce ECL Western Blotting Substrate Thermo Scientific 
Plasmid Midi kit Qiagen 
QIAamp DNA Mini Kit Qiagen 
QIAprep Spin Miniprep kit Qiagen 
QIAquick Gel Extraction kit Qiagen 
QIAquick PCR Purification kit Qiagen 
RNeasy Mini kit Qiagen 
  
Antibodies Source 
Monoclonal mouse anti-human C5b-9 Dako 
Polyclonal rabbit anti-human C3d complement Dako 
AlexaFluor 488 goat anti-mouse IgG H+L Invitrogen 
AlexaFluor 488 chicken anti-rabbit IgG H+L Invitrogen 
Mouse anti-Opc (B306) Mark Achtmann, Ireland 
Peroxidase-conjugated AffiniPure Goat Anti-Mouse 
IgG+IgM (H+L) 
Jackson Immuno 
Research 
Peroxidase-conjugated AffiniPure Goat Anti-Rabbit 
IgG, (Fab’)2 fragment specific 
Jackson Immuno 
Research 
Rabbit anti-znuD #1041 
Martine Bos, 
The Netherlands 
Mouse mAb735 Frosch et al. (1985) 
L3,7,9 Wendell Zollinger, USA; 
L8 Scholten et al (1994) 
3F11 Sanjay Ram, USA  
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Enzymes Source 
Klenow Roche 
Lysozyme Biomol 
Phusion High Fidelity DNA Polymerase Finnzymes 
Proteinase K Roth 
Recombinant DNase I (RNase-free) Invitrogen 
Restriction endonucleases New England Biolabs 
RNase A Sigma 
RNase Out Invitrogen 
Superscript II Invitrogen 
T4 DNA ligase New England Biolabs 
Taq DNA polymerase New England Biolabs 
  
Protein/DNA ladders Source 
DIG III ladder / DIG VII ladder Roche 
Page Ruler prestained protein marker, 10-170 kDa Fermentas 
Smart ladder Eurogentec 
Agilent RNA 6000 Nano ladder Agilent Technologies 
 
 
4.4 Plasmids 
 
Table 6. Vectors and plasmids used and in this study. 
Plasmid 
E. coli 
DH5α 
(WUE-ID) 
Description References 
pBluescript II 
SK (pBS) 
315 Cloning vector Stratagene 
pCR-XL-Erm1 19 Vector comprising the gene encoding rRNA 
methyltransferase conferring erythromycin 
resistance (ErmR cassette) 
Claus, H; 
unpublished 
pHp45 2963 Vector carrying the -fragment of plasmid 
R100.1 with the aadA gene conferring 
spectinomycin resistance (SpecR cassette) 
Prentki & 
Krisch (1984) 
pUC4K 58 Vector comprising gene encoding an amino-
glycoside 3’-phosphotransferase conferring 
kanamycin resistance (KanR cassette) 
GE 
Healthcare 
pQE-60 2269 Vector for expression of recombinant 
protein, with a C-terminal HIS tag and 
AmpR 
Qiagen 
pEWoc2a 2738 Knockout construct for opc of N.m. B1940 
in pUC18 with central insertion of KanR 
cassette from pUC4K 
Unkmeir et 
al. (2002b) 
pGH7 2326 Knockout construct for lst of N.m. B1940 in 
pCR-Script with central insertion of KanR 
cassette from pUC4K 
Vogel et al. 
(1997a) 
pHC47 4343 Overexpression construct for nmb1053 
(opc) of MC58 in pAP1 (ErmR) 
Hubert et al 
(2012) 
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pIK3 4082 Knockout construct for znuD (nmb0964) of 
N.m. H44/76 in pBS, exchange of znuD 
against KanR cassette from pUC4K 
Hubert et al, 
unpublished 
pIK6 4288 Overexpression construct for znuD 
(nmb0964) of H44/76 in pAP2-1 (SpecR) 
Hubert et al, 
unpublished 
pMF32.35::T5 43 Knockout construct for siaD of N.m. B1940 
with a Tn1725 insertion in pMF32.35 siaD 
Vogel et al. 
(1997b) 
pMP1 4170 Knockout construct for fhbp of N.m. MC58 
in pBS, exchange of fhbp against SpecR 
cassette from pHp45 
this work 
pMP2 4658 Knockout construct for asnC of MC58 in 
pBS, exchange of asnC against ErmR 
cassette from pCR-XL-Erm1 
this work 
pMP3 4664 Knockout construct for nrrF of MC58 in 
pBS, exchange of nrrF against ErmR 
cassette from pCR-XL-Erm1 
this work 
pMP4 4670 Knockout construct for zur of MC58 in pBS, 
exchange of zur against ErmR cassette from 
pCR-XL-Erm1 
this work 
pMP5 4811 Knockout construct for zur of MC58 in pBS, 
exchange of zur against KanR cassette from 
pUC4K 
this work 
pMP12 4892 Overexpression construct of zur of MC58 in 
pQE-60 for recombinant protein expression 
this work 
 
 
4.5 Oligonucleotides 
 
Table 7. Oligonucleotides used. 
ID Sequence (5’-3’) 
Target 
region 
(gene) 
Amplicon 
length [bp] 
Cloning (Underlined bases indicate restriction sites.) 
MP1 GCTCTAGACCAGCCACGCGCATAC 
MP6 GCGCGCCAATTGGACGGCATTTTGTTTACAGG 
fhbp up* 
(nmb1869) 525 
MP4 CCCGCTCGAGCAGCGTATCGAACCATGC 
MP7 GCGCGCCAATTGCGCCAAGCAATAACCATTG 
fhbp down* 
(nmb1871) 
567 
MP8 GCGCGCTCTAGATTGGCAATGCTGTCTTCGC 
MP9 GCGCGCGAATTCTGCCCTTCCGATTTTCCC 
asnC up 
(nmb0572) 533 
MP10 
GCGCGCGAATTCAAAAGTTATACCGTCATCCGGG
AC 
MP11 GCGCGCCTCGAGTTTGTTCAGATGCCGCCC 
asnC down 
(nmb0573 
down) 
429 
MP12 GCGCGCTCTAGAATGCCGTCTGAAGGCTTCAG 
MP13 GCGCGCGAATTCCTGTCCGCCGATGTTTGTG 
nrrF up 
(nmb2073) 
478 
MP14 GCGCGCGAATTCACTTGAGGTTCAGTTTGCCG 
MP15 GCGCGCCTCGAGCACGTTGCCAGCAGGAG 
nrrF down 
(nmb2074) 381 
MP16 GCGCGCTCTAGAGATGGCGGAATACATTTTG 
MP17 GCGCGCGAATTCTTCTCTGTTTATGCCGTCTG 
zur up 
(nmb1267) 
470 
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MP18 GCGCGCGAATTCATAAGCCTTTCGAAAGGAGC 
MP19 GCGCGCCTCGAGCGTTTTCACCGATAAGGAAC 
zur down 
(nmb1264/65) 
475 
MP183 
GCGCGCTCATGAAAACAAATTTCAAACAGAAAAT
TA 
MP184 GCGCGCAGATCTCTGCTGACATTTTTTACAAATC 
nmb1266 
(zur) 
469 
Verification of genomic microarrays 
MP46 GACGCAGCAAGGGCAGTC 
MP47 GCCCACACCTTATGCATGG 
nmb0500 646 
MP48 GACATTAGCAGGGCAAGGG 
MP49 TGGAACGCGTGCGTGCTG 
nmb0501 496 
MP52 GCTGGCGGTTTTGGGCAAC 
MP53 CCTACGCGAGACTGACGAC nmb1043 543 
MP64 GCTGCTGACGCTGCATGG 
MP65 CTTCCGCCCTGACCCGTA nmb0495 653 
MP80 TGCCATTGCCGATCTCGCT 
MP81 CACGGGGTACGCTCAGCA nmb1755/1756 629 
qRT-PCR 
MP126 GGTATTCGACAGCAGCAAAGC 
MP127 GTCCAACCCGGAATCACTTG 
nmb1567 72 
MP117 CCGTTCCCCGGTTTTGA 
MP118 CTGCATCGCCTGCTTTTTC 
nmb0964 
(znuD) 80 
MP141 GCAAATCCCTGAAACTCTACCTCTT 
MP142 TGATGTTGACGCAGTCTTCATG 
nmb0317 72 
MP143 CGGCGTTCCGAATACCTTT 
MP144 GCGTAAATCGCGGCATAGAG nmb0525 66 
MP145 GCAACTACCAAATGCAGCTCAA 
MP146 CAGCAGGGACGGCATTAAAT 
nmb0586 
(znuA) 
69 
MP147 GGCTTTGGCACGTCCTCTT 
MP148 GTGTGCCGAGGGCTTGAA 
nmb0587 
(znuB) 72 
MP149 TCGCCCGCGAAAAAATT 
MP150 CTTGGGCGAGGTAGGGTTCT 
nmb0588 
(znuC) 66 
MP151 AGGATGTCCTGAATGTACTCGAAAT 
MP152 CTGTCTCTGTGTCCTCCAACCTAA nmb0817 80 
MP153 CCCTCCTCATCCTCGACACA 
MP154 CAGCACCTGCGGCAGTAA nmb0819 69 
MP155 CCGCCAAAGCCCTAAACA 
MP156 GGTTGTCGGGATTTGAACGT 
nmb0820 72 
MP157 CCGCTGTTTTCGCTGGATA 
MP158 GTGTTGACGTTGCGCTGTTT nmb0942 71 
MP159 TCGGACAAAACTTGGAAATCG 
MP160 TTTGAAGCGTTCGCCTACGT 
nmb1475 68 
MP161 TGCCCAACATCCAAGAAATGT 
MP162 CTGGTTTTAAGGCGGTGTGAA nmb1497 68 
MP163 ACGACGGCGGTCATCTTTAC 
MP164 CGCCGTATGATGCACCATT 
nmb2142 68 
MP165 CTGCCGCCGGAATCG 
MP166 GACCAAAGAGCCGACCACTTC nmb0546 75 
MP171 TGCCATTATCGCGCTTGTC 
MP172 GCCTGCTGCTTCGCAAAT nmb0990 81 
MP179 CGGGCGCGGATAACG 
MP180 AGGCAGACGCTCCGCATA nmb0577 61 
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EMSA 
MP185 TAAAAAATGTAATGTTATATAATAACAAACTTTT 
MP186 TTTCAAAAGTTTGTTATTATATAACATTACATTT 
nmb0964 
(unaltered) 
34 
MP187 CGATACCTATTTTGTTATAACATAACAAAATCTT 
MP188 GTTAAAGATTTTGTTATGTTATAACAAAATAGGT 
nmb1475 
(short) 
34 
MP189 
TCTTCACACGATACCTATTTTGTTATAACATAACA
AAATCTTTAACCCACA 
MP190 
CTCGTGTGGGTTAAAGATTTTGTTATGTTATAACA
AAATAGGTATCGTGTG 
nmb1475 
(long) 51 
MP191 CTTTCCAAGATGTTATAATATAACATATAATCTAT 
MP192 AAATATAGATTATATGTTATATTATAACATCTTGG nmb0546 35 
MP193 TAAAAAATGTAATGTTATATAACGATGAACTTTT 
MP194 TTTCAAAAGTTCATCGTTATATAACATTACATTT 
nmb0964 
(TA/CA) 34 
MP195 TAAAAAATGTAATGTTATATAATAATGAACTTTT 
MP196 TTTCAAAAGTTCATTATTATATAACATTACATTT nmb0964 (CA) 34 
MP197 TAAAAAATGTAATGTTATATAACGACAAACTTTT 
MP198 TTTCAAAAGTTTGTCGTTATATAACATTACATTT nmb0964 (TA) 34 
MP199 TAAAAAATGTAATGTTATATAATAATAAACTTTT 
MP200 TTTCAAAAGTTTATTATTATATAACATTACATTT 
nmb0964 (C) 34 
General primers 
AP1 GGCATTTATCAGATATTTGTTC 
AP2 CGTCAGAGCATGGCTTTATG 
Amplification of 
an insert within 
pAP1 
variable 
GH155 GAACATGATGAGTGATCGTTA 
ermR GAGGTCGACGGTATCGATTC 
Amplification of 
ErmR cassette 
~1000 
Kana1 CACGAGGCAGACCTCAA 
Amplification of 
region down of 
KanR cassette 
variable 
Kana2 GATTTTGAGACACAACGTGG 
Amplification of 
region up of 
KanR cassette 
variable 
GSK2R AGCGTTTGTTGCGCAGGTC 
KH9 TAATCAACACACCCCTCCTC 
nmb0964 
(znuD) ~1000 
KB9 AATACGACTCACTATAGGGC 
329 ACCATGATTACGCCAAGC 
Amplification of 
an insert within 
pBS 
variable 
SpecF ATGCGCTCACGCAACTGGT 
SpecR TTATTTGCCGACTACCTTGGT 
Amplification of 
SpecR cassette  ~1000 
Que-F CGGATAACAATTTCACACAG 
Que-R GTTCTGAGGTCATTACTGG 
Amplification of 
an insert within 
pQE-60 
variable 
*Note: up, upstream; down, downstream 
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4.6 Bacterial strains and mutants 
 
The E. coli strain DH5α was used for general cloning (Hanahan, 1983). E coli M15 [pREP4] was used for overexpression of Zur (5.2.6.2). 
 
Table 8. Meningococcal wild type strains used. 
ID Epidemiology ST cc 
PorA-
VR1 
PorA-
VR1 FetA penA PorB Reference 
α16 Carriage 41 41/44 7-2 4 1-5 1 3-1 
α528 Carriage 41 41/44 7-2 15-39 1-5 1 3-301 
DE9686 Disease 42 41/44 7-2 4 1-5 1 3-1 
German reference laboratory for 
meningococci (NRZM); Bavarian 
carriage study (Claus et al, 2005) 
          
MC58 Disease 74 32 7 16-2 1-5 3 3-24 
Richard Moxon, Oxford; 
McGuiness et al. (1991) 
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Table 9. Meningococcal mutant strains used. 
WUE-
ID1 
Parental strain Genotype Resistances2 
2344 MC58 (WUE2135) Δlst Kan 
4209 α16 ΔsiaD Cm 
4240 DE9686 ΔsiaD Δfhbp Cm, Spec 
4294 α16 ΔsiaD Δlst Δfhbp Cm, Kan, Spec 
4297 α528 ΔsiaD Δlst Δfhbp Cm, Kan, Spec 
4300 DE9686 ΔsiaD Δlst Δfhbp Cm, Kan, Spec 
4353 WUE4294 ΔsiaD Δlst Δfhbp fnr+ Cm, Kan, Spec, Erm 
4320 WUE4294 ΔsiaD Δlst Δfhbp hfq+ Cm, Kan, Spec, Erm 
4547 WUE4294 ΔsiaD Δlst Δfhbp rpoH+ Cm, Kan, Spec, Erm 
4659 WUE4294 ΔsiaD Δlst Δfhbp ΔasnC Cm, Kan, Spec, Erm 
4665 WUE4294 ΔsiaD Δlst Δfhbp ΔnrrF Cm, Kan, Spec, Erm 
4671 WUE4294 ΔsiaD Δlst Δfhbp Δzur Cm, Kan, Spec, Erm 
4684 WUE4209 ΔsiaD znuD+ Cm, Spec 
4686 WUE4209 ΔsiaD ΔznuD Cm, Kan 
4712 WUE4240 ΔsiaD Δfhbp ΔopcA Cm, Spec, Kan 
4747 WUE4240 ΔsiaD Δfhbp Δnmb0865 Cm, Spec, Kan 
4748 WUE4712 ΔsiaD Δfhbp ΔopcA opcA+ Cm, Spec, Kan, Erm 
4792 WUE4240 ΔsiaD Δfhbp ΔnspA Cm, Spec, Kan 
4812 MC58 (WUE2135) Δzur Kan 
1 According to strain collection of the Institute for Hygiene and Microbiology (IHM) Würzburg; 
2 Cm, chloramphenicol; Kan, kanamycin; Spec, spectinomycin; Erm, erythromycin 
 
 
4.7 Culture media 
 
GC medium 
Difco™ GC Medium Base [Becton Dickinson] 36 g 
De-ionised H2O ad 990 ml 
 Autoclave 
PolyVitex [bioMerieux] 10 ml 
 
LB medium 
Difco™ LB agar Lennox [Becton Dickinson] 35 g 
De-ionised H2O ad 1000 ml 
 
Proteose peptone medium (PPM) 
Bacto™ proteose peptone [Becton Dickinson] 15 g 
NaCl [Roth] 5 g 
Starch from potatoes [Fluka] 0.5 g 
KH2PO4 [Roth] 4 g 
K2HPO4 [Roth] 1 g 
De-ionised H2O ad 1000 ml 
  pH 7.8 
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PPM was supplemented with 500 µl of 2 M MgCl2, 500 µl of 8.4% NaHCO3 and - shortly 
before use - 1 ml PolyVitex [bioMerieux] per 100 ml to obtain PPM+, the final medium 
used for cultivation. 
 
SOC medium for electroporation 
Bacto tryptone [Becton Dickinson] 2% 
Bacto™ Yeast extract [Becton 
Dickinson] 
0.5% 
NaCl [Roth] 10 mM 
KCl [Roth] 2.5 mM 
 
SOC medium was prepared freshly by adding 10 mM MgCl2, 10 mM MgSO4 and 20 mM 
Glucose to SOB medium. 
 
For agar plates, 1.5% agar was added to the medium before autoclaving. 
 
Additional solid media used were purchased from Becton Dickinson, i.e. Columbia agar 
plates with 5% sheep blood and GC chocolate agar plates. Furthermore, RPMI medium 
supplied from Invitrogen was used. 
 
 
Medium for cryopreservation of bacteria 
Standard nutrient broth [Merck] 5 g 
Glycerol 20% 
De-ionised H2O ad 200 
ml 
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4.8 Buffers and solutions 
 
If not stated elsewise, all buffers and solutions were prepared with de-ionised water. 
 
4.8.1 For microbiological methods 
 
4.8.1.1 Serum bactericidal assay 
 
VBS/BSA buffer  
Barbital 5 mM 
NaCl 145 mM 
MgCl2 0.5 mM 
CaCl2 0.15 mM 
BSA 0.5 % 
 pH 7.4 
 storage at -20°C 
 
4.8.2 For molecular methods 
 
4.8.2.1 Isolation of chromosomal DNA 
 
Buffer B1    Buffer B2  
Na2EDTA·2 H2O 50 mM   Guanidin-HCl 0.33 M 
Tris 50 mM   Tween 20 20% 
Tween 20 5%   
Triton X-100 5%   
 storage at 4°C 
 pH 8.0   TE  
 storage at 4°C   Tris-HCl, pH 8.0 10 mM 
   EDTA 1 mM 
 
4.8.2.2 Electrophoretic separation of DNA in agarose gels 
 
GEBS    1xTBE  
Glycerol 20%   Tris/HCl 100 mM 
EDTA 50 mM   Boris acid 100 mM 
N-Lauroylsarcosine 0.5%   EDTA 2.5 mM 
Bromophenol blue 0.05%    
 pH 8.0    
 pH 8.3 
 
4.8.2.3 Southern blot 
 
Denaturing buffer    Neutralising buffer 
NaOH 0.5 M   Tris/HCl, pH 7.0 1 M 
NaCl 1.5 M   NaCl 3 M 
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SSPE (20x)    SSC (20x)  
NaCl 3.6 M   NaCl 3 M 
NaH2PO4 0.1 M   Sodium citrate 0.3 M 
Na2HPO4 0.1 M    
EDTA 20 mM    
 pH 
7.0 
      
‘High SDS’ hybridisation buffer   Stringent washing buffer 1 
SDS 7%   SSC 2x 
Formamide 50%   SDS 0.1% 
SSC 5x     
Sodium phosphate 
buffer, pH 7.0 
50 mM   
Stringent washing buffer 2 
N-Lauroylsarcosine 0.1%   SSC 0.1x 
Blocking reagent 2%   SDS 0.1% 
 storage at -20°C     
      
Maleic acid buffer    Washing buffer  
Maleic acid 0.1 M   Maleic acid buffer  
NaCl 0.15 M   Tween 20 0.3% 
 pH 7.5     
      
Blocking solution (10x)   Antibody solution  
Maleic acid buffer    Blocking solution 1x 
Blocking reagent (w/v) 
10
% 
  Anti-DIG-AP 1:10,00
0 
 autoclave & store at -20°C    storage at 4°C 
      
Detection buffer    CSPD working solution 
Tris/HCl 0.1 M   Detection buffer  
NaCl 0.1 M   CSPD 1:250 
 pH 9.6    storage at 4°C 
 
4.8.2.4 Microarrays (cDNA and gDNA) 
 
Blocking solution    Labelling buffer (10x) 
Ethanolamine 50 mM   Tris/HCl, pH 7.2 0.5 M 
Tris/HCl, pH 9.0 0.1 M   MgCl2 0.1 M 
SDS 0.1%   DTE 1 mM 
    BSA 0.2% 
      
    dNTP buffer (10x)  
    dATP/dGTP/dTTP each 1 mM 
    dCTP 0.5 mM 
    Tris/HCl, pH 8.0 0.1 mM 
    EDTA, pH 8.0 10 mM 
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4.8.3 For protein analysis 
 
4.8.3.1 SDS-PAGE 
 
‘Lower Tris’ buffer    ‘Upper Tris’ buffer 
Tris/HCl, pH 8.8 1.5 M   Tris/HCl, pH 6.8 0.5 M 
SDS 2%   SDS 2% 
      
Solution for separation gel 
(12.5%)  
 
Solution for loading gel 
30% PAA 2.5 ml   30% PAA 0.375 ml 
‘Lower Tris’ 1.5 ml   ‘Upper Tris’ 0.625 ml 
dH2O 2 ml   dH2O 1.625 ml 
TEMED 10 µl   TEMED 10 µl 
10% APS 30 µl   10% APS 17.5 µl 
      
Sample Solution (1x)   Electrophoresis buffer 
-ME 5%   Tris 25 mM 
SDS 2%   SDS 0.05% 
Glycerol 12.5%   Glycine 50 mM 
Tris/HCl, pH 6.8 0.5 M     
Bromophenol blue spatula tip     
 
4.8.3.2 Staining of SDS-polyacrylamide gels 
 
Coomassie staining solution   Destaining solution (Coomassie) 
Methanol 50%   Acetic acid 7.5% 
Acetic acid 10%   Methanol 20% 
Coomassie 
Brilliant Blue 
G250 
0.275% 
   
 
      
Fixing solution (Silver staining)  Silver staining solution 
Methanol 50%   Silver nitrate 0.1% 
Acetic acid 10%   Formaldehyde 0.027% 
      
    Developing solution 
    Sodium carbonate 6% 
    Formaldehyde 0.018% 
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4.8.3.3 Western blot 
 
Blot Buffer    PBS-T  
Tris 0.3%   PBS (1x)  
Glycine 1.44%   Tween 20 0.1% 
Methanol 20%     
 
4.8.3.4 LPS analysis 
 
Lysis buffer    Proteinase K/Lysis buffer 
SDS 2%   Proteinase K 2.5 mg 
-ME 4%   Lysis buffer 1 ml 
Glycerol 10%   
Tris/HCl, pH 6.8 1 M   
 storage at -20°C 
Bromophenol blue spatula tip     
 storage at -20°C    
    
AA/BA solution for separation gel  AA/BA solution for loading gel 
Acrylamid 46.5%   Acrylamid 48% 
Bisacrylamid 3%   Bisacrylamid 1.5% 
SERDOLIT 1.5%   SERDOLIT 1.5% 
      
Tricine Sample Solution (2x)   Gel buffer 
Glycerin 24%   Tris/HCl, pH 8.45 3 M 
SDS 8%   SDS 0.3 M 
Tris/HCl, pH 6.8 0.1 M     
-ME 4%     
Coomassie 
Brilliant Blue 
G250 
0.02% 
 
  
 
 storage at -20°C     
    
Solution for tricine separation gel  Solution for tricine loading gel 
AA/BA solution for 
separation gel 2.5 ml 
 
 
AA/BA solution for 
loading gel 0.25 ml 
Gel buffer 2.5 ml   Gel buffer 0.78 ml 
dH2O 1.5 ml   dH2O 2.1 ml 
Glycerol (86%) 1 ml   TEMED 3 µl 
TEMED 7.5 µl   10% APS 30 µl 
10% APS 75 µl     
    
Cathode buffer    Anode buffer  
Tris/HCl 0.1 M   Tris/HCl, pH 8.9 0.2 M 
Tricine 0.1 M     
 pH 8.25     
SDS 0.2 M    
      
Fixer (LPS silver staining)   Oxidiser (LPS silver staining) 
Ethanol 40%   Ethanol 40% 
Acetic acid 5%   Acetic acid 5% 
    Periodic acid 0.7% 
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LPS silver staining solution   Developer (LPS silver staining) 
NaOH 0.47 M   Citric acid 1.3 M 
Silver nitrate 0.27%   Formaldehyde 0.25% 
Ammonia 0.33%     
 
4.8.3.5 Flow cytometry analysis 
 
HBSS++/BSA  
HBSS--  1x 
MgCl2 1 mM 
CaCl2 0.15 mM 
BSA 1 % 
 storage at 4°C 
 
4.8.3.6 Expression and purification of recombinant protein 
 
Lysis buffer    Wash buffer 
NaH2PO4 50 mM   NaH2PO4 50 mM 
NaCl 0.3 M   NaCl 0.3 M 
Imidazole 10 mM   Imidazole 20 mM 
 pH 8.0    pH 8.0 
      
Elution buffer    
NaH2PO4 50 mM     
NaCl 0.3 M     
Imidazole 0.25 M     
 pH 8.0     
 
4.8.3.7 Electrophoretic Mobility Shift Assay (EMSA) 
 
TEN buffer    TB buffer (10x) 
Tris/HCl 10 mM   Tris/HCl 890 mM 
EDTA 1 mM   Boric acid 890 mM 
NaCl 0.1 M   
 pH 8.0   
 pH 8.0 
      
Binding buffer (5x)  
 Native polyacrylamide gel 
(8%) 
Tris/HCl, pH 8.0 0.1 M   TB buffer (10x) 1 ml 
KCl 0.25 M   30% PAA 5.3 ml 
DTT 5 mM   dH2O 13.6 ml 
Glycerol 25%   TEMED 20 µl 
    10% APS 90 µl 
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5 METHODS 
 
5.1 Microbiological Methods 
 
5.1.1 Cultivation 
 
Meningococci were cultivated o/n on GC agar (supplemented with PolyVitex) or GC 
Chocolate agar plates at 37°C/5% CO2 in an incubator. For selection of recombinant 
clones, the solid medium was supplemented with chloramphenicol (7 µg/ml), 
erythromycin (7 µg/ml), kanamycin (100 µg/ml), spectinomycin (125 µg/ml) or 
combinations of these antibiotics. For liquid cultures either proteose peptone medium 
supplemented with PolyVitex (PPM+) or defined RPMI media supplemented with 100 µM 
FeCl3 was used. Meningococcal strains were grown at 37°C while shaking at 200 rpm in 
an incubator shaker.  
 
Escherichia coli were cultivated o/n on LB agar in an incubator at 37°C or in LB media at 
37°C while shaking at 200 rpm in an incubator shaker. For growth of recombinant strains 
the solid or liquid medium was supplemented with ampicillin (100 µg/ml), 
chloramphenicol (30 µg/ml), erythromycin (250 µg/ml), kanamycin (30 µg/ml) or 
spectinomycin (75 µg/ml). 
 
To adjust bacterial suspensions or cultures to a defined cell count, the optical density was 
defined in an UV-Vis spectrophotometer. For this purpose, 1 ml of the bacterial 
suspension was pipetted in a cuvette and the absorption at 600 nm was measured. An 
OD600 1.0 approximately equates to a cell count of 1x10
9 cells/ml. 
 
5.1.2 Generation of electrocompetent E. coli DH5α 
 
An o/n culture of E. coli DH5α was used to inoculate 700 ml of LB medium to an OD600 
0.1. The culture was grown to exponential growth phase (OD600 ~0.6) at 37°C/200 rpm. 
Bacterial growth was stopped by incubation of the culture in ice water for 10 min. Cells 
were pelleted at 4°C and 5000 rpm for 15 min (centrifuge RCB5, rotor GS3). The 
bacterial precipitate was washed twice in 500 ml and 200 ml of 4°C cold dH2O, 
respectively, and once with 20 ml of 4°C cold 10% glycerol. Cells were centrifuged at 
4°C/5000 rpm for 15 min each again. Finally, the bacterial precipitate was resuspended 
in 1.5 ml of cold 10% glycerol. Aliquots of the suspension were frozen immediately in 
liquid nitrogen and stored at -70°C. 
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5.1.3 Transformation of E. coli 
 
An aliquot of the electrocompetent E.coli DH5α was thawed slowly on ice. To the 
bacteria, 1 µl of plasmid DNA obtained from ligation (5.2.5) was added. The sample was 
incubated on ice for 5 min until it was pipetted into a pre-cooled electroporation cuvette. 
The cuvette then was put into the electroporation system which was set at 2.5 kV, 25 µF 
and 400 Ω. The short electric pulse destabilises the bacterial membrane of specially 
prepared E. coli which enables small DNA fragments to pass. After electroporation, 
bacteria were immediately transferred into 37°C warm SOC medium and incubated at 
37°C/200 rpm for an hour. Following, bacteria were plated on LB agar supplemented with 
the suitable antibiotic(s) for selection of correct transformants and incubated o/n at 
37°C. 
 
5.1.4 Transformation of N. meningitidis 
 
Meningococci are naturally competent. The strain to be transformed was grown o/n on 
GC agar plate at 37°C/5% CO2. Bacterial suspensions were adjusted to an OD600 between 
0.2 and 0.5 in 5 ml of PPM+. The culture was grown at 37°C/200 rpm for one hour and 
then diluted to OD600 0.1. For transformation, 200 ng to 1 µg of the plasmid DNA was 
added to 1 ml the diluted bacterial culture. The culture was incubated for five to six hours 
at 37°C/200 rpm. Following, 100 µl and 900 µl of the transforming culture were plated 
on GC agar supplemented with the required antibiotic for selection of correct 
transformants. Plates were incubated o/n at 37°C/5% CO2. 
 
5.1.5 Serum killing assay 
 
Serum killing assays (serum bactericidal assays, SBAs) were conducted in modification as 
described previously (Vogel et al, 1997b). Meningococci were grown o/n at 37°C/5% CO2 
on GC agar plates. Under the safety cabinet, bacteria from the third fraction were 
resuspended in VBS/BSA buffer (4.8.1.1) and diluted to 106 cfu/ml. Each serum stress 
reaction was prepared by firstly placing (360-x) µl of VBS/BSA buffer in a 1.5 ml cap on 
ice, followed by adding of 40 µl of the thoroughly vortexed bacterial suspension. Finally x 
µl of freshly thawed pooled human complement serum (normal human serum, NHS), e.g. 
40 µl=10% NHS, were added to the sample. As negative control, a sample without any 
NHS or with addition of an equal amount of heat-inactivated serum (HIS) was used. HIS 
was obtained by incubation of NHS at 50°C for at least 30 min. The samples were 
incubated at 37°C/700 rpm on a thermo shaker, usually for 30 min. Afterwards the 
serum reactions were stopped by adding 400 µl cold 1xPBS. The amount of bacteria that 
survived the serum exposure was determined by plating of serial dilutions of each sample 
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on Columbia agar with 5% sheep blood. Plates were incubated o/n at 37°C/5% CO2. 
Colony forming units (cfu) were counted using a colony counter. 
 
 
5.2 Molecular methods 
 
5.2.1 Isolation of plasmid DNA and chromosomal DNA 
 
For preparation of plasmid DNA either the QIAprep Spin Miniprep kit or the Qiagen 
Plasmid Midi kit was used after the manufacturer’s protocol. 
 
Isolation of chromosomal DNA was achieved at small scale by using the QIAamp DNA 
Mini Kit after the manufacturer’s instructions.  
If higher amounts of DNA were needed, Genomic-tips 100/G were used. Meningococci 
were cultivated o/n at 37°C/5% CO2 on GC agar plates. Under the safety cabinet, a cell 
count of 1.5x1010 cfu was adjusted in 5 ml 1xPBS. The suspension was centrifuged at 
4000 rpm for 10 min. The bacterial precipitate was resuspended in 7 ml buffer B1 
(4.8.2.1) and 14 µl RNase (100 mg/ml) were added. After vortexing, 160 µl of lysozyme 
(100 mg/ml) were added. The solution was incubated for 30 min at 37°C in an incubator 
and then frozen at -70°C for one hour. After thawing in a 50°C water bath, 200 µl 
proteinase K (20 mg/ml) and 2.4 ml buffer B2 were added to the solution, which was 
vortexed and incubated in the 50°C water bath for one hour. Proceeding now on the work 
bench, 15 ml of buffer QBT of the Genomic-tips 100/G kit were added. Further steps of 
the isolation were done according to the manufacturer’s protocol. The resulting DNA 
precipitate was dried and 100 µl TE were added to slowly resuspend DNA o/n at 4°C. 
Concentration and purity of the DNA were measured using the NanoDrop, DNA was 
stored at -20°C. 
 
5.2.2 Polymerase Chain Reaction (PCR) 
 
Polymerase Chain Reactions (PCR) were used to specifically amplify DNA fragments and 
to screen for correct clones after a transformation (5.1.3, 5.1.4). Thereby, for cloning 
purposes Phusion polymerase was used for PCR because of its proof-reading activity. 
Other than that, the Taq polymerase was used. PCR samples were prepared according to 
the manufacturer’s protocol as follows: 
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Taq 
polymerase 
(NEB) 
 
Phusion 
Polymerase 
(Finnzymes) 
5 µl 
10x NEB buffer/ 
Phusion HF buffer 10 µl 
5 µl dNTPs [2 mM] 5 µl 
0.5 µl Fw primer [20 µM] 1.25 µl 
0.5 µl Rev primer [20 µM] 1.25 µl 
0.1 µl Taq / Phusion 0.5 µl 
ad 50 µl dH2O  ad 50 µl 
 
As a template, either 20 ng of chromosomal DNA, 10 ng of plasmid DNA or a part of a 
bacterial colony were used.The PCR programmes were adjusted to the following 
conditions: 
 
Taq polymerase 
(NEB) 
 
Phusion 
Polymerase 
(Finnzymes) 
 
95°C, 1 min 
Initial 
Denaturation 98°C, 30 sec 
 
95°C, 1 min Denaturation 98°C, 10 sec  
TaNEB, 1 min Annealing 
(Ta Finnzymes), 20 
sec 
      35 x 
72°C, 1 min/kb Extension 72°C, 30 sec/kb  
72°C, 10 min Final Extention 72°C, 10 min  
16°C Cooling 16°C  
 
The annealing temperatures (Ta) of the NEB Taq polymerase were obtained by 
calculating the melting temperatures (Tm) of each primer with the formula 
[4×(G+C)+2×(A+T)], and subtracting 4°C of the lower Tm calculated. For Phusion 
polymerase, the Tm was determined using the Finnzymes online calculator 
(http://www.finnzymes.fi/tm_determination.html). If primers were not longer than 20 
nucleotides, the Ta equated the lower Tm given; for primers with more than 20 
nucleotides, 3°C were added to the lower Tm given by the calculator. 
 
5.2.3 Visualisation and Purification of PCR products 
 
PCR products were electrophoretically separated in an agarose gel using TBE buffer 
(4.8.2.2). Depending on the size of the DNA fragment and the subsequent application, 
concentrations of agarose gels varied between 0.8% and 3.5%. 
GEBS buffer was added to the PCR probes at the rate of 1:5, and the samples were 
pipetted into the slots of the gel. The Smart ladder was used as molecular weight 
marker. DNA probes were separated at 170 to 200 V. After gel electrophoresis, the gel 
was incubated in 0.001% ethidium bromide solution for 10 to 20 min. DNA bands are 
visualised by UV light due to intercalation of ethidium bromide into the DNA. 
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For sequencing or cloning procedure, DNA probes were then purified directly from the 
remaining PCR samples using the QIAquick PCR Purification kit. DNA was eluted in 30 µl 
of buffer EB (of the kit), mixed with dH2O at the rate of 1:4. 
 
5.2.4 Sequencing of PCR products and plasmids 
 
Sequencing was performed with the ABI Prism 3130 DNA sequencer by the DNA 
laboratory of our institute. Sequencing reactions were prepared to a final volume of 9 µl 
with dH2O, with 1 µl of the respective primer [10 µM] and 2 µl of 5x sequencing buffer. 
As template DNA, either purified PCR products (100 ng) or plasmid DNA (400 ng) was 
used. 
 
5.2.5 Cloning procedure: Digest of DNA fragments, Ligation and 
Purification for electroporation 
 
For cloning, purified PCR products were enzymatically digested using different restriction 
endonucleases. In a final volume of 20 µl, 1 µl of each enzyme [20 U/µl], 2 µl of the 
suitable buffer (NEB buffers 1-4), and if necessary 2 µl of 10xBSA, were filled up with the 
purified PCR product or plasmid (vector) DNA [1-2 µg] and dH2O. The mixture was 
incubated at 37°C for one to two hours. Next, digested DNA fragments were purified 
using the QIAquick PCR Purification kit. Opened vector DNA was then applied to a 0.8% 
agarose gel (5.2.3), sliced out of the gel and extracted using the QIAquick Gel Extraction 
kit according to the manufacturer’s instructions. If two enzymes had to be used, but 
buffers were not combinable, each digest was done separately with a purification step in 
between.  
 
Ligation of purified digested DNA fragments and the opened vector was achieved using 
the T4 DNA ligase. For that purpose, the correct proportion of inserts to the vector was 
calculated with the following formula: 
 
Amount of vector 
[ng] 
Amount of insert 
[ng] 
Size of vector [kb] 
x 3 = 
Size of insert [kb] 
 
For each ligation sample, 100 ng of the purified vector DNA was mixed on ice with the 
respective amount of each insert. Then, 1 µl of the ligase buffer [10x] and 1 µl of T4 DNA 
ligase [400 U/µl] was added. If necessary, dH2O was added to adjust a final volume of 
10 µl. Samples were incubated o/n at 16°C. 
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5.2.6 Construction of mutant strains 
 
5.2.6.1 Construction of deletion mutants 
 
Deletion mutants were constructed for fhbp, asnC, nrrF and zur (Table 10). For this 
purpose, a fragment upstream and a fragment downstream of the gene to be deleted 
were amplified by PCR from N. m. MC58 with primers introducing restriction sites. 
Fragments were enzymatically digested and purified. A suitable resistance cassette was 
chosen and excised from its vector. We either used: A) a polar spectinomycin resistance 
cassette (SpecR) with a terminator excised from vector pHp45Ω using EcoRI; B) a polar 
erythromycin resistance cassette (ErmR) with a terminator gained by EcoRI digest of 
vector pCR-XL-Erm1; or C) a kanamycin resistance cassette (KanR) excised from vector 
pUC4K with EcoRI. The cloning vector pBluescript II SK (pBS) was opened with 
XbaI/XhoI (suitable for the outer restriction sites of the upstream and downstream 
fragment). All three fragments - upstream fragment, downstream fragment and the 
resistance cassette - were ligated with the opened vector (5.2.5). The ligation sample 
was purified and transformed into E. coli DH5α. Antibiotic-resistant clones were screened 
by PCR with cloning primers, as well as primers binding within the resistance cassette 
(SpecF+SpecR for SpecR; GH155+ermR for ErmR; Kana1+Kana2 for KanaR) and within 
the vector (KB9+329). Correct ligation was confirmed by sequencing. Finally, the 
resulting plasmid was isolated from E. coli DH5α and transformed into mutants of N. m. 
strains MC58, α16, α528 or DE9686. Deletion of the gene was then confirmed by PCR 
and Southern blot using a probe generated with the outer cloning primers (5.2.7). 
 
5.2.6.2 Construction of a mutant overexpressing a recombinant Zur protein 
 
The entire coding region of zur gene without start and stop codon (469 bp) was amplified 
from MC58 using primers MP183 and MP184 harbouring a BspHI and a BglII restriction 
site, respectively. The PCR product was digested with BspHI and BglII (5.2.5). The 
chosen expression vector pQE-60 contained an IPTG-inducable promoter, a C-terminal 
HIS tag, as well as own start and stop codons. pQE-60 was opened at its NcoI and BglII 
sites. Next, the opened vector and the digested zur fragment were ligated (5.2.5). E. coli 
M15 [pREP4] was transformed with the gained recombinant vector pMP12. Clones 
resistent to kanamycin and ampicillin were selected, and correctness of the plasmid was 
verified by DNA sequencing. The resulting Zur-overexpressing E. coli strain was 
designated WUE4892. 
METHODS 
 
45 
5.2.7 Generation of Digoxigenin-tagged DNA probes 
 
The respective gene (e.g. zur) that has been deleted in meningococcal strains and the 
surrounding region was amplified using the Phusion polymerase with the primers also 
used for generation of the deletion constructs. Following PCR purification and elution in 
15 µl EB:H2O (1:4), the DNA was denatured by incubation in a water bath at 95°C for 
10 min and then immediately cooled down on ice. To the denatured DNA, 2 µl of 
Hexanucleotide Mix [10x], 2 µl DIG DNA Labeling Mix [10x] and 1 µl of Klenow enzyme 
were added. The samples were incubated o/n at 37°C in an incubator. Addition of 2 µl 
EDTA [0.2 M, pH 8.0] stopped the reaction, and 2.5 µl sodium acetate [3 M, pH 4.5] and 
75 µl of cold ethanol [96%] were added to precipitate the DNA. Samples were incubated 
at -70°C for 30 min. After centrifugation at 4°C and 13,000 rpm for 15 min in the 
Heraeus Megafuge 1.0 R, precipitates were washed with cold ethanol [70%], centrifuged 
again, dried in vacuum and finally resuspended in 50 µl TE buffer (4.8.2.1). For 
quantification, 1 µl of serial dilutions of the tagged DNA and a tagged control 
oligonucleotide were pipetted onto a nylon membrane. The DNA was cross linked to the 
nylon membrane by UV light. DNA was detected by chemiluminescence (5.2.8.2) and 
concentration was determined based on the comparison with the control DNA of known 
concentration. 
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Table 10. Generation of deletion constructs. 
Gene Gene 
size 
[bp] 
Upstream 
fragment 
primers & 
restriction 
sites 
Upstream 
fragment 
size [bp] 
Downstream 
fragment 
primers & 
restriction 
sites 
Down-
stream 
fragment 
size [bp] 
Resistance 
cassette1 
Resulting 
plasmid 
Southern 
Blot probe 
Reference 
fhbp 
(nmb1870) 
963 MP1 (XbaI)+ 
MP6 (MfeI) 
525 MP7 (MfeI)+ 
MP4 (XhoI) 
567 SpecR pMP1 MP1+MP4 Masignani et 
al. (2003) 
asnC 
(nmb0573) 
564 MP8 (XbaI)+ 
MP9 (EcoRI) 
533 MP10 (EcoRI)+ 
MP11 (XhoI) 
429 ErmR pMP2 MP8+MP11 Ren et al. 
(2007) 
nrrF 
(between 
nmb2073-
74) 
223 MP12 (XbaI)+ 
MP13 (EcoRI) 
478 MP14 (EcoRI)+ 
MP15 (XhoI) 
381 ErmR pMP3 MP12+MP15 Metruccio et 
al. (2009) 
zur 
(nmb1266) 
477 MP16 (XbaI)+ 
MP17 (EcoRI) 
470 MP18 (EcoRI)+ 
MP19 (XhoI) 
475 ErmR 
 
KanR 
pMP4  
 
pMP5 
MP16+MP19 Masignani et 
al. (2003) 
1 Erm, erythromycin; Kan, kanamycin; Spec, spectinomycin 
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5.2.8 Southern blot 
 
5.2.8.1 Digest, electrophoresis, capillary transfer and hybridisation 
 
Chromosomal DNA was isolated of the respective mutant strains and the wild type strain 
and digested with a suitable restriction enzyme (5.2.5). DNA probes as well as the DIG-
tagged ladders III or VII (for subsequent size determination of DNA fragments) were 
applied to a 0.8% agarose gel. The digested DNA was separated at 170 V for ~2.5 h 
(5.2.3) and the gel was stained to monitor correct DNA digest and separation. The DNA 
was depurinated by incubation of the agarose gel in 0.25 M HCl for 20 min, denatured in 
suitable buffer (4.8.2.3) for 30 min, and finally neutralised in respective buffer for 
another 30 min. The “transfer sandwich” was build up at RT. The flow of 10xSSPE buffer 
led to capillary transfer of DNA from the agarose gel to the positivated nylon membrane. 
After transfer for 4 h or o/n, the nylon membrane was dried and cross linked. 
 
The nylon membrane was pre-hybridised in 10 ml of ‘High SDS’ hybridisation buffer 
(4.8.2.3) for at least 30 min at 42°C in a hybridisation oven. Meanwhile, 100 ng of the 
DIG-tagged DNA probe (5.2.7) were added to 10 ml of hybridisation buffer. Next, the 
mixture was incubated in a water bath at 95°C for 10 min and immediately cooled down 
on ice. The pre-hybridisation buffer was exchanged against the DNA-buffer solution in 
which the membrane was incubated o/n at 42°C. 
 
5.2.8.2 Detection of DIG-tagged DNA by chemiluminescence 
 
The next day the DNA-buffer solution was poured off and stored at -20°C for repeated 
use. The nylon membrane was washed two times each in Stringent washing buffer 1 
(4.8.2.3) at RT for 5 min, and in Stringent washing buffer 2 at 68°C for 15 min. 
Subsequent steps were carried out at RT on a shaker. The membrane was first incubated 
in Washing buffer for 5 min, then in 1xBlocking solution for 30 min, an finally in Antibody 
solution for another 30 min. The membrane was washed two times in Washing buffer for 
15 min each, and equilibrated in Detection buffer for 5 min. Next, CSPD working solution 
was poured onto the membrane for another 5 min. The blot was wrapped into cling film 
and left in an incubator at 37°C for 15 min. An X-ray film was placed onto the membrane 
for 20 min to 1 h. 
 
For subsequent hybridisation with a different DNA probe, the nylon membrane was 
stripped by shaking it two times in 0.2 M NaOH/0.1% SDS at 37°C for 15 min. After 
washing in 2xSSC and pre-hybridisation, the membrane was pre-hybridised and 
hybridisation with another DIG-tagged DNA probe was carried out. 
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5.2.9 RNA preparation 
 
5.2.9.1 RNA isolation from liquid culture 
 
For RNA preparation from liquid culture strain MC58 and its zur deletion mutant 
WUE4812 were grown on GC agar o/n at 37°C/5% CO2. Bacteria from the third fraction 
were suspended into 20 ml RPMI medium supplemented with 100 µM FeCl3, and an 
OD600 0.2 was adjusted. Under this low zinc condition, cultures were incubated at 37°C 
while shaking at 200 rpm until middle exponential growth phase (OD600~1.0). Cultures 
were then diluted in fresh RPMI+FeCl3 to OD600 0.2 and the MC58 culture was divided 
into two cultures. High zinc condition was applied to the first culture by adding 0.5 µM 
ZnSO4 to the medium according to Stork et al. (2010). The second culture and the MC58 
Δzur culture were further grown under low zinc condition. All three cultures were grown 
at 37°C/200 rpm for another 2 h leading to an OD600~1.0 again. 
In 2 ml caps, 500 µl of the bacterial cultures were directly added to 1 ml RNAprotect 
Bacteria Reagent (4.2). The mixture was vortexed and incubated at RT for 5 min 
previous to centrifugation in a Heraeus Biofuge 15 at 6,000 rpm for 10 min. The bacterial 
pellet was resuspended in 200 μl TE buffer containing 15 mg/ml Proteinase K and 
4 mg/ml lysozyme, vortexed and incubated on a thermo shaker at RT for 10 min. RLT 
buffer of the Qiagen RNeasy kit (4.3) was mixed 1:100 with β-mercaptoethanol. To each 
sample, 700 μl RLT/β-ME and 500 μl of 96% ethanol were added, and gently mixed by 
inverting the cap. The sample was then applied to a Qiagen column of the RNeasy Mini 
kit. The next steps were carried out in slight modification to the manufacturer’s protocol. 
The column was washed with buffer 700 μl buffer RW1 and 700 μl buffer RPE, followed 
by washing twice with 800 μl of 80% ethanol to rinse guanidine salts. Finally, the column 
was dried by centrifugation in a Heraeus Biofuge 15 at 13,000 rpm for 3 min. RNA was 
eluted twice with 45 μl Nuclease-free H2O each, followed by incubation for 1 min and 
centrifugation at 13,000 rpm for 1 min. DNA remains were digested by adding 2 µl (4 U) 
of RNase-free recombinant DNase I (rDNase I) to each ~43 µl RNA sample gained, and 
5 µl of 10x rDNase I buffer. After incubation at 37°C for 1 h, the two digested samples of 
the same RNA eluate were reunified (~100 µl) and mixed with 350 µl RLT/β-ME and 
250 µl of 96% ethanol. Samples were purified and concentrated using another Qiagen 
RNeasy column, and finally eluted by applying 10 µl Nuclease-free H2O twice. Of the final 
RNA sample yielded, an aliquot of 4 μl was saved for quantity measurement and quality 
controls, and RNA samples were stored at -70°C. 
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5.2.9.2 Determination of RNA quantity and quality 
 
RNA samples were analysed with the NanoDrop 1000. RNA was considered pure with a 
260 nm/280 nm ratio above 2.0, because lower ratios imply contamination with DNA or 
protein remains. Additionally, a 260 nm/230 nm ratio above 2.0 indicated no 
contamination with organic chemicals as EDTA. Furthermore, RNA concentration was 
determined. 
To ensure complete digest of all DNA remains, a control PCR was set with 1 µl of the RNA 
sample, and primers KH9 and GSK2R (4.5). As a positive control, chromosomal DNA of a 
serogroup B meningococcal strain was used. 
The Agilent 2100 Bioanalyzer was used to determine RNA integrity of RNA samples by 
electrophoretic separation and subsequent laser induced fluorescence detection. With the 
Agilent RNA 6000 Nano Reagents kit (4.3) an RNA gel was prepared in the RNA Nano 
Chip. Aliquots of all RNA samples to be tested were incubated at 70°C for 2 min, and 
immediately set on ice. One microliter of each RNA sample was pipetted in a sample well 
of the RNA Nano Chip. The RNA chip was placed in the instrument and bioanalysis was 
performed using the Agilent 2100 software with the programme ‘Prokaryote total nano 
series II’. For RNA quality assessment, the Bioanalyzer software calculates a RNA 
Integrity Number (RIN) for every RNA sample based on its entire electrophoretic trace 
including degradation products. The RIN obtained should be ≥8.0 for microarray or qRT-
PCR analysis. 
 
5.2.10 Microarray Analysis 
 
5.2.10.1 cDNA microarray 
 
For each microarray analysis, at least three biological (independent bacterial cultures) 
with each two technical replicates (independent transcription including dye swap) were 
conducted which resulted in at least six microarray slides. 
 
5.2.10.1.1 Transcription of RNA in cDNA 
 
Nonamer random primers were purchased from Sigma-Aldrich at a concentration of 
1 µmol, and were adjusted with Nuclease-free H2O to a final concentration of 5 µg/µl. For 
microarray comparison of two RNA samples, each sample was labelled twice with 
different dyes (dye swap). For each sample, 10 µg of the isolated RNA (0) were adjusted 
with Nuclease-free H2O to a final volume of 13 µl (for a Cy3 sample) or 12 µl (for a Cy5 
sample). Then, 2 µl of the nonamer primer were added. The mixture was incubated at 
70°C for 10 min and set on ice. Meanwhile, a dNTP mix was prepared as follows: 
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Reagent Volume Final concentration 
dCTP [10 mM] 0.6 µl 200 µM 
dATP [20mM] 0.8 µl 500 µM 
dGTP [20mM] 0.8 µl 500 µM 
dTTP [20mM] 0.8 µl 500 µM 
DTT [0.1 M] 1.5 µl 5 mM 
5x First Strand Buffer 6 µl 1x 
RNase Out 1 µl 2 U 
Superscript II 2 µl 4 U 
 
Of this dNTP mix, 13.5 µl were pipetted to each sample. Finally either 1.5 µl Cy3-dCTP or 
2.5 µl Cy5-dCTP were added to each sample. To avoid bleaching of the dyes all 
incubation steps were performed in the dark. After vortexing, quick centrifugation and 
incubation at RT for 10 min, samples were incubated for 2 h at 42°C on a heating block 
for transcription of RNA into cDNA. Samples were then heated at 70°C for 15 min to 
inactivate the Superscript II transcriptase and set on ice. The samples were incubated for 
45 min at 37°C with 2 µl DNase-free RNase to digest the RNA template. The labeled 
cDNA was purified using the illustra AutoSeq G-50 dye terminator removal kit (4.3) 
according to the manufacturer’s instructions which yielded in 40 µl of purified Cy3- or 
Cy5-labelled cDNA.  
 
5.2.10.1.2 Prehybridisation of microarray slides 
 
Microarray analysis was performed using whole-genome DNA microarrays. Seventy-mer 
oligonucleotides covering four meningococcal genomes (MC58, Z2491, FAM18, and α14) 
were spotted in quadruplicate onto epoxy-coated Nexterion E slides as described 
previously (Schwarz et al, 2010). Slides were prehybridised according to the 
manufacturer’s protocol. For this purpose, four microarray slides were set into a rack and 
incubated in the following solutions: 1) in 0.1% Triton X-100 for 5 min at RT; 2) two 
times in 1 mM HCl for 2 min at RT; 3) in 0.1 M KCl for 10 min at RT; 4) in dH2O for 1 min 
at RT; 5) in Blocking Solution (4.8.2.4) for 15 min at 50°C; and 6) in dH2O for 1 min at 
RT. For all incubation steps except of 5) the rack which was placed on a stirrer to keep 
the solutions in movement. Slides were placed in a 50 ml Cellstar tube and dried by 
centrifugation in the Heraeus Megafuge 1.0 R at 1600 rpm for 5 min. 
 
5.2.10.1.3 Hybridisation 
 
One Cy3- and one Cy5-labeled cDNA sample were combined and dH2O was added to a 
final volume of 97.5 µl. Then, 13 µl 1% SDS and 19.5 µl 20xSSC were added. The 
resulting 130 µl hybridisation probe was incubated for 5 min at 95°C, shortly cooled 
down on ice and finally loaded onto the prehybridised microarray slide. The slide was 
then placed into the hybridisation chamber. Used liquids in the channels (Ch) were as 
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follows: 1) 2xSSC, 0.2% SDS; 2) 2xSSC; 3) 0.2xSSC; 4) 0.1xSSC; 5) dH2O. 
Hybridization was carried out at the Tecan HS4800 Pro hybridization station using the HS 
Pro Control Manager software and the following hybridisation programme: 
 
1 - WASH: 60°C, Ch:1, Runs:1, Wash time: 30 sec 
2 - SAMPLE INJECTION: 60°C, Agitation 
3 - HYBRIDISATION: 52°C, Agitation frequency: High, Time: 17 h 
4 - WASH: 60°C, Ch:1, Runs: 2, Wash time: 1 min 
5 - HYBRIDISATION: 52°C, Agitation frequency: High, Time: 1 min 
6 - WASH: 23°C, Ch:2, Runs: 1, Wash time: 1 min, Soak time: 1 min 
7 - HYBRIDISATION: 23°C, Agitation frequency: High, Time: 1 min 
8 - WASH: 23°C, Ch:3, Runs: 2, Wash time: 1 min 
9 - HYBRIDISATION: 23°C, Agitation frequency: High, Time: 30 sec 
10 - WASH: 23°C, Ch:4, Runs: 2, Wash time: 30 sec 
11 – SLIDE DRYING: 23°C, Ch5, Time: 2 min, Final manifold cleaning 
 
5.2.10.1.4 Data analysis 
 
Hybridised slides were scanned with the Genepix 4200 scanner. Using Genepix Pro 4.0, 
raw data files for each microarray slide were generated and further processed with the 
Limma package (Smyth, 2005). Data normalisation was done by Dr. Biju Joseph. After 
implementing data in R (The-R-Development-Core-Team, 2008), only genes with a false 
discovery rate (FDR)<0.01 and a B statistic value>0 were considered for further analysis. 
 
5.2.10.2 gDNA microarray 
 
Microarray comparative genomic hybridisation (mCGH) analysis with chromosomal DNA 
(genomic DNA, gDNA) was carried out in modification to Joseph et al (2011). 
Chromosomal DNA was isolated using Genomic Tip 100/G (5.2.1) from N. m. strains α16, 
α528 and DE9686. Four micrograms of gDNA were adjusted with TE buffer (4.8.2.1) to a 
final volume of 12 µl. The sample was incubated at 95°C for 10 min and immediately set 
on ice. A master mix each was prepared for Cy3- and Cy5-labelling: 
 
Reagent Volume 
10xdNTP 2 µl 
Nonamer primer 2 µl 
10x Labelling buffer 2 µl 
Klenow 1 µl 
Cy3- or Cy5-dCTP 1 µl 
 
The master mix was vortexed, shortly centrifuged and pipetted to the DNA sample. The 
samples were incubated o/n at 37°C in an incubator in the dark. The next day, reactions 
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were stopped by adding 2 µl of 0.2 M EDTA (pH 8). DNA was precipitated by addition of 
2 µl 4 M sodium acetate (pH 4.5) and 75 µl cold 96% ethanol and subsequent 
centrifugation in the Heraeus Megafuge 1.0 R at 13,000 rpm for 15 min at 4°C. After 
washing with 1 ml of 70% cold ethanol, centrifugation was repeated. The DNA precipitate 
was dried and dissolved in 2 µl dH2O. One Cy3- and one Cy5-labelled probe were 
combined, and 3 µl salmon sperm ssDNA and 113 µl PerfectHyb Plus hybridization buffer 
(4.2) were added to yield a 120 µl gDNA hybridisation probe. The probe was incubated at 
95°C for 5 min in the dark, briefly cooled down on ice and applied to a prehybridised 
microarray slide (5.2.10.1.2) which was placed in the hybridisation chamber. Liquids 
were used in the channels (Ch) as follows: 1) 2xSSC, 0.2% SDS; 2) 2xSSC; 3) 0.2xSSC; 
4) 0.1xSSC; 5) dH2O. The hybridisation was conducted at the Tecan HS4800 Pro 
hybridization station using the following hybridisation programme: 
 
1 - WASH: 60°C, Ch: 1, Runs:1, Wash time: 30 sec 
2 - SAMPLE INJECTION: 60°C, Agitation 
3 - HYBRIDISATION: 50°C, Agitation frequency: High, Time: 17 h 
4 - WASH: 60°C, Ch: 1, Runs: 2, Wash time: 1 min 
5 - HYBRIDISATION: 50°C, Agitation frequency: High, Time: 1 min 
6 - WASH: 23°C, Ch: 2, Runs: 1, Wash time: 1 min, Soak time: 1 min 
7 - HYBRIDISATION: 23°C, Agitation frequency: High, Time: 1 min 
8 - WASH: 23°C, Ch: 3, Runs: 2, Wash time: 1 min 
9 - HYBRIDISATION: 23°C, Agitation frequency: High, Time: 30 sec 
10 - WASH: 23°C, Ch: 4, Runs: 2, Wash time: 30 sec 
11 – SLIDE DRYING: 23°C, Ch: 5, Time: 2 min, Final manifold cleaning 
 
5.2.11 Quantitative real-time PCR (qRT-PCR) 
 
qRT-PCR analysis was performed as recently described using the StepOnePlus™ system 
(Schielke et al, 2011). Total RNA was extracted (0) and reversely transcribed into cDNA 
(5.2.10.1.1). Primers were designed using the Primer Express 3.0 software. Each primer 
pair was first tested in PCR with chromosomal DNA as well as cDNA. If PCR products 
displayed the expected size, primer efficiency and unique melting temperature were 
tested using relative standard curve experiments of the StepOne software v2.0. 
Additionally, the best cDNA concentration for the subsequent analysis was determined. 
qRT-PCR reactions comprised the Power SYBR Green Master Mix, 15 ng cDNA and 
primers at a final concentration of 900 nM. nmb1567, coding for a putative membrane-
associated peptidyl-prolyl isomerase, was used as endogenous control, and expression 
levels of the target genes were normalised to nmb1567 expression. Negative controls 
without cDNA template were added. In each assay, triplicates of each sample were 
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conducted. Furthermore, each gene was analysed in three independent qRT-PCRs 
(technical replicates) based on RNA from independent bacterial cultures (biological 
replicates). Data analysis was done with the StepOnePlus™ software based on the ΔΔcT 
method. For each gene, RQ (relative quantity) values were obtained that represented the 
fold change of expression of the investigated gene. 
 
 
5.3 Protein analysis 
 
5.3.1 Preparation of whole cell lysate protein from N. meningitidis 
 
Bacteria were grown o/n on GC agar plates. OD600 0.2 was adjusted in 1xPBS, bacterial 
cells were pelleted and resuspended in 50 µl 1x Sample Solution (4.8.3.1).  
 
5.3.2 SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
 
SDS-polyacrylamide gels were cast on the previous day, composed of a 10% or 12.5% 
separation gel and a loading gel (4.8.3.1). Prior to electrophoresis, protein samples 
(5.3.1) were incubated at 95°C for 10 min and cooled down on ice. For Silver gels and 
Western blots, 5 µl of protein samples were loaded on the gel. For Coomassie gels, 20 µl 
of protein samples were used. For determination of the protein size, 5 µl of the Page 
Ruler prestained protein marker were pipetted in one slot. Separation of proteins was 
carried out for approximately 1.5 h in Electrophoresis buffer. Thereby, 10 mA/gel were 
applied first until samples passed the border to the separation gel, followed by 20 mA/gel 
until the dye front completely ran off. 
 
5.3.3 Staining of SDS-Polyacrylamide Gels 
 
Following SDS-PAGE, gels were stained either by Coomassie or Silver staining. For 
Coomassie staining, the gels were shaken in Coomassie staining solution (4.8.3.2) for 
30 min. The gel was then incubated in Destaining solution for at least 2 h until protein 
bands became visible against the background. 
Silver staining was performed in modification to Blum et al. (1987). Gels were incubated 
in the following solutions: 1) Fixing solution for 30 min; 2) 50% ethanol for 10 min; 3) 
10% ethanol for 10 min; 4) 0.02% sodium thiosulfate for exactly 1 min to block 
unspecific binding sites; 5) dH2O three times for 20 sec each to wash and 6) freshly 
prepared Silver staining solution for 20 min. Then, the gel was washed twice with dH2O 
for 20 sec each. By subsequent shaking in Developing solution for few minutes protein 
bands became visible. Developing procedure was stopped with 10% acetic acid, in which 
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the gel then was incubated for another 15 min. Gels were kept in dH2O until scanning on 
the gel scanner and preservation in plastic film. 
 
5.3.4 Western Blot 
 
Western blots were used for antibody-mediated detection of specific proteins. Proteins 
separated in SDS-polyacrylamide gels were transferred from the gel to a nitrocellulose 
membrane by electroblotting for 1 h at 300 mA in Blot buffer (4.8.3.3). Non-specific 
binding sites were saturated by incubation of the membrane in 5% low fat milk in PBS-T 
for 1 h. The blot was then incubated o/n at 4°C in a dilution of the primary antibody (4.3) 
in 1% low fat in PBS-T. The membrane was washed twice for 5 min each in PBS-T, and 
the horse reddish peroxidase-conjugated secondary antibody diluted in PBS-T was 
applied for 1 h at RT. After washing in PBS-T three times for 5 min each, the blot was 
developed with the Pierce ECL chemiluminescence detection system according to the 
manufacturer’s instructions. An X-ray film was placed for usually 10 sec to 2 min. 
For subsequent incubation with another primary antibody, the nitrocellulose membrane 
was incubated in Stripping buffer (2% SDS; 20 mM Tris/HCl, pH 6.8; 0.7% β-ME) for 3 h 
at 50°C or o/n at RT. After washing in PBS-T three times for 10 min each and blocking of 
unspecific binding sites, another primary antibody could be used. 
 
5.3.5 Analysis of the Lipopolysaccharide (LPS) 
 
5.3.5.1 LPS preparation 
 
Preparation of the Lipopolysaccharide (LPS) was done in modification to Hitchcock & 
Brown (1983). Meningococcal strains were grown o/n at 37°C/5% CO2 on GC agar plates 
with CMP-NANA [0.5% in Tris/HCl]. Supplementation with CMP-NANA (Cytidine-5′-
monophospho-N-acetylneuraminic acid), an additional substrate for sialyltransferases, 
ensures full LPS sialylation if the strain is capable of it. OD600 0.2 was adjusted in 1xPBS, 
bacteria were pelleted in a Heraeus Biofuge 15 at 13,000 rpm for 2 min and resuspended 
in 50 µl Lysis buffer (4.8.3.4). After incubation in a water bath at 95°C for 10 min and at 
60°C for another 10min, 10 µl Proteinase K/lysis buffer was added and incubation was 
continued at 60°C for 1 h. Samples were stored at -20°C. 
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5.3.5.2 LPS SDS-PAGE 
 
To more efficiently separate low-molecular proteins and LPS, Tricine-sodium dodecyl 
sulfate-polyacrylamide gels were used (Schägger & von Jagow, 1987). For this purpose, 
tricine gels were cast analogous to SDS-polyacrylamide gels, but made of the Solution for 
tricine separation gel (4.8.3.4), and a loading gel made of the Solution for tricine loading 
gel. The inner chamber of the SDS-PAGE system was filled with Cathode buffer, the outer 
one with Anode buffer. Then, a mixture of 1.5 µl LPS preparation and 1.5 µl 2x Tricin 
Sample Solution was pipetted into each slot of the tricine gel. No molecular weight 
marker was needed. Samples were separated for approximately 4.5 h, first at 30 V until 
they passed the border to the separation gel, and then at 110 V. 
 
5.3.5.3 LPS silver staining 
 
For LPS silver staining after Tsai & Frasch (1982) all buffers were prepared with distilled 
water in plastic material, and for each step a new plastic container was used. The gel first 
was incubated in: 1) Fixer (4.8.3.4) for at least 1 h or o/n; 2) Oxidiser (4.8.3.4) for 
5 min; 3) dH2O three times for 15 min each; 4) freshly prepared LPS silver staining 
solution for 10 min; and 6) in dH2O three times for 10 min each. The gel was then 
shaken in Developer for approximately 2 min until the LPS bands became visible. 
Developing procedure was stopped by adding 5% acetic acid in which the gel was 
incubated for another 15 min. Then, the gel was put into dH2O, scanned on a gel scanner 
and preserved in plastic film. 
 
5.3.6 Enzyme-Linked Immunosorbent Assay (ELISA) 
 
ELISAs were used to analyse meningococcal capsule and LPS structure. All incubation 
steps were performed at 37°C in an incubator. Meningococci grown o/n on GC agar 
plates were adjusted to an OD600 0.1 in 1xPBS. A 96 well ELISA microplate was coated 
with 50 µl of poly-D-lysine (25 mg/l) for 30 min to promote the adhesion of bacterial 
cells to the microplate. Following three times of washing of the microplate with 1xPBS, 
20 µl of each bacterial suspension were pipetted in duplicates into the wells and 
incubated for 1 h. Adherent bacteria were fixed to the surface by addition of 100 µl 
0.05% glutaraldehyde/PBS to each well and incubation for 10 min. The wells were 
washed three times with 1xPBS. Non-specific binding sites were blocked by addition of 
150 µl of 1% BSA/PBS for 30 min. Next, 20 µl of primary antibody solution were added 
to each well and incubated for 1 h. As a primary antibody against the B capsule, mouse 
monoclonal antibody (mAb) 735 was used and diluted 1:4,000 in 1% BSA/PBS. For LPS 
ELISA, different murine antibodies were used in different dilutions in 1% BSA/PBS, i.e. 
L3,7,9 (1:100); L8 (1:1,000) and 3F11 (undiluted). After washing three times with 
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1xPBS the secondary antibody, a Peroxidase-conjugated goat anti-mouse IgG+IgM 
antibody (4.3), was diluted 1:2,500 in 1%BSA/PBS and 20 µl were added to each well. 
After 45 min of incubation, the wells were washed another three times with 1xPBS. 
Finally, 20 µl ABTS [1 mg/ml] were pipetted in each well. ABTS acts a substrate to the 
peroxidase, resulting in a colour reaction that was measured photometrically after 10 min 
in an ELISA reader at 414 nm. 
 
5.3.7 Flow cytometry analysis 
 
Flow cytometry was used to analyse complement deposition on the meningococcal 
surface. For this purpose, deposition of the complement components C3 or C5b-9 on the 
meningococcal surface was detected by incubation with adequate antibodies and 
subsequent measurement in a flow cytometer. 
 
5.3.7.1 Serum killing assay for flow cytometry 
 
Neisseria meningitidis strains were grown on GC chocolate agar plates o/n (~16 h) at 
37°C/ 5% CO2. An OD600 0.2 of bacteria of the third fraction was adjusted in VBS/BSA 
buffer (4.8.1.1) in a 1.5 ml reaction tube. Bacteria were pelleted and resuspended in 
(400-x) µl VBS/BSA buffer. NHS was thawed on ice and x µl (e.g. 40 µl=10%) of NHS 
were added to the bacterial suspension. For each strain in the assay, a negative control 
was set with HIS (5.1.5) instead of NHS. All samples were incubated at 37°C and 
200 rpm in an incubator shaker for 10 min up to 30 min. The serum stress was stopped 
by setting the reaction tube on ice and adding 400 µl of cold HBSS
++
/BSA (4.8.3.5). 
 
5.3.7.2 Antibody binding 
 
All centrifugation steps following were carried out at 11,000 rpm/7 min in a Heraeus 
Biofuge 15. Bacteria were pelleted, washed with 700 µl HBSS++/BSA, and centrifuged 
again. The bacterial pellet was resuspended of in 50 µl of a 1:50 dilution of the 
monoclonal mouse anti-human C5b9 antibody (4.3) or the polyclonal rabbit anti-human 
C3d complement antibody in HBSS++/BSA. One sample served as an antibody negative 
control and was resuspended in 50 µl HBSS++/BSA only. All samples were incubated for 
30 min at 37°C/700 rpm on a thermo shaker. Bacteria were pelleted and washed with 
700 µl HBSS++/BSA. The bacterial pellet was then resuspended in 50 µl of a 1:200 
dilution of the AlexaFluor 488 goat anti-mouse IgG antibody or the AlexaFluor 488 
chicken anti-rabbit IgG antibody in HBSS++/BSA. After incubation for 30 min at 
37°C/700 rpm, samples were pelleted and washed with 700 µl HBSS++/BSA. Pellets were 
resuspended in 1 ml of 1% formaldehyde in 1xPBS for fixation and killing of the 
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meningococci. After incubation at 4°C in the dark for at least 1 h or o/n, bacterial cells 
were pelleted at 11,000 rpm for 10 min and resuspended in 400 µl PBS. 
 
5.3.7.3 Flow cytometry 
 
Samples were transferred into FACS tubes and measured with a flow cytometer at the 
following settings: 
Parameter Detector Voltage AmpGain Mode 
P1 FCS E02 3.50 lin 
P2 SSC 350 1.00 log 
P3 FL1 650 1.00 log 
 
After measurement of the negative control without primary antibody, a gate was defined 
corresponding to the densest bacterial population. Measurement was adjusted to 20,000 
counts of bacteria within the defined gate. Histogram graphs of data were generated 
using Weasel software (http://www.wehi.edu.au). 
 
5.3.8 Expression and Purification of recombinant protein Zur 
 
Protein expression was carried out according to the QIAexpressionist kit manual 
(Qiagen). Purification of the recombinant protein Zur was performed under native 
conditions. One liter of LB medium supplemented with ampicillin and kanamycin (5.1.1) 
was inoculated with a 20 ml o/n culture of WUE4892 (0) harbouring pMP12 (5.2.6.2). 
Bacteria were grown to an OD600 0.6 at 37°C shaking at 250 rpm. Protein expression was 
induced by adding 1 mM IPTG to the culture and incubation was continued for another 
4.5 h at 37°C. After harvesting of cells (10,000xg at 4°C for 30 min), bacterial pellets 
were resuspended in Lysis buffer (4.8.3.6). Cells were lysed by adding 1 mg/ml lysozyme 
for 30 min on ice and subsequent sonification in an ice water bath. Using an ultrasonic 
homogenizer, six 30 sec bursts at 130 W, with a minute cooling period in between each 
burst, were applied. The lysate was then centrifuged at 10,000xg at 4°C for 30 min, and 
the supernatant was saved on ice. The supernatant was loaded on a HIS GraviTrap Ni 
sepharose column equilibrated with Lysis buffer. After washing three times with Wash 
buffer, the HIS-tagged recombinant protein was eluted in Elution buffer. The Zur eluate 
was dialysed at 4°C four times for 12 h each against 5 l of 0.5xTB buffer each (4.8.3.7) 
to remove imidazol and nickel. Protein concentration was determined (5.3.9) and purity 
was verified by SDS-PAGE with Coomassie staining. Protein samples were stored in 
aliquots of 200 µl at -20°C. 
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5.3.9 Quantification of protein 
 
Protein concentrations were determined using the Pierce BCA Protein Assay Kit according 
to the manufacturer’s protocol. Briefly, dilution series of BSA as a standard and of the 
protein were prepared. Of every sample 25 µl were pipetted in duplicates into the wells 
of a 96-well ELISA microplate, and the dilution reagent was used as a blank (e.g. 
1xPBS). Then, 200 µl of Working reagent were added to each well and the plate 
incubated at 37°C for 30 min. Absorption was measured with an ELISA reader at 570 nm. 
The protein concentration was calculated based on the BSA standard curve. 
 
5.3.10 Electrophoretic Mobility Shift Assay (EMSA) 
 
For electromobility shift assays (EMSAs) the DIG Gel Shift Kit (4.3) was used. Short 
complementary oligonucleotides of 34-51 bp with sticky ends, comprising the Zur boxes 
of three chosen genes, were designed using the NCBI Primer BLAST. Oligonucleotides 
were resuspended in TEN (10 mM Tris, 1 mM EDTA, 0.1 M NaCl; pH 8.0) to a final 
concentration of 100 µM. To generate dsDNA fragments, 300 µl each of the 100 µM 
complementary oligonucleotides were mixed and annealed by incubation for 10 min at 
95°C and subsequent slow cool down to RT. Obtained dsDNA fragments were labelled 
with digoxigenin (5.2.7).  
 
Binding reactions of the labelled dsDNA fragments and the purified recombinant protein 
(5.3.8) were performed in 5x Binding buffer (4.8.3.7) in modification to Shin et al. 
(2007), supplemented with poly (dI-dC) [1 µg/µl] and poly-L lysine [0.1 µg/µl] that are 
included in the DIG gel shift kit. Standard reactions were pipetted as follows: 
Reagent Volume 
Final 
concentration 
Binding buffer (5x) 2 µl 1x 
poly (dI-dC) [vial9] 0.5 µl 0.1 µg/µl 
poly-L lysine [vial 11] 0.5 µl 0.01 µg/µl 
Labelled dsDNA fragment 1 µl 
0.4 ng 
(15.5 fmol) 
Purified protein (Zur) 1 µl 
15 pmol 
(250 ng) 
ZnSO4 1 µl 100 µM 
dH2O ad 10 µl  
 
As zinc was required for Zur-DNA interaction, standard reactions were supplemented with 
ZnSO4 to reach a final concentration of 100 µM according to Gaballa & Helmann (1998). 
To furthermore avoid chelation of zinc, EDTA was omitted from the binding and the 
running buffer. A native 8% polyacrylamide gel was cast the previous day (4.8.3.7). The 
gel was pre-run with 4°C cold 0.5xTB buffer at 120 V and 4°C for at least 30 min. 
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Meanwhile, binding reactions were pipetted and incubated at RT for 20 min. Next, 2.5 µl 
loading buffer [vial 13] was added on ice and samples were applied to the gel and 
separated at 120 V at 4°C for 110 min in 0.5xTB buffer. Proteins were electroblotted on a 
nylon membrane (5.3.4) in 0.5xTB buffer, and chemiluminescent detection of the bound 
dsDNA fragments was carried out. 
For analysis of the influence of ions other than zinc, the salts CaCl2, CoCl2, CuSO4, FeSO4, 
MgCl2, MnSO4 or NiSO4 were added at a final concentration of 100 µM. For specific 
chelation of zinc in some reactions, EDTA and TPEN (N,N,N′,N′-tetrakis-(2-pyridyl-
methyl)ethylenediamine) were added at a final concentration of 312.5 µM. For 
competition of binding, 125- to 1000-fold excess of the unlabelled dsDNA probe was 
added to the reactions. 
 
 
5.4 Computational Analysis 
 
Microsoft Excel 2003 was used for general data analysis and evaluation of data obtained 
by ELISA, Flow cytometry, microarray, SBA, qRT-PCR and protein quantification. 
 
The DNAStar Lasergene 8 software package was used for a variety of applications, e.g. 
MegAlign for alignment of gene sequences of different strains; SeqBuilder for planning of 
digests with restriction endonucleases for cloning and Southern blots; SeqMan for 
assembling of partial sequences to one sequence. BioEdit 7.0.9 (Hall, 1999) was applied 
for sequence visualization, analysis and alignments. 
The Primer BLAST of the National Center for Biotechnology Information (NCBI) 
[http://www.ncbi.nlm.nih.gov/tools/primer-blast] and Primer Express 3.0 (Applied 
Biosystems) were used for designing oligonucleotides. 
The NCBI BLAST programme of the National Center for Biotechnology Information (NCBI) 
[http://blast.ncbi.nlm.nih.gov/Blast.cgi] was used for similarity searches. 
 
Sequences of genes of strain MC58 were retrieved from NeMeSys (Rusniok et al, 2009) 
and the J. Craig Venter Institute [http://cmr.jcvi.org]. Annotation data were retrieved 
from NeMeSys (Rusniok et al, 2009) and Uniprot (UniProt-Consortium, 2012) databases. 
Operons predictions were kindly provided by Dr. Biju Joseph, based on RNAseq data 
(Joseph et al., unpublished) and the DOOR database (Mao et al, 2009). Promoter 
predictions were carried out using the online software tools NNPP (Reese, 2001) and 
BPROM [http://linux1.softberry.com/berry.phtml]. Conserved motifs within upstream 
sequences were searches using the GIBBS Motif Sampler (Thompson et al, 2007). The 
meningococcal Zur binding motif was visualised using WebLogo 3.2 (Crooks et al, 2004). 
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6 RESULTS 
 
6.1 Impact of global regulators of gene expression on 
serum resistance 
 
During this thesis I aspired to identify novel serum resistance factors of serogroup B 
meningococci. Initially, I tried to adapt meningococci to higher levels of serum resistance 
by alteration of various environmental conditions, i.e. growth under microaerophilic 
conditions, hydrogen peroxide stress, exposure to very high serum concentrations and 
repeated passage in serum. However, all these attempts failed. I therefore used mutants 
of meningococcal global regulators to investigate the impact of their regulons on serum 
resistance. The global regulators analysed in this study are presented in Table 1 (3.7). 
These global regulators were either deleted or overexpressed to simulate specific 
environmental conditions and modify target expression. All mutations were carried out in 
a mutant of carriage strain α16 deficient in expression of capsule and fHBP as well as LPS 
sialylation (α16 ΔsiaD Δlst Δfhbp). 
I constructed deletion mutants of asnC, nrrF and zur by transformation of the generated 
plasmids pMP2, pMP3 and pMP4, respectively (5.2.6.1). The mutant strains were 
designated WUE4659, WUE4665, and WUE4671. Deletion of AsnC simulates reduced 
nutrient levels (amino acid deficiency) leading to reduced expression of major outer 
membrane proteins which may emphasise the role of minor surface proteins. Deletion of 
the sRNA NrrF results in constant expression of its target mRNAs independently of Fur 
and iron. Deletion of Zur simulates zinc starvation and leads to de-repression of its target 
genes, resulting e.g. in enhanced zinc uptake. 
Furthermore, overexpressing mutants of RpoH (WUE4547), Fnr (WUE4353) and Hfq 
(WUE4320) were generated by Dr. Kerstin Hubert of our work group using the plasmids 
pAB1, pAB2 and pAB3, respectively. Overexpression of Fnr simulates oxygen restrictive 
conditions in the cell leading to constant expression of its target genes involved in 
anaerobic metabolism. Overexpression of the RNA chaperon Hfq simulates increased 
environmental stress, resulting in enhanced sRNA stability and regulation of their mRNA 
targets. Overexpression of RpoH, the major regulator of stress response, simulates 
environmental stress such as a heat shock, which results in increased expression of 
target genes, e.g. chaperones. 
 
Flow cytometry measurement of complement deposition on surface of these mutants in 
comparison to their parental strain was conducted after treatment with 10% NHS for 10 
min (5.3.7). MAC deposition on surface of all three overexpression mutants equalled that 
of the parental strain (Figure 3A). Therefore, overexpression of the fumarate and nitrate 
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reduction regulator Fnr, the RNA chaperone Hfq and the major regulator of stress 
response RpoH had no influence on serum resistance.  
Similarly, deletion of AsnC, a transcriptional activator at poor nutrition, and of the small 
regulatory RNA NrrF had no effect (Figure 3B). However, the knockout mutant of Zur, the 
regulator of zinc uptake, showed reduced binding of complement components C5b-9 
(Figure 3B). 
 
 
Figure 3. FACS analysis of MAC deposition of different global regulators mutants. MAC 
deposition was detected with the mAb mαhC5b-9 after incubation with 10% NHS for 10 min. 
Representative results are shown as seen in independent experiments. A) Overexpression 
mutants: MAC deposition on surface of Fnr, Hfq and RpoH mutants was similar to the parental 
strain α16 ΔsiaD Δlst Δfhbp. B) Deletion mutants: MAC deposition on surface of ΔasnC and ΔnrrF 
mutants did not differ compared to the parental strain. Deletion of zur led to reduced MAC 
deposition.  
 
Analysis of deposition of complement component C3d let to same results for all mutants. 
Compared to the parental strain, C3d deposition was only reduced on surface of the zur 
knockout mutant (data not shown). We therefore assumed that deletion of zur led to 
changes in regulation that might remodel the meningococcal surface and thus affect the 
interaction with serum complement. 
 
6.1.1 Analysis of the Zur-regulated protein ZnuD with regard to mediation 
of serum resistance 
 
Zur is known as a regulator of zinc uptake in different bacterial species (Hantke, 2001), 
and the meningococcal gene nmb1266 was identified as a homologue of the E. coli zur 
(Stork et al, 2010). Furthermore, Stork et al demonstrated that ZnuD, a TonB-dependent 
RESULTS 
 
62 
outer membrane receptor, is involved in the uptake of zinc at zinc-limited conditions. 
They also identified a putative Zur responsive element in the promoter region of znuD, 
and showed that deletion of the meningococcal zur homologue resulted in increased 
ZnuD expression (Stork et al, 2010). Besides of that, nothing was known about the 
meningococcal Zur and the regulatory processes in response to zinc. 
 
As shown above, deletion of Zur reduced complement deposition indicating enhanced 
serum resistance. Hence, we wanted to know if the reason for this might be increased 
expression of ZnuD on the meningococcal surface. We constructed a znuD 
overexpressing and a znuD knockout mutant by transformation with plasmids pIK6 and 
pIK3, respectively. The resulting znuD+ and ΔznuD strains were WUE4684 and WUE4686, 
respectively (Table 9). Due to the combination of resistance cassettes, this was 
performed in a α16 ΔsiaD background. The parental strain and both mutants were treated 
with 10% or 20% NHS for 10 minutes and MAC deposition on surface was measured by 
FACS analysis. After 10% NHS treatment, the znuD knockout mutant was covered only 
marginally more with MAC than the parental strain and the znuD overexpressing strain. 
Incubation with 20% NHS led to equal MAC deposition on surface of all three strains 
(Figure 4). 
 
 
Figure 4. FACS analysis of MAC deposition on surface of znuD overexpression and 
deletion mutants. Deposition of C5b-9 (MAC) was detected using the mAb mαhC5b-9 after 
incubation with 10% and 20% NHS for 10 min. Exemplary graphic presentation of comparable data 
obtained in three independent experiments. Deposition on surface of the znuD+ and the ΔznuD 
mutant in comparison to the parental strain α16 ΔsiaD were similar after 10% NHS for 10 min, and 
equalled after 20% NHS for 10 min. 
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Thus, ZnuD did not seem to be the key player leading to the considerably reduced 
complement deposition on surface of the zur deletion mutant. In order to identify the 
potential serum resistance factor, we decided to elucidate first the zinc-dependent Zur 
regulon which had not been studied before. 
 
 
6.2 The zinc-responsive regulon of Neisseria 
meningitidis 
 
To address the Zur regulon of N. meningitidis, two decisions were made: (1) I selected 
strain MC58 for further analysis because of the availability of microarrays covering the 
genome of this strain (Schwarz et al, 2010). (2) In order to avoid the transcriptional 
analysis of genetically engineered mutants and possible indirect effects, the addition of 
ZnSO4 was selected as stimulus. 
 
Zur was shown to mainly act as a repressor in other bacteria (Gaballa et al, 2002; Maciag 
et al, 2007; Schröder et al, 2010). Therefore, mRNA of most Zur-regulated genes is 
expected to be present in a zur knockout strain. We selected for a common reference 
design of microarray analysis which also offered the possibility for future extension of the 
dataset (Yang & Speed, 2002). Deletion of zur in MC58 was achieved using the generated 
plasmid pMP5 (5.2.6.1). The resulting Δzur strain was designated WUE4812 and used as 
common reference. Gene expression was compared at low and high zinc condition. 
 
As outlined in Figure 5, cDNA obtained from strain MC58 grown with or without zinc 
supplementation (i.e. low and high zinc conditions, respectively) was hybridised 
separately along with the common reference, i.e. cDNA obtained from strain MC58 Δzur 
grown at low zinc condition. Data analysis finally led to genes differentially regulated 
between low and high zinc condition. 
 
This study has been published in Pawlik et al (2012). 
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Figure 5. Common reference design of microarray comparison. cDNA obtained from MC58 
grown at high low and high zinc conditions were hybridised along with cDNA of the common 
reference, a MC58 zur deletion strain grown at low zinc condition. The zinc-dependent promoter 
repression by Zur is visualised by cartoons using the example of znuD. In modification from Pawlik 
et al (2012). 
 
6.2.1 Validation of growth conditions 
 
Growth of the zur deletion strain in the chemically defined medium RPMI supplemented 
with FeCl3 was indistinguishable from its parental strain MC58 (data not shown). I next 
conducted experiments to select the best possible time point of harvesting bacteria for 
RNA extraction. Western blot analysis and qRT-PCR of znuD, which was recently shown 
to be increased in a zur knockout mutant (Stork et al, 2010), was used as a marker. 
MC58 and MC58 Δzur were grown at low zinc condition in RPMI medium supplemented 
with FeCl3 until exponential phase. The MC58 culture was split in half and all three 
cultures were diluted in fresh medium. For one of the MC58 cultures, 0.5 µM ZnSO4 were 
added to the medium. Incubation was continued for one, two and three hours, 
respectively. At each time point, samples of the three cultures were taken for analysis of 
protein and RNA levels in Western blot (5.3.4, Figure 6A) and qRT-PCR (5.2.11, Figure 
6B), respectively. 
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Figure 6. Validation of growth conditions by monitoring znuD expression by Western blot 
and qRT PCR. RNA was extracted after growth of MC58 with or without supplementation with 
ZnSO4 for one, two and three hours, respectively. R, RPMI; Zn, RPMI+0.5 µM ZnSO4; Δzur, MC58 
Δzur grown in RPMI was used for comparison. A) Western blot analysis of ZnuD expression. 
Protein detection using a rabbit anti-znuD antibody #1041. (-), znuD deletion strain (+), znuD 
overexpressing strain. ZnuD expression between RPMI (low zinc) and RPMI+ZnSO4 (high zinc) 
condition was most differential after 2h. ZnuD expression of MC58 and MC58 Δzur grown at low 
zinc condition is comparable after 2h. B) qRT-PCR analysis of znuD expression. Relative 
quantity (RQ) of znuD expression in MC58 grown at low or high zinc relative to MC58 Δzur. After 
2h, MC58 and MC58 Δzur grown at low zinc showed equal expression of znuD, whereas znuD 
expression was strongly repressed in MC58 grown at high zinc. 
 
After one hour, ZnuD expression in Western blot was comparable for MC58 grown at low 
and high zinc, but less for MC58 Δzur (Figure 6A). This was confirmed in qRT-PCR where 
MC58 grown with zinc addition showed reduced znuD expression compared to MC58 
Δzur. However, expression of znuD was still reduced in MC58 grown at low zinc, probably 
due to intracellular zinc remains of the overnight culture on GC agar (Figure 6B). After 
two and three hours, protein levels of MC58 (RPMI) were comparable to MC58 Δzur 
(RPMI), whereas the ZnuD band almost vanished after two hours of zinc addition, but 
was visible again after three hours (Figure 6A). Also in qRT-PCR, znuD expression was 
most differential between MC58 grown at high and low zinc, but most equal between 
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MC58 and MC58 Δzur grown at low zinc condition after two hours (Figure 6B). Based on 
this data, zinc exposure for two hours was selected as suitable condition for the 
microarray comparison. 
 
 
6.2.2 Transcriptome analysis of zinc-dependent genes 
 
Strain MC58 was grown at low zinc (only RPMI) and high zinc conditions (RPMI + 0.5 µM 
ZnSO4) as defined by Western blot and qRT-PCR of znuD; strain MC58 Δzur was grown at 
low zinc condition to yield a common reference. RNA was then extracted from all three 
cultures (5.2.9.1) and transcriptome analysis was carried out as described in 5.2.10.1. 
Gene expression profiles of MC58 at high and low zinc condition were compared by Dr. 
Biju Joseph using MC58 Δzur as the common reference (Figure 5). The analysis revealed 
that sixteen genes were up-regulated, whereas three genes were down-regulated in 
MC58 grown at low zinc compared to high zinc condition. We checked all genes of this 
dataset for operon structures by using RNAseq data (Joseph et al, unpublished) and the 
DOOR database (Mao et al, 2009). For confirmation of microarray analysis, I performed 
qRT-PCR for all single genes and each first gene of predicted operon structures. This 
confirmed all genes except of two to be differentially expressed (Table 11).  
 
The regulon verified in this study comprised 15 genes up-regulated and only two down-
regulated in MC58 grown at low zinc compared to high zinc (Table 11). Nine genes were 
organised in four transcriptional units: nmb0317-nmb0316 coding for a 
7-cyano-7-deazaguanine reductase and an integral membrane protein, respectively; 
nmb0817-nmb0818, encoding hypothetical proteins that belong to the DUF723 family 
and may have a role in DNA-binding (UniProt-Consortium, 2012); nmb0942-nmb0941, 
coding for paralogues of 50S ribosomal proteins; and nmb0588-nmb0587, together with 
one single gene, nmb0586, encoding the components of the putative ABC transporter for 
zinc, ZnuCBA (Stork et al, 2010). Proteins encoded by the single genes nmb0819 and 
nmb0820 contain putative DNA-binding helix-turn-helix motifs. The highly differential 
expression of znuD (nmb0964), the TonB-dependent outer membrane receptor involved 
in zinc uptake (Stork et al, 2010), represents a positive control for our analysis as znuD 
was used for optimisation of our microarray conditions as mentioned above. 
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Table 11. Differentially expressed genes in N. meninigitidis MC58 observed by comparison of low to high zinc conditions. 
Locus Gene Predicted function Predicted  Size Differential gene expression 
   localization [bp] Array1 qRT-PCR2 
NMB0546 adhP Alcohol dehydrogenase, propanol-preferring Cytoplasmic 1047 -4.1 -21.7 
NMB0577 - NosR-related protein Unknown 351 -1.8 -1.8 
       
NMB0588 znuC ABC transporter, ATP-binding protein Cytoplasmic 756 1.4 4.4 
NMB0586 znuA 
Putative ABC transporter substrate-binding 
protein Cytoplasmic Membrane 915 1.5 6.3 
NMB0820 - Hypothetical protein Unknown 198 1.6 1.9 
NMB1497 - Putative TonB-dependent receptor Outer Membrane 2766 1.6 1.8 
NMB0818 - Hypothetical protein Unknown 411 1.9 - 
NMB0817 - Hypothetical protein Unknown 384 2.0 3.1 
NMB0587 znuB Putative ABC transporter permease protein Cytoplasmic Membrane 876 2.1 3.3 
NMB0942 rpmE2 50S ribosomal protein L31 type B Cytoplasmic 276 2.2 41.6 
NMB0819 - Hypothetical protein Unknown 393 2.3 1.8 
NMB0525 queC 7-cyano-7-deazaguanine synthase Cytoplasmic 660 2.5 3.9 
NMB0941 rpmJ 50S ribosomal protein L36 Cytoplasmic 126 2.7 - 
NMB0317 queF 
NADPH-dependent 7-cyano-7-deazaguanine 
reductase Cytoplasmic 474 3.4 5.8 
NMB1475 - Conserved hypothetical periplasmic protein Periplasmatic 807 3.6 96.4 
NMB0964 znuD TonB-dependent receptor Outer Membrane 2277 4.4 51.1 
NMB0316 - 
Conserved hypothetical integral membrane 
protein Cytoplasmic Membrane 687 4.6 - 
Gene information were retrieved from the online databases NeMeSys (Rusniok et al, 2009) and Uniprot (UniProt-Consortium, 2012). Genes are in order of 
their differential expression in microarray analysis; 1 Fold change values obtained by cDNA microarray hybridisation; 2 Relative quantification (RQ) values 
obtained by qRT-PCR. Table taken from (Pawlik et al, 2012). 
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Expression of another putative TonB-dependent receptor of yet unknown function, 
nmb1497, was also increased at low zinc. Furthermore, expression of nmb0525 (queC) 
and nmb1475, encoding a zinc-binding 7-cyano-7-deazaguanine synthase and a 
conserved hypothetical periplasmic protein with similarities to the acetate kinase AckA of 
Bacillus spp., respectively, were strongly increased at low zinc. Only two genes showed 
enhanced expression at low zinc: nmb0546 (adhP), encoding a zinc-containing alcohol 
dehydrogenase, and nmb0577 that shows similarities to the H. influenzae pfkA coding for 
a 6-phosphofructokinase. 
 
 
6.2.3 In silico prediction of promoter organisation and the Zur binding 
motif 
 
Stork et al (2010) previously postulated Zur binding to a palindromic sequence upstream 
of znuD. This sequence resembles the in silico predicted Zur binding motif for 
β-proteobacteria of RegPrecise database (Novichkov et al, 2010). Based on this motif, I 
scanned the promoter regions of all confirmed zinc-responsive genes for a conserved Zur 
binding motif. I found homologies in the upstream regions of all regulated transcription 
units, i.e. genes or operons. We therefore assumed that we at least partially elucidated 
the Zur regulon with our approach, and that zinc treatment of the bacteria did not 
deregulate genes other than Zur-controlled ones. 
The consensus motif deduced from all putative Zur-binding motifs found was graphically 
visualised by WebLogo 3.2 (Figure 7A). The meningococcal Zur binding motif (Zur box) 
consists of 23 bp and has a central palindromic part that comprises hexameric inverse 
repeats separated from each other by three nucleotides. This part is present in the 
predicted motif for znuD published by Stork et al (2010). 
I conducted an alignment of all putative Zur boxes found. The output indicated that the 
strength of gene regulation by Zur was dependent on the precision and length of the 
palindrome. If nucleotides on both sides of the central three nucleotides formed pairs 
leading to a true palindrome, relative expression differences of the respective gene were 
considerably higher in qRT-PCR than if less nucleotide pairs were present (Figure 7B). 
This observation was confirmed when mismatches in the palindromic part of each Zur 
box were counted in comparison to the perfect palindrome of the znuD Zur box: 
Occurrence of at least one mismatch in the palindrome of the putative Zur box reduced 
the extent of zinc-dependent gene regulation (Figure 7C). 
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Figure 7. Prediction of the putative meningococcal Zur box. A) Graphical display generated 
with WebLogo 3.2 of the meningococcal Zur box based on consensus sequences of predicted Zur 
binding sites for all zinc-responsive genes. B) Nucleotide sequence alignment of putative Zur boxes 
upstream of zinc-regulated genes. For each gene, distances of the Zur motif to the start codon of 
translation and expression differences determined by qRT-PCR (RQ; low to high zinc) are provided. 
Motifs are ordered by RQ values. The two genes upregulated by Zur are marked in grey, bold 
letter. The highly conserved palindrome is marked (#) and boxed for all motifs. Bold nucleotides 
highlight complementary nucleotide pairs between both sides of each motif. Symbols indicate: 
* alternative start for the gene possible; ‡ two differing putative Zur motifs were found in the same 
promoter region. C) Comparison of gene expression (absolute RQ) with the number of mismatches 
in the palindrome sequence of each Zur box with reference to the znuD (nmb0964) palindrome. 
Gene expression changes were significantly higher in genes with a perfect Zur box compared to 
genes with at least one mismatch in the Zur box. In modification from Pawlik et al, (2012). 
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Differential gene expression was calculated from the absolute ΔΔcT values obtained by 
qRT-PCR. It was significantly higher in genes with a perfect Zur box compared to genes 
with imperfect Zur boxes having at least one mismatch (Wilcoxon rank sum test with 
continuity correction, p<0.01). Some genes showed a palindromic sequence with 
extended length, e.g. nmb0317 or nmb0588, which might partly compensate for 
mismatches in the central palindrome. The longest palindrome with a decameric inverse 
repeat was found for nmb1475. This probably represented the perfect Zur box as this 
gene showed the highest repression of gene expression upon zinc exposure (RQ=96.4). 
Interestingly, we detected two putative Zur boxes upstream of nmb0586. However, the 
reason for that remains unclear as this duplication did not seem to affect the strength of 
gene expression. 
 
Promoter predictions were carried out using two software tools available online: NNPP 
(Reese, 2001), applying a minimum promoter score of 0.8, and BPROM 
[http://linux1.softberry.com]. I then analysed the position of the Zur boxes relative to 
the predicted promoter sequences which was surprisingly flexible (Figure 8).  
 
 
Figure 8. Promoter organisation of representative Zur-regulated genes. Predicted 
transcription start sites (+1) are given in bold letter with larger font; underlined, bold nucleotides 
show the predicted -10 and -35 regions. Putative ribosomal binding sites (RBS) are indicated in 
bold letter; the start codons are boxed and name the referring genes. Zur boxes are shaded in 
grey. A) Zur box situated upstream of the -10/-35 region. B) Zur box overlapping the 
-10/-35 region. C) Zur box located downstream of the -10/-35 region. 
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Zur boxes were either located upstream of the promoter (Figure 8A; i.e. nmb0317 and 
nmb0819), or directly overlapping the -10/-35 elements (Figure 8B; i.e. nmb0546, 
nmb0586, nmb0588, nmb0964 and nmb1475), or downstream of the promoter (Figure 
8C; i.e. nmb0525, nmb0577, nmb0817, nmb0820, nmb0942 and nmb1497). 
Nevertheless, for most of the genes the Zur box was either overlapping with or located 
downstream of the promoter region. The Zur boxes of three out of four genes with high 
RQ values were directly overlapping with the promoter elements. However, only three of 
the five genes with overlapping Zur box showed high RQ values. Therefore, due to the 
limited number of regulated genes, a statistical proven association of the Zur box 
location with the extent of regulation of the respective gene was not possible. Genetically 
engineered strains will be needed to address this question. 
 
6.2.4 Correia elements in the vicinity of Zur-regulated genes 
 
I found insertions of Correia elements (CEs) in the surrounding regions of seven Zur-
regulated genes (Figure 9). These transposon-like repeat elements are found in 
numerous copies within the meningococcal genome (Liu et al, 2002). CEs comprise two 
terminal inverted repeats (TIR) that harbour promoter element-like sequences (-10, -35 
and TATA box). Eight different subtypes of CEs were defined, built up of four types of 
TIRs, i.e. α, α’, β and β’ (Siddique et al, 2011). Insertions of the following CEs were 
found in the vicinity of the Zur-regulated genes: CEs of the α-α subtype were inserted 
upstream and downstream of the nmb0316-317 operon, as well as upstream of nmb1475 
and nmb1497. CEs with an internal deletion, also comprising the IHF-binding site, were 
noticed downstream of nmb0586 (α-α‘ subtype), as well as upstream and downstream of 
nmb0577 and nmb0941 (α-β'subtypes), respectively (Figure 9). 
However, I could not identify a pattern of CE insertion as they occur in low as well as 
highly differential expressed genes upon comparison of low to high zinc conditions; in 
Zur-repressed genes as well as one Zur-activated gene; and upstream as well as 
downstream of the Zur motif and the promoter elements or between those elements. 
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Figure 9. Nucleotide sequence alignment of Correia elements inserted upstream or downstream of seven Zur-regulated genes. Randomly 
scattered point mutations are shaded in grey, dashes indicate gaps. The two sites of polymorphic consensus nucleotides (R-53 and Y-129) are marked with 
asterisks; boxes indicate predicted –10 and –35 boxes within the Terminal inverted repeats (TIR) and the position of the IHF binding site [according to Siddique 
et al (2011)]. 
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6.2.5 Verification of Zur binding to predicted DNA motifs by EMSA 
 
In a next step, I analysed whether Zur binds to the in silico predicted DNA motifs. For 
that purpose, I aimed to perform EMSAs with a HIS-tagged recombinant Zur protein and 
synthetic dsDNA fragments. To yield recombinantly expressed Zur protein, the zur gene 
of MC58 was cloned into the expression vector pQE-60 (5.2.6.2), and the protein was 
overexpressed in E. coli and purified (5.3.8). Purified protein was analysed by SDS-PAGE. 
Only one distinct band was seen at approximately 17.5 kDa which verified protein purity 
(Figure 10). 
 
 
Figure 10. Coomassie-stained 15% SDS-PAGE of the purified HIS-tagged Zur protein. The 
17.5 kDa protein (NMB1266) of N. meningitidis MC58 was recombinantly expressed in E. coli M15 
[pREP4] and purified using HIS nickel sepharose columns. Lane 1 and 2: ~90 pmol (1.5 µg) and 
~45 pmol (750 ng) of Zur protein, respectively; MW: molecular weight ladder. 
 
Three of the Zur-regulated genes were selected for generation of short digoxygenin-
labelled dsDNA fragments containing their Zur box (5.3.10). These labelled dsDNA 
fragments were incubated with the recombinant Zur protein and EMSAs were conducted 
(5.3.10). 
The 34 bp dsDNA fragment comprising the nmb0964 Zur box showed a mobility shift 
upon incubation with Zur. This shift was competed by 125-fold excess of the unlabelled 
nmb0964 dsDNA fragment (Figure 11A). Thus, the binding of Zur to the Zur box seems 
to be specific. 
I could only observe a band shift when 100 µM ZnSO4 was added to the reactions, 
whereas other ions as CaCl2, CoCl2, CuSO4, FeSO4, MgCl2, MnSO4 and NiSO4 did not 
support binding of Zur to the dsDNA fragment. This indicates that zinc is specifically 
needed to mediate the Zur-DNA interaction (Figure 11B). The effect of zinc also could be 
blocked by addition of EDTA and TPEN due to chelation. That underlines the importance 
of zinc (Figure 11B). 
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Figure 11. EMSAs of Zur binding to dsDNA fragments. Arrows indicate band shifts, asterisk 
unbound dsDNA fragments. A) Zur binding to a dsDNA fragment comprising the Zur box of 
nmb0964. Different amounts of Zur (3.75 pmol to 60 pmol) were added to the 34-mer dsDNA 
fragment, leading to band shifts. Addition of the unlabeled nmb0964 dsDNA fragment at a 125-fold 
excess specifically competed the band shift. B) Effect of divalent ions and chelators on Zur 
binding to the nmb0964 dsDNA fragment. Reactions were supplemented with 100 µM of 
different divalent ions. Zur binding to the nmb0964 dsDNA fragment was only mediated by Zn2+. 
Band shifts were abrogated by addition of 312.5 µM EDTA or TPEN. C) Mutational analysis of 
the Zur box. Band shift were inhibited by mutation of conserved nucleotides in the 3’-inverse 
repeat of the palindrome of the nmb0964 Zur box. In bold the four highly conserved nucleotides 
are shown, in grey mutated nucleotides are highlighted. D) Binding of Zur to dsDNA fragments 
containing the nmb0546 and nmb1475 Zur boxes. Zur binding to the 34-mer nmb0546 
dsDNA and the 51-mer nmb1475 dsDNA fragment comprising the respective Zur boxes resulted in 
band shifts. Addition of the respective unlabelled dsDNA fragment in 1000-fold excess competed 
the shifts. E) Competition studies using the nmb0964 dsDNA fragment.  Zur binding to the 
nmb0964 dsDNA fragment was competed by incubation with unlabelled nmb0964 and nmb1475 
dsDNA fragments (125-fold excess). Addition of unlabelled mutated nmb0964 dsDNA fragments 
harbouring mismatches within the palindrome (see Figure 11C) in 125-fold excess did not fully 
compete the shift. In modification from Pawlik et al (2012). 
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Mutations of either one, two or all four of the four most conserved nucleotides of the 
palindrome (ATAACA) were introduced in the 3’-inverse repeat of the palindrome of the 
nmb0964 dsDNA fragment. Zur binding was almost completely abrogated upon deletion 
of all four or the inner two nucleotides (Figure 11C). However, upon mutation of the 
marginal nucleotides or only a single nucleotide, interference with the band shifts was 
less clear. This indicates that i) all four conserved nucleotides of the palindrome are 
important for binding of Zur; ii) however, the inner nucleotides (TA) are more essential 
than marginal ones (CA); and iii) only one mutated nucleotide is not sufficient to 
abrogate the shift. 
Binding of Zur to in silico predicted Zur boxes of two more genes was investigated. The 
first gene selected was nmb0546, one of the two genes activated in response to zinc. 
Incubation of Zur led to a clear band shift of the nmb0546 dsDNA fragment which could 
be inhibited by addition of the unlabelled nmb0546 dsDNA fragment. The second gene 
chosen was nmb1475, the one harbouring a Zur box with an extended perfect 
palindrome. I surprisingly could not observe any shift with a 34-mer dsDNA fragment 
(data not shown) as I did for the other two genes. I therefore extended the surrounding 
region by 8 and 9 bp on each side of the extended perfect palindrome, leading to a 
51-mer dsDNA fragment. Upon incubation with Zur, this longer fragment then also 
showed a clear shift (Figure 11D). The Zur protein may probably need more flanking DNA 
sequence for binding to this perfect oversized palindrome that might stabilise the DNA 
structure. 
 
As these results indicated that binding specifity mainly depends on the palindrome, I 
wanted to confirm this by competition experiments. EMSAs with the nmb0964 dsDNA 
fragment and different unlabelled dsDNA fragments were carried out. The unlabelled 
nmb0964 dsDNA fragment was used for a specific competition, whereas the nmb1475 
and the mutated nmb0964 dsDNA fragments comprising mismatches within the 
3’-inverse repeat palindrome (see above) were implemented for a more unspecific 
competition. EMSAs affirmed that the unlabelled nmb0964 dsDNA fragment itself as well 
as the unlabelled nmb1475 dsDNA fragment comprising the same palindrome abrogated 
the band shift. However, the mutated nmb0964 dsDNA fragments were not completely 
able to compete the shift (Figure 11E). Hence, the palindrome seems to be of 
considerable importance for Zur binding. 
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6.3 Analysis of closely related strains differing in serum 
resistance 
 
6.3.1 Selection and analysis of suitable strains 
 
A second approach for identification of novel factors involved in meningococcal serum 
resistance during this thesis was the comparison of genetically closely related MenB 
strains that however differed in their resistance to serum complement attack. 
Various strains from strain collections of the affiliated German reference laboratory for 
meningococci (NRZM) and a Bavarian carrier study (Claus et al, 2005) were reviewed. Of 
these, eight strains originating from different sources, i.e. from carriage or disease, were 
analysed in more detail. The fine type of each strain was determined by the NRZM using 
PCRs for PorA, PorB and FetA. In addition, the sequence type (ST) and clonal complex 
(cc) of each strain were identified using MLST (Maiden et al, 1998). 
The polysaccharide capsule is the most important virulence factor of meningococci and 
protects the bacteria against complement-mediated killing and phagocytosis (Virji, 
2009). To confirm the capsular serogroup of our chosen strains I performed an ELISA 
(5.3.6) with mAb735. All strains were meningococcal isolates of serogroup B (MenB). 
Because meningococci show a large variety in LPS structure, an ELISA was performed to 
determine the LPS immunotype of the chosen ST-41/44 cc strains. Of the 12 different 
LPS immunotypes described, MenB strains display types L1-L9 (Mandrell & Zollinger, 
1977; Zollinger & Mandrell, 1980). All strains expressed an LPS reactive with the L3,7,9 
mAb or the L8 mAb. L3, 7 and 9 comprise a Lacto-N-neotetraose (LNT) moiety which can 
be sialylated (Tsai et al, 2002). 
Meningococci circumvent the immune defence of their host by recruitment of negative 
regulators of complement like fH onto their surface (Schneider et al, 2007). Binding of fH 
by the factor H binding protein (fHBP) was shown to enhance serum resistance (Madico 
et al, 2006). Therefore, PCR and sequencing was conducted for fhbp (nmb1870) for all 
selected strains. All strains expressed fHBP of variant 1 and allele 14 or 371. 
I also analysed the strains for possession of the MDA, a chromosomal islands that has 
been associated with strains causing disease (Bille et al, 2005). I furthermore determined 
conducted flow cytometry analysis (5.3.7) of MAC deposition on the strains’ surface after 
serum exposure. 
 
Three of these eight strains differed in only one of the fine type characteristics and 
belonged to the same clonal complex. Although closely related, they remarkably differed 
in their resistance to serum complement exposure. Therefore, they were finally chosen 
RESULTS 
 
77 
for this study. Their sources and characteristics are listed in Table 12. The colouring in 
blue, green and red will be followed throughout this section to ease comparison of data. 
 
Table 12. Closely related N. meningitidis strains used in this study. 
Strain Source cc ST Fine type LPS fhbp MDA 
α16 Carriage 41/44 41 B.P1.7-2,4: F1-5:PorB3-301 L3,7,9 1.14 + 
α528 Carriage 41/44 41 B.P1.7-2,15-39: F1-5:PorB3-1 L3,7,9 1.14 + 
DE9686 Disease 41/44 42 B.P1.7-2,4: F1-5:PorB3-1 L3,7,9 1.14 + 
P1, PorA with its variable regions 1 and 2; F, FetA (single variable region); ST, multilocus 
sequence type; cc, clonal complex; MDA, meningococcal disease associated island. Different 
characteristics are marked in bold.  
 
Strain DE9686 is a clinical isolate from the cerebrospinal fluid of a four year-old female 
from North Rhine-Westphalia that caused meningitis and sepsis. Strains α16 and α528 
are non-invasive carrier isolates from a 19-year old male from a Bavarian military base 
and a 14-year old female from a Bavarian school, respectively. 
The three strains are of sequence types (ST)-41 and -42 which differ in only one single 
nucleotide polymorphism (SNP) within the seven gene fragments analysed by MLST and 
belong to the same clonal complex, i.e. ST-41/44 cc (Table 12). The invasive isolate 
DE9686 did not show any MAC deposition on surface, whereas the carrier isolates α16 
and α528 were considerably loaded with MAC (Figure 12). 
 
Figure 12. Flow cytometry analysis of complement deposition for the three selected 
strains. Incubation with mAb mαhC5b-9 after exposure to 20% NHS for 10 min. C5b-9 (MAC) 
deposition is clearly reduced on surface of the invasive isolate DE9686 in comparison to the carrier 
isolates α16 and α528. Graphical display of a representative experiment; control: merged curves of 
HIS controls for all strains. 
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6.3.2 Mutation of selected strains 
 
To exclude factors that were already known to influence the resistance of meningococci 
to serum exposure, the respective genes for the capsule polysialyltransferase (siaD), the 
lipopolysaccharide sialyltransferase responsible for sialylation of LPS (lst), and fHBP 
(fhbp) were knocked out in the three strains using plasmids pMF32.35::T5, pGH7 and 
pMP1, respectively (4.4, 5.2.6.1). 
 
All three mutations were genetically verified by sequencing and Southern blot, and those 
for capsule and LPS were also phenotypically confirmed: A capsule ELISA (5.3.6) with 
mAb735 verified unencapsulation of the mutants, and the lst mutation was confirmed by 
LPS gels (5.3.5).  As shown for mutants of strain α528, the LPS band of a lst mutant runs 
below that one of the wild type strain, because the missing NeuNAc molecule leads to a 
LPS of reduced molecular weight (Figure 13). The gained triple mutants α16 ΔsiaD Δlst 
Δfhbp, α528 ΔsiaD Δlst Δfhbp and DE9686 ΔsiaD Δlst Δfhbp were designated WUE4294, 
WUE4297 and WUE4300, respectively. 
 
 
Figure 13. Tricine SDS-PAGE of LPS preparations. MC58 and MC58 Δlst were applied for 
comparison. The LPS of α528 and the α528 triple mutant (*=Δfhbp ΔsiaD Δlst) run at same 
molecular weight as LPS of MC58 and MC58 Δlst, respectively. 
 
 
6.3.3 Analysis of serum resistance in the mutants 
 
These ST-41/44 mutants were then again compared in their resistance to serum 
exposure. Survival was measured in an SBA (5.1.5) with 5% NHS (Pooled human 
complement preserved serum, 4.2) at 10 min of incubation (Figure 14A). Approximately 
94% of cells of the DE9686 triple mutant survived the serum stress (reduction from log10 
5.9 cfu/ml to log10 5.5 cfu/ml). In comparison, triple mutants of the carrier isolates α16 
and α528 were less serum resistant: Cell counts of α528 triple and a16 triple fell from 
initial log10 5.9 cfu/ml to log10 4.3 cfu/ml and log10 2.6 cfu/ml, respectively. 
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Furthermore, MAC deposition on the bacterial surface after exposure with 20% serum for 
10 min was measured using flow cytometry analysis (5.3.7) with an mαhC5b-9 
monoclonal antibody (4.3). There was clearly less MAC deposition on surface of the 
invasive isolate than of the carrier isolates (Figure 14B). 
These results suggested that the elevated serum resistance of the disease isolate DE9686 
is not only dependent on the already described dominant factors, i.e. capsule, LPS 
sialylation and recruitment of fH. 
 
 
Figure 14. Comparison of serum response of the closely related strains. Triple mutants of 
the invasive isolate DE9686 and the carrier isolates α16 and α528 were exposed to serum 
complement. Experiments were repeated three times yielding comparable results. A) Serum 
Killing Assay. Survival after exposure to 5% NHS for 10 min. DE9686 showed enhanced serum 
resistance compared to α16 and α528. B) Flow cytometry analysis. Incubation with mAb 
mαhC5b-9 after exposure to 5% NHS for 10 min. Control: merged curves of HIS controls for all 
strains. C5b-9 deposition (MAC) is reduced in DE9686 compared to α16 and α528. 
 
 
6.3.4 DNA microarray-based comparative genomic hybridisation (mCGH) 
of the three selected strains 
 
To elucidate novel factors behind the differential serum resistance, I compared the gene 
content of the three ST-41/44 cc wild type strains by microarray analysis (5.2.10.2) 
using slides covering four meningococcal genomes, i.e. Z2491, MC58, FAM18, α14 
(Schwarz et al, 2010). Labelled gDNA of α16 as well as α528 was separately hybridised 
against gDNA of DE9686. An intersection of the two data sets obtained yielded gene 
differences of both carrier strains compared to the disease isolate, i.e. genes present in 
α16 as well as α528, but absent in DE9686 and vice versa. Microarray results were 
verified by PCR and genome alignment with the DE9686 genome that was recently 
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sequenced in cooperation of our work group with Dag Harmsen using the Ion Torrent 
PGM sequencing technology of Life Technologies (Vogel et al, 2012b). 
I did not encounter any gene that was exclusively present in the invasive isolate. In fact, 
the analysis confirmed that the invasive isolate DE9686 lacked six genes that were 
present in the genomes of the carrier isolates α16 and α528 (Table 13). Five out of these 
six genes encode proteins with unknown location and function according to the MC58 
genome annotation in the NeMeSys database (Rusniok et al, 2009). None of the genes 
absent in DE9686 were predicted to be membrane-located. 
 
Table 13. Genes present in α16 and α528, but absent in DE9686.  
Gene 
size 
Protein 
size 
Gene content 
differences1 
Locus Predicted function Location 
[bp] [aa] DE9686/ α16 
DE9686/ 
α528 
NMB0495  
Replication initiation 
protein 
Cytoplasm 984 327 -16.6 -14.7 
NMB0500  Hypothetical protein Unknown 378 125 -11.7 -5.9 
NMB0501  Hypothetical protein Unknown 375 124 -24.4 -18.1 
NMB1043 Hypothetical protein Unknown 207 68 -5.8 -4.1 
NMB1755  Hypothetical protein Unknown 345 114 -47.4 -19.7 
NMB1756  Hypothetical protein Unknown 195 64 -200.3 -71.0 
1 Fold change values obtained by gDNA microarray hybridisation; Genes belonging to the IHT-B 
and –C are shaded in light and dark grey, respectively. 
 
Furthermore, all six genes genes seemed to be single transcripts according to RNA 
sequence data obtained by Dr. Biju Joseph (unpublished data, personal communication). 
According to the MC58 genome annotation, four of these six genes belong to putative 
Islands of Horizontally Transferred DNA [IHT] (Tettelin et al, 2000). NMB0500 and 
NMB0501 are within the IHT-B that contains hypothetical proteins. They share 36% 
protein identity with each other and have duplications in NMB1773 and NMB1774, 
respectively (Rusniok et al, 2009). None of the four protein sequences contains 
conserved domains. The NMB0500 amino acid sequence is 34% similar to E. coli AdiA, a 
biodegradative arginine decarboxylase with functions in the amino acid metabolism and 
the intracellular pH elevation in response to acids. NMB0501 has 37.5% similarity to 
Lactococcus lactis UvrC, a protein of the UvrABC system involved in repair of DNA lesions 
(UniProt-Consortium, 2012). NMB1755 and NMB1756 belong to the IHT-C which harbours 
homologues of toxins, putative virulence factors and mobile elements (Tettelin et al, 
2000). Sequences of both proteins do not comprise any conserved domain. NMB1755 
shows 37% similarity to Pseudomonas aeruginosa AccA, the carboxyl transferase of the 
Acetyl-coenzyme A carboxylase (ACC) complex involved in lipid and fatty acid 
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biosynthesis (UniProt-Consortium, 2012). NMB1756 does not show any similarity to 
proteins of bacteria other than Neisseria. 
Two more genes were absent in the DE9686 genome, i.e. NMB0495 and NMB1043. In the 
Uniprot database, NMB0495 is annotated in MC58 as replication initiation protein and 
shows 27% protein similarity to E. coli RepE, a replication initiation protein for plasmid 
copy control. NMB1043 has 56.5% similarity to a probable ABC transporter permease of 
Haemophilus influenzae, and 42% similarity to the cell volume regulation protein A 
(CvrA) of Salmonella spp. that transports potassium ions over the inner membrane 
(UniProt-Consortium, 2012). 
 
 
6.3.5 Further analysis of the strains within the Eranet consortium 
 
As within the gene content of the three isolates I did not find any explanation for 
enhanced serum resistance of DE9686, within the Eranet consortium the three strains 
were furthermore compared using transcriptome and proteome analysis (unpublished). 
The transcriptome analysis particularly revealed a stronger expression of nmb0865 in the 
more serum resistant isolate DE9686 compared to both carrier isolates (unpublished). 
Proteome analysis revealed enhanced protein levels of the fH-binding protein NspA 
(Lewis et al, 2010) in DE9686 compared to α16 and α528. 
Another approach within the Eranet consortium was the screening of individual colonies 
for increased serum resistance (Hubert et al, 2012). The strain used for this study was a 
DE9686 mutant deficient in LPS sialylation and expression of capsule, fHBP, and MutS (a 
protein involved in missmatch repair). In the majority of serum resistant mutants, 
expression of the adhesin Opc (Virji et al, 1993) was increased. Differential expression 
was due to phase variation in the opc promoter (Hubert et al, 2012). The opc promoter 
sequence contains a variable number of cytidine residues that may cause slipped strand 
mispairing leading to incorrect translation which is associated with no, intermediate or 
strong protein expression (Sarkari et al, 1994). 
Tracing back to the transcriptome analysis of the three ST41/44 strains conducted within 
the Eranet consortium, we noticed that Opc was more abundant on translational level in 
DE9686 compared to α16, but not to α528. Differential expression of Opc in the three 
strains was confirmed in Western Blot analysis (5.3.4) with whole cell extracts (data not 
shown). 
 
We hence wanted to know which impact these three interesting candidates - Opc, 
NMB0865 and NspA – do have on the resistance to serum complement exposure. 
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6.3.6 Impact of Opc on serum resistance 
 
As increased expression of Opc was the most important phenotype of serum resistant 
mutants within the screening approach, and the invasive isolate DE9686 showed 
enhanced Opc expression compared to the carrier isolates, it seemed likely that Opc 
expression is of advantage for meningococci to cope with serum complement exposure.  
To test this hypothesis, I deleted opc in the DE9686 ΔsiaD Δfhbp background using 
pEWoc2a leading to strain WUE4712. The deletion was then complemented with pHC47 
(opc+) resulting in strain WUE4748. I analysed complement deposition on surface of the 
parental strains and both mutants by FACS after incubation with 20% NHS for 10 min 
(Figure 15).  
 
 
Figure 15. FACS analysis of isogenic opc mutants of DE9686 ΔsiaD Δfhbp. Control: merged 
HIS controls. The graphical displays are each based one representative result of three repeated 
experiments. A) C3d deposition is equal on the parental strain and the mutants after incubation 
with 20% NHS for 10 min and detection with pAb rαhC3d. B) MAC deposition on the opc deletion 
mutant is enhanced in comparison to the Opc-positive parental strain and the opc complemented 
strain DE9686 ΔsiaD ΔfHbp Δopc opc+. C) Vitronectin binding is considerably enhanced in the 
complemented mutant compared to the parental strain and the Δopc mutant. Vitronectin analysis 
was conducted by Dr. Hanna Jarva, Helsinki. In modification from Hubert et al (2012). 
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Deposition of C3d on the opc deletion mutant was comparable to the parental and the 
opc-complemented strain (Figure 15A). However, enhanced MAC deposition was noticed 
upon deletion of opc. This effect could be restored by complementation (Figure 15B). 
Thus, Opc blocks MAC insertion. 
 
It is moreover well known that Opc binds vitronectin to invade human brain endothelial 
cells (Sa et al, 2010), and that vitronectin is a negative regulator of the complement 
system interfering with membrane attack complex deposition (Milis et al, 1993). 
Therefore, our Finish Eranet Pathogenomics partners performed vitronectin binding 
assays using the same set of mutants. They showed that deletion of opc reduced 
vitronectin binding to the surface of the meningococcal strains. After complementation of 
opc, binding of vitronectin to the complemented mutant again increased and was even 
stronger than to the parental strain (Figure 15C). This confirmed that expression of Opc 
enhances vitronectin binding. Taken together, the data demonstrate that Opc interacts 
with vitronectin that blocks MAC insertion, which results in slightly reduced serum killing. 
 
 
6.3.7 Contribution of NMB0865 and NspA to serum resistance 
 
In a next step, our work group constructed deletion mutants of nmb0865 and nspA in an 
acapsulated, fHBP-negative background of DE9686, designated WUE4747 and WUE4792, 
respectively. I conducted FACS analysis of MAC deposition with these mutants. 
MAC deposition on the surface of the nmb0865 knockout mutant in DE9686 background 
was slightly, but reproducibly enhanced compared to the parental strain, though only 
after exposure to a higher serum concentration of 20% NHS for 10 minutes (Figure 16, 
right side). This shifted the extent of complement deposition towards MAC deposition on 
surface of the α16 background strain. NMB0865 therefore seems to at least partially 
contribute to the enhanced serum resistance of DE9686 compared to the carrier strains. 
Unfortunately, during the course of this thesis the work group did not succeed to 
recombinantly express NMB0865 in meningococci. 
 
MAC deposition on surface of the nspA knockout mutant was strongly enhanced 
compared to the parental strain DE9686 ΔsiaD Δfhbp. Interestingly, MAC deposition on 
the surface of the DE9686 ΔsiaD Δfhbp ΔnspA mutant was comparable to strain α16 
ΔsiaD Δfhbp (Figure 16, left side). This suggests that the level of NspA expression indeed 
is the major factor leading to differed serum resistance between the three closely related 
strains. Studies are ongoing in the work group to analyse mechanisms and impact of the 
findings. 
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Figure 16. FACS analysis of MAC deposition of nmb0865 and nspA deletion mutants. 
Incubation with mAb mαhC5b-9 after exposure to 10% or 20% NHS for 10 min. Control: merged 
curves of HIS controls for all strains. Graphical displays are representative results out of three 
repetitions. After incubation with 20% NHS, MAC deposition is slightly enhanced on surface of 
DE9686 Δnmb0865 compared to the parental strain. MAC deposition on surface of DE9686 ΔnspA 
is clearly enhanced compared to the parental strain and equals MAC deposition on α16 ΔsiaD Δfhbp 
ΔnspA. 
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7 DISCUSSION 
 
Neisseria meningitidis is a major cause of bacteraemia and meningitis worldwide (Tan et 
al, 2010). Learning more about meningococci and their pathogenicity is therefore of high 
importance to counter devastating IMD. One characteristic of meningococci is their 
resistance to serum exposure and complement-mediated killing. N. meningitidis 
developed effective mechanisms to circumvent the host immune system which 
contributes to the fulminant course of disease and high-level bacteraemia (Schneider et 
al, 2007; Vogel & Frosch, 1999). Researchers therefore aim to identify virulence factors 
mediating meningococcal serum resistance. Using a high-throughput screening, Sun et 
al. generated mutants by STM and analysed those with reduced survival in an infant rat 
model. They showed deficiencies in genes encoding the capsule, LPS or iron acquisition 
molecules (Sun et al, 2000). The importance of capsule and LPS for meningococcal 
serum resistance was also confirmed by another STM study screening for resistance to 
complement-mediated lysis (Geoffroy et al, 2003). Furthermore, the impact of 
meningococcal adhesins has been highlighted in several studies. Among those are 
integral outer membrane proteins like PorA (Jarva et al, 2005; Orihuela et al, 2009) and 
Opc (de Vries et al, 1998; Sa et al, 2010). The recruitment of negative regulators of 
complement by specific outer membrane proteins, especially fHBP and NspA, is another 
way to mediate to serum resistance (Lewis et al, 2010; Madico et al, 2006). Although 
complement regulator binding proteins have been exploited for vaccine development 
(Johnson et al, 2012; Pajon et al, 2012), the expected number of outer membrane 
proteins without assigned functions initiated the search for further candidates. Minor 
OMPs may be attractive from a vaccine point of view, as they are not immunodominant 
and potentially less variable. An intriguing work of Poolman and colleagues studied the 
effect of minor OMPs (e.g. NspA, Msf) on eliciting bactericidal antibodies in a mouse 
model. Efficient complement-mediated killing was seen if at least two different minor but 
well-conserved OMPs were overexpressed in a PorA-deficient mutant. Adding further 
OMPs led to even higher bactericidal titres. The group developed the hypothesis that the 
more OMPs are targeted the closer are bactericidal antibodies on the bacterial surface, 
which is necessary to allow the first step of the classical pathway of complement cascade 
(Weynants et al, 2007). 
 
We therefore developed two hypotheses that were investigated within this work: 
i) Mutation of major global regulators of gene expression might have an impact on the 
composition of the outer membrane and bacterial surface structures and thereby affect 
serum resistance of meningococci; 
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ii) There are further OMPs not yet related to serum resistance which ought to be 
identified by genomic approaches. 
 
 
7.1 Impact of global regulators of gene expression on 
serum resistance 
 
Upon infection, meningococci have to face the host immune defences which include the 
action of antimicrobial proteins, phagocytes, and the complement system (Gasparini et 
al, 2012; Lo et al, 2009) and face changing environmental conditions. In the human 
body, bacteria have to cope with microaerophilic conditions and oxidative stress due to 
aerobic respiration and interaction with phagocytes (Seib et al, 2004), as well as 
limitation of essential transition metals like iron, zinc, manganese (Kehl-Fie & Skaar, 
2010). At the beginning of this thesis I therefore experimentally applied a variety of 
conditions, and aimed for selection of clones with enhanced serum resistance. There 
were two lines of thought behind these approaches: Firstly, application of certain 
environmental conditions, for example growth under microaerophilic conditions or 
hydrogen peroxide stress, might change gene expression and leads to altered expression 
of proteins that may be of advantage for coping with serum stress. Secondly, analogue to 
bacteria becoming resistant to antimicrobial agents by mutation and selection (Tenover, 
2006), I tried to select for meningococci carrying natural mutations that are of advantage 
for survival. I applied repeated passage in serum over hours, days and even weeks; 
alternatively, I treated meningococci with very high serum concentrations up to 80% 
NHS. However, using these approaches I did not gain clones with enhanced serum 
resistance. A possible explanation might be that resistance to serum is due to interplay of 
multiple factors and that enhanced resistance of a single clone due to one or more 
mutation events would likely stay unnoticed within a bacterial culture. 
 
Since global regulators of gene expression respond to a variety of environmental 
conditions and influence the transcription on a range of genes, they are ideal targets to 
create a differential bacterial surface structure. To date, in meningococci only few global 
regulators, i.e. ten transcriptional regulators, three alternative sigma factors and one 
functional TCS, have been described (3.7). According to literature, few of these might 
have the potential to either directly or indirectly influence the outer membrane structure 
(3.7, Table 1). We analysed the influence of overexpression of the fumarate and nitrate 
reduction regulator Fnr, the major stress regulator RpoH and the RNA chaperon Hfq on 
deposition of complement on cell surface. All three mutations did not alter complement 
deposition on the meningococcal surface, which was also true for deletion of the 
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transcriptional regulator AsnC or the small regulatory RNA NrrF. However, the Zur 
knockout showed a considerable decrease in deposition of complement components C3 
and MAC. We hypothesised that elimination of the global regulator Zur leads to 
remodelling of the bacterial surface which affects the interaction with components of the 
complement system. 
Zur was described as the regulator of zinc uptake in different bacterial species, such as E. 
coli, B. subtilis and M. tuberculosis (Hantke, 2001). Tommassen and colleagues identified 
the meningococcal homologue to the E. coli zur gene, i.e. nmb1266; as well as 
homologues of the putative znuCBA operon encoding a zinc uptake transporter, i.e. 
nmb0588-86 (Stork et al, 2010). The group analysed in detail the meningococcal TonB-
dependent outer membrane receptor ZnuD, encoded by nmb0964, which is expressed 
under zinc limitation and involved in zinc uptake. They showed that deletion of zur 
resulted in enhanced expression of ZnuD (Stork et al, 2010). If increased expression of 
ZnuD was the reason for reduced complement deposition on surface of the zur knockout 
strain, we postulated that overexpression of znuD would also lead to reduced deposition. 
However, deposition of C3 and MAC on meningococcal mutants overexpressing znuD was 
comparable to the wild type strain. Furthermore, the other way around, deletion of znuD 
did not lead to enhanced complement deposition as we would have expected if ZnuD was 
the Zur-dependent key player influencing serum resistance. 
 
In summary, of six global regulators analysed, only Zur influenced serum resistance of 
the α16 mutant strain. The TonB-dependent outer membrane receptor ZnuD was not the 
key component mediating enhanced serum resistance of the zur deletion mutant. Neither 
there was information available about further genes whose transcription is regulated by 
Zur, nor had the Zinc uptake regulator of meningococci been studied in more detail. We 
therefore aimed to elucidate the meningococcal response to zinc by transcriptome 
analysis.  
 
 
7.2  The zinc-responsive regulon of N. meningitidis 
 
By analysing the transcriptional response of meningococci upon exposure to human 
serum and whole blood, microarray studies identified various differentially expressed 
genes encoding components that are potentially involved in serum resistance 
(Echenique-Rivera et al, 2011; Kurz et al, 2003). As described above, we discovered that 
deletion of the meningococcal regulator Zur let to reduced complement deposition on the 
bacterial surface. In order to elucidate the factors behind, we wanted to know more 
about the meningococcal Zur and the genes under its control, i.e. the Zur regulon. In the 
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past, Zur regulons of a variety of bacteria have been analysed, but not the 
meningococcal one. Anyway, the meningococcal ferric uptake regulator Fur which is 
closely related to Zur has been studied in detail using transcriptome microarrays. Genco 
and colleagues analysed the Fur regulon, comprising iron-activated and –repressed Fur-
dependent genes, by comparison of gene expression upon iron-repletion and –depletion. 
They also identified a Fur binding motif (Grifantini et al, 2003). Three years later, 
Scarlato and co-workers used a transcriptional analysis comparing the response to 
different iron levels in wild type, fur knockout and fur complemented mutant to define 
the meningococcal Fur modulon (Delany et al, 2006). 
 
In accordance with these studies, we comparably analysed the gene expression at low 
and high zinc condition using the MC58 wild type and its zur deletion mutant. In various 
studies of the iron response, iron was depleted for one condition using specific iron 
chelators (Delany et al, 2006; Grifantini et al, 2003; Shaik et al, 2007). In contrast, we 
deliberately abstained from using a zinc chelator such as TPEN to deplete zinc, because it 
could not be excluded that TPEN chelates ions other than zinc and interferes with the 
membrane integrity. Rather than zinc depletion, we therefore used a low zinc condition, 
yielded by meningococcal growth in RPMI medium which does not contain any source of 
zinc according to the manufacturer. Growth in RPMI promotes the expression of znuD 
indicative of Zur derepression. 
Microarray studies elucidating the Zur regulon of bacteria such as B. subtilis, Y. pestis, 
M. tuberculosis and C. glutamicum directly compared a wild type strain with its zur 
knockout mutant at the same condition (Gaballa et al, 2002; Li et al, 2009; Maciag et al, 
2007; Schröder et al, 2010). In contrast to that, in our common reference approach we 
also analysed the response to zinc by comparing the wild type strain at low and high zinc 
condition. The advantage is that pleiotropic effects of a constitutive zur knockout are 
most likely rejected. 
The meningococcal Zur regulon we deduced from the transcriptome data and the 
consecutive Zur box analysis indeed is remarkably small. We identified 15 genes 
downregulated and two genes upregulated at high zinc using microarray analysis and 
qRT-PCR. A Zur binding motif (Zur box) was found for all transcriptional units. The entity 
of 17 regulated genes is comparable to the number found in microarray analyses of Zur 
regulons of other bacteria, i.e. 18 genes and 32 genes upregulated in a zur deletion 
mutant of C. glutamicum (Schröder et al, 2010) and M. tuberculosis (Maciag et al, 2007), 
respectively. The only exception is a comparative microarray analysis of a Y. pestis wild 
type strain and its zur deletion mutant, both grown at zinc-rich conditions, where 154 
Zur-regulated genes were found (Li et al, 2009). However, only four of those harboured 
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a Zur box, which suggests that regulation of most genes reflects a general transcriptional 
response rather than a direct result of Zur binding to the promoters. 
 
Two of the 17 genes regulated upon exposure to zinc were upregulated, i.e. nmb0546 
and nmb0577. Gene activation by Zur has only been reported in two other studies: A 
microarray analysis of the B. subtilis Zur regulon identified two genes upregulated in the 
wild type compared to its zur deletion mutant. However, Zur motifs could not be detected 
in the genes’ regulatory regions, so that upregulation presumably was due to indirect 
effects of the altered zinc homeostasis (Gaballa et al, 2002). This can be excluded in our 
study as we identified Zur boxes in the upstream regions of both Zur-activated genes. 
Only in one other study of the phytopathogen Xanthomonas campestris, Zur acted as a 
repressor of zinc-uptake systems, and also directly activated expression of one gene 
encoding a zinc efflux pump by binding to two distinct DNA motifs different from each 
other (Huang et al, 2008). Yet, in our study, the same Zur boxes were detected 
upstream of upregulated and downregulated genes. Furthermore, Zur binding to the 
nmb0546 motif was demonstrated by EMSA.  
Nevertheless, the ferric uptake regulator Fur has been described to activate gene 
expression in meningococci, either indirectly by repression of sRNAs, i.e. NrrF (Mellin et 
al, 2007) or directly by binding to the promoter of regulated genes, i.e. norB and nspA 
(Delany et al, 2004; Shaik et al, 2007). However, it has been proposed that the position 
of the Fur box relative to the promoter may be crucial to determine if a gene is repressed 
or activated upon Fur binding, i.e. Fur activates and represses transcription if the binding 
motif is upstream of and overlapping with the promoter, respectively (Delany et al, 
2004). 
 
7.2.1 Analysis of the promoter region of zinc-regulated genes 
 
Based on the prediction of the Zur binding motif for znuD by Stork et al (2010), I 
analysed the promoter regions of all genes that were found to be zinc-regulated in our 
study and identified the binding motif for meningococcal Zur with the palindromic 
sequence TGTTATDNHATAACA. This sequence is identical to the Zur binding motif 
proposed for znuD (Stork et al, 2010) and consistent with the palindrome in the 
bioinformatically predicted motif for the related γ-proteobacteria (Panina et al, 2003). An 
ideal palindrome sequence of the Zur box as shown above only was found in the 
promoter regions of nmb0546, nmb0942, znuD and nmb1475. These genes also showed 
the highest expression differences between low and high zinc condition. Zur boxes in the 
promoter regions of the other regulated genes constitute variations of the ideal 
palindrome with a varying number of mismatches when compared to the ideal 
palindrome. The number of mismatches was inversely correlated with the extent of gene 
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regulation. Mutations introduced into the palindrome led to abrogation of the full shift in 
EMSAs which has also been shown for the Zur binding motif of C. glutamicum (Schröder 
et al, 2010). We hypothesise that mismatches in the palindrome part of the Zur binding 
motifs may lead to reduced binding strength of Zur to the DNA. Nevertheless, at some 
circumstances the surrounding region of the Zur binding motif might be important for 
binding of Zur to DNA as only the 51-mer nmb1475 dsDNA fragment led to a shift in 
EMSA. However, this seemed to be an exception of the rule. 
 
Zur boxes of most of the meningococcal Zur-regulated genes were found to be either 
directly overlapping or downstream of the -10/-35 region which might interfere with the 
RNA polymerase (Madan Babu & Teichmann, 2003; Payankaulam et al, 2010). However, 
for two regulated genes, the motif was located upstream of the -10/-35 region. 
Therefore, the position of the Zur box relative to the promoter is more flexible in 
meningococci compared to other bacteria (Gaballa et al, 2002; Li et al, 2009; Maciag et 
al, 2007; Schröder et al, 2010; Shin et al, 2007). The Zur box location also did not 
determine whether a gene was repressed or activated. Local DNA topology, bending or 
supercoiling might be involved in activation of genes by high zinc and Zur binding, but 
detailed investigations were beyond the scope of this work.  
The zinc-activated gene nmb0546 was previously shown to be Hfq-repressed in 
N. meningitidis (Mellin et al, 2010; Pannekoek et al, 2009). The RNA chaperone Hfq 
stabilises small regulatory RNAs (sRNAs) and mediates their binding to their mRNA 
targets, which leads to subsequent repression of mRNA translation (Mellin et al, 2010). 
Therefore, regulation by a sRNA is feasible but needs to be investigated. Assuming that 
nmb0546 and nmb0577 were targets of a yet unknown sRNA regulated by zinc and Zur, 
comparable to the iron- and Fur-regulated sRNA NrrF (Mellin et al, 2007), one could 
hypothesize that activation of the genes occurred indirectly due to Zur-mediated 
repression of the putative sRNA that otherwise leads to degradation of the mRNAs. 
Therefore, we postulate that meningococcal Zur, like Fur, can directly activate and 
repress gene expression by binding to the same DNA motif. However, the mechanism 
determining the mode of action remains to be discovered. 
 
Insertions of Correia elements (CEs), transposon-like repeat elements, were observed in 
the vicinity of seven Zur-regulated genes, namely nmb0316-317, nmb0577, nmb0586, 
nmb0941, nmb1475 and nmb1497. In the MC58 genome, 261 CEs have been identified 
representing approximately 2% of the genome (Liu et al, 2002; Siddique et al, 2011). 
Comparable numbers were found for MenA strain Z2491 and MenC strain FAm18 (Bentley 
et al, 2007; Schoen et al, 2009). Two of the eight defined CE subtypes were shown to 
encode strong promoters that may affect the expression of adjacent genes (Siddique et 
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al, 2011). All of the CEs found in proximity of Zur-regulated genes, harboured the left α-
repeat that has been associated with especially high transcription levels (Siddique et al, 
2011). The CE inserted upstream of nmb1497 even contained both, the left α-repeat and 
the right α-repeat with Y-130-T, also found to strongly drive transcription (Siddique et al, 
2011). 
As CEs often are located close to genes involved in virulence, metabolism and transport, 
their abundance in Neisseria genomes may pose a significant role in the control of gene 
expression. Furthermore, conversion events occurring between different meningococcal 
strains during evolution led to subtype switch of CEs. This might represent a novel 
phase-variation mechanism as gene expression could be modulated depending on the 
strength of the encoded CE promoter (Liu et al, 2002; Siddique et al, 2011). However, 
Correia element insertion in the proximity of our Zur-regulated genes might rather be a 
coincidence, because it was not associated with gene expression. 
 
7.2.2 Functions of zinc-regulated genes 
 
The meningococcal genes nmb0588-nmb0587-nmb0586, previously identified as 
homologues to the E. coli znuCBA operon encoding an ABC transporter for high-affinity 
zinc uptake, and nmb0964 (znuD) coding for a TonB-dependent receptor mediating zinc 
uptake at low zinc concentration (Stork et al, 2010), were shown to be repressed at high 
zinc in our study. This finding is reminiscent to E. coli (Patzer & Hantke, 2000), 
M. tuberculosis (Maciag et al, 2007), B. subtilis (Gaballa et al, 2002), C. glutamicum 
(Schröder et al, 2010), Y. pestis (Li et al, 2009) and Streptomyces coelicolor (Shin et al, 
2007).  
In our study, nmb1475 was most strongly regulated which encodes a conserved 
hypothetical periplasmic protein with 34% similarity to the acetate kinase AckA of 
Bacillus spp. This enzyme is involved in the conversion of acetate to acetyl-CoA (UniProt-
Consortium, 2012) and its E. coli homologue was shown to bind zinc (Katayama et al, 
2002). The protein furthermore harbours a conserved domain, similar to the CbiK 
(COG5266) domain of the periplasmic component of an ABC-type Co2+ transport system, 
as identified by NCBI Blast. Thus, NMB1475 may be involved in the uptake of zinc and/or 
other transition metals. 
Zinc-uptake systems most likely are important for bacterial survival and pathogenicity 
during infection as access to zinc is limited within the human host (Hantke, 2001; Stork 
et al, 2010). Indeed, nmb0586 (znuA) was shown to contribute to in vivo pathogenicity 
of Salmonella enterica (Ammendola et al, 2007). In addition, ZnuABC and ZnuD help E. 
coli (Gabbianelli et al, 2011) and N. meningitidis (Kumar et al, 2012), respectively, to 
adhere to epithelial cells. Interestingly, van Alen et al found expression of NMB0586 (in 
this study named MntC instead of ZnuA) and NMB1475 being increased in biofilms, and 
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showed that deletion of nmb0586 reduces biofilm formation (van Alen et al, 2010). 
Extenuated biofilm formation also was previously seen upon deletion of znuA in gonococci 
(Lim et al, 2008) and znuB in E. coli (Gunasekera et al, 2009). A link between the 
availability of zinc and biofilm formation has also been reported for staphylococci where 
zinc chelation prevented biofilm formation because the intercellular adhesion is 
dependent on zinc-containing proteins (Conrady et al, 2008). A similar mechanism may 
apply for meningococci, resulting in increased expression of zinc-uptake proteins upon 
reduced zinc availability within the biofilm and extenuated biofilm formation upon zinc 
limitation. 
 
Furthermore, nmb1497 encoding a putative TonB-dependent receptor was identified to 
be Zur-regulated gene in a zinc-dependent manner in this study. It also was defined as 
one of 60 putative neisserial core pathogen-specific genes in a microarray study 
comparing N. meningitidis and N. lactamica strains (Dunning Hotopp et al, 2006). This 
protein might therefore contribute to pathogenicity of the meningococcus. 
 
Two meningococcal genes repressed at high zinc and harbouring an upstream Zur box, 
i.e. nmb0317 and nmb0525, are most likely involved in queuosine biosynthesis as 
determined by protein similarity analysis. nmb0525 codes for QueC, a zinc-binding 7-
cyano-7-deazaguanine synthase, and nmb0317 encodes QueF, a 7-cyano-7-
deazaguanine reductase (UniProt-Consortium, 2012). Until now queuosine biosynthesis in 
bacteria is still not fully understood, but the pathways have been studied in E. coli and 
B. subtilis (Gaur & Varshney, 2005; Lee et al, 2007). Queuosine is a highly complex 
modified nucleoside which is incorporated at the wobble position of a subset of tRNAs 
(Durand et al, 2000). Such modification of tRNAs improves efficiency and correctness of 
translation (Durand & Bjork, 2003). Varshney and colleagues demonstrated that a 
natural defect in queuosine biosynthesis of E. coli leads to reduced fitness under nutrient 
limitation (Dineshkumar et al, 2002). Furthermore, lack of queuosine attenuated Shigella 
flexneri virulence (Durand & Bjork, 2003; Durand et al, 2000). Queuosine biosynthesis in 
meningococci seems to be considerably Zur-regulated since two enzymes of the 
biosynthesis are up-regulated at zinc-limiting conditions (Kehl-Fie & Skaar, 2010). The 
question arises if increased queuosine modification of tRNAs may be a result of zinc 
depletion and contributes to the elevated expression of virulence factors which could 
support fitness of N. meningitidis during infection. 
 
Another interesting finding was that the expression of several genes encoding ribosomal 
proteins (r-proteins) was also Zur-repressed in N. meningitidis. This is in accordance with 
other bacteria such as E. coli (Graham et al, 2009; Panina et al, 2003), Y. pestis (Li et al, 
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2009), M. tuberculosum (Maciag et al, 2007), S. coelicolor (Shin et al, 2007) and 
B. subtilis (Akanuma et al, 2006). Several bacterial genomes encode two paralogous 
forms of r-proteins (Makarova et al, 2001). The first form (C+) contains a metal-binding 
Zn2+-ribbon usually consisting of four conserved cysteines, whereas in the second form 
(C-) this zinc ribbon is degenerated (Sankaran et al, 2009). The paralogous pair of the 
L31 r-protein in B. subtilis is RpmE (C+) and YtiA (C-). YtiA (C-), whose expression is 
repressed by Zur, liberates RpmE (C+) from the ribosome upon lack of zinc (Akanuma et 
al, 2006; Li et al, 2009). Candidate binding sites for several zinc repressors have been 
identified upstream of genes coding for (C-) paralogues of the r-proteins L31, L33, L36 
and S14 in a variety of bacterial species. Thereby, Gelfand and co-workers confirmed 
that upon existence of a (C+) and a (C-) copy of the r-protein the gene encoding the (C-) 
copy is regulated by a zinc-dependent repressor (Panina et al, 2003). The replacement of 
zinc-containing r-proteins by non-zinc containing paralogues upon zinc-depletion might 
liberate zinc for maintenance of zinc homeostasis and may enhance bacterial survival 
when facing zinc-restrictive conditions in vivo (Kehl-Fie & Skaar, 2010; Panina et al, 
2003). Paralogous forms of r-proteins with different zinc content may have evolved 
because ribosomal assembly needs to be maintained at zinc-restrictive conditions in any 
case. In meningococci, the 50S ribosomal proteins L31 and L36 are encoded by 
paralogous gene pairs. Based on sequence similarity to B. subtilis RpmE and Yti, the 
paralogous meningococcal proteins are NMB1956 (C+) and NMB0942 (C-) for L31, as 
well as NMB0164 (C+) and NMB0941 (C-) for L36 (Makarova et al, 2001; Rusniok et al, 
2009). In this study, we showed that the nmb0942-nmb0941 (rpmEJ) operon is 
repressed at high zinc, and furthermore identified a Zur box upstream of nmb0942. We 
therefore presume that also in meningococci the r-protein without zinc ribbon (C-) takes 
over the function of the C+ protein at zinc-deficient condition. 
 
7.2.3 In vitro binding of Zur to Zur boxes of regulated genes 
 
The meningococcal Zur binding motif (Zur box) and its variants are described above. 
Using qRT-PCR it was previously shown that Zur possibly represses the genes znuD and 
znuA in meningococci (Stork et al, 2010). However, binding of meningococcal Zur to the 
Zur box has not been demonstrated before this study. In E. coli and B. subtilis, Zur has 
been shown to be active as a dimer, and in the dimeric complex each monomer binds 
two zinc ions (Ma et al, 2011; Patzer & Hantke, 2000). In case of E. coli Zur, dimerisation 
appeared to be zinc-independent, whereas DNA binding required presence of zinc (Patzer 
& Hantke, 2000). In this study, EMSAs proved that binding of meningococcal Zur to its 
Zur binding motif is specifically dependent on zinc and cannot be mediated by any of the 
other bivalent ions tested. Studies of other bacterial Zinc uptake regulators also directly 
demonstrated by EMSA that activity of Zur is dependent on the presence of zinc (Gaballa 
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& Helmann, 1998; Li et al, 2009; Maciag et al, 2007; Schröder et al, 2010; Shin et al, 
2007), and for some bacteria it was shown that also manganese is able to mediate Zur 
interaction with the DNA (Gaballa & Helmann, 1998; Maciag et al, 2007; Schröder et al, 
2010).  
 
7.2.4 Comparison to other regulons 
 
Recently, Serruto and colleagues analysed the transcriptomic response of N. meningitidis 
upon exposure to whole human blood. In their study, some of the genes were 
deregulated that had also altered expression upon zinc exposure in our study. The genes 
nmb0964 and nmb1497, encoding TonB-dependent receptors, as well as nmb0546, 
coding for an alcohol dehydrogenase, were increasingly upregulated with the duration of 
meningococcal growth in human blood (Echenique-Rivera et al, 2011). This finding 
suggests that zinc depletion upon transfer of bacteria from liquid culture to whole blood 
is responsible for a part of the transcriptional changes observed. However, in our study in 
contrast to the whole blood study, nmb0546 was downregulated at low zinc condition 
rather than upregulated, which might be due to further factors influencing gene 
expression in a more complex in vivo situation. Furthermore, the finding of Echenique-
Rivera et al also reinforces that changes of zinc concentration mimic an important 
environmental signal encountered by bacteria during pathogen-host interaction. 
 
Several of the genes that are Zur-regulated in this work, were also differentially 
regulated in a microarray study comparing transcriptional profiles of N. meningitidis 
grown with different host iron binding proteins, i.e. haemoglobin, transferrin and 
lactoferrin, as a sole iron source. Upon exposure to lactoferrin (compared to haemoglobin 
or transferrin) nmb0941, nmb0942, nmb1475 and nmb1497 were downregulated, and 
nmb0546 was upregulated (Jordan & Saunders, 2009). Lactoferrin is present in 
secretions and on mucosal surfaces of the human host, and bacteria are able to acquire 
iron from the protein using a lactoferrin receptor (Morgenthau et al, 2012). A possible 
explanation for the seen overlap of the zinc and lactoferrin regulons is that lactoferrin 
also was reported to loosely bind zinc besides iron (Ainscough et al, 1980). It therefore 
might be an additional source of zinc for meningococci which then acts as a cofactor for 
Zur, resulting in Zur-mediated regulation of the genes mentioned above as it was seen in 
our study. 
However, a second explanation for the lactoferrin-dependent regulation of zinc-regulated 
genes might be that upon lactoferrin exposure regulation of these genes is not only 
accomplished in zinc-dependent, but also in iron-dependent manner. This hypothesis is 
supported by expression of znuD. This gene recently was shown to be repressed by zinc 
but also induced by iron, because its promoter site not only contains a Zur box but also a 
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Fur box (Kumar et al, 2012). I confirmed in vitro binding of Zur to the znuD Zur box in 
this study [also see Pawlik et al (2012)], whereas in vitro Fur binding to its Fur box was 
shown by Kumar et al (2012). However, we neither detected a Fur box upstream of 
nmb0942-nmb0941, nmb1475, nmb1497, and nmb0546, nor has znuD been regulated 
upon lactoferrin exposure in the work of Jordan & Saunders (2009).  
Nevertheless, another study again supports the hypothesis of a link between iron-
dependent regulation by Fur and zinc-dependent regulation by Zur: Genco and 
colleagues analysed the transcriptional response to iron in strain MC58 and identified Fur-
regulated genes. Among these also were nmb0316 and nmb0317, encoding a conserved 
hypothetical integral membrane protein and QueF, respectively, both involved in 
queuosine biosynthesis. They predicted a Fur box in the nmb0317 promoter region and 
showed in vitro Fur binding to it in an EMSA (Grifantini et al, 2003), whereas we 
determined zinc-dependent regulation of the nmb0316-nmb0317 operon in our 
transcriptome analysis and identified a Zur binding motif upstream of nmb0317. In line 
with hypotheses mentioned previously, lack of various trace metals might be sensed by 
meningococci as an indication for the host environment and may lead to coordinated 
action of the different respective transcriptional regulators resulting in elevated 
expression of virulence factors that support meningococcal survival. Increased 
modification of tRNAs with queuosine may be one factor contributing to this. 
 
7.2.5 Zur regulon and serum resistance 
 
Initially we found Zur to be connected with increased serum resistance since a zur 
deletion mutant of the carriage strain α16 showed reduced complement deposition on 
surface in comparison to its parental strain. We decided to analyse the Zur regulon in the 
MC58 rather than the α16 background since the α16 genome was neither represented on 
the available microarray nor was a genome sequence available of this strain. Of the 17 
genes found to be regulated by Zur in MC58, none was previously described to be 
involved in serum resistance. Our first target protein was the TonB-dependent receptor 
ZnuD (NMB0964), which we however determined to not be responsible for the effect of 
zur deletion on serum resistance using the same serum source. Nevertheless, the second 
TonB-dependent receptor regulated by Zur, NMB1497, might be a promising target for 
future studies. Since lack of zinc in the human host poses a challenge for bacteria during 
infection (Hantke, 2001), it would furthermore be worth to study the influence of the ABC 
transporter ZnuCBA on serum resistance. Moreover, NMB1475 may be a promising 
candidate as it was most strongly regulated in this study and may also be involved in zinc 
uptake. 
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Future studies should analyse the outer membrane location of members of the Zur 
regulon, their binding of bactericidal antibodies and the individual contribution to serum 
resistance. 
 
7.3 Analysis of genetically closely related strains with 
differing serum resistance 
 
In another approach during this dissertation, we identified closely related meningococcal 
strains that differed in serum resistance. In collaboration with the research group, these 
strains were analysed by a variety of genomic methods and a screening approach. 
The three selected strains belonged to the same clonal complex (ST-41/44 cc). The 
invasive isolate DE9686 showed enhanced resistance to complement exposure and 
reduced complement deposition of surface in comparison to the carrier isolates α16 and 
α528. Gene content comparison of the three strains using microarrays and PCR led to a 
total of only six genes that are present in the carrier isolates, but absent in the invasive 
isolate. One of these genes, nmb0495, encodes a replication initiation protein that might 
be involved in plasmid copy control due to 27% protein similarity to E. coli RepE. 
Plasmids generally are not essential for bacterial survival and rather represent an 
advantage in the competition with other microorganisms (Actis et al, 1999). However, 
plasmid copies have to be regulated as plasmids probably constitute a slight metabolic 
burden for their host. Therefore, a possible explanation for sorting out NMB0495 may be 
that another protein accomplishes the same function rendering the protein redundant. 
Candidates may be NMB1076, NMB1543 or NMB1634 that are all annotated to be 
involved in DNA replication initiation in MC58 (UniProt-Consortium, 2012). Alternatively, 
DE9686 may have evolved towards a protein-independent mechanism of plasmid copy 
control, i.e. achieved only by action of an antisense RNA (del Solar & Espinosa, 2000). A 
second gene, nmb1043, shows similarity to genes coding for membrane transport 
proteins, e.g. 56.5% similarity to a probable ABC transporter permease of Haemophilus 
influenzae. Therefore, nmb1043 might be an OMP that is a target for complement attack 
and absence of the gene in DE9686 may have been evolved to evade complement attack. 
 
Three of the remaining four genes absent in DE9686 show similarities to proteins of 
different bacterial species that have functions in metabolism and DNA repair. The first 
gene, nmb0500 codes for a protein with 34% similarity to E. coli AdiA, a biodegradative 
arginine decarboxylase with functions in the amino acid and glutamate metabolism and 
the intracellular pH elevation in response to acids. The second protein encoded by 
nmb1755 shows 37% similarity to Pseudomonas aeruginosa AccA, the carboxyl 
transferase of the Acetyl-coenzyme A carboxylase (ACC) complex involved in lipid and 
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fatty acid biosynthesis. The data suggest that the metabolom of the isolates should be 
analysed, also with respect to a possible association with resistance to serum 
complement. It has for example been shown that lactate supports meningococcal 
colonisation and enhances resistance to complement-mediated killing (Exley et al, 
2005a; Exley et al, 2005b). DE9686 may therefore have evolved to focus on specific 
metabolic pathways that are important for pathogenicity. 
The third gene, nmb0501, encodes a protein with 37.5% similarity to the Lactococcus 
lactis UvrC, a member of the UvrABC system. Regulated by SOS response, the UvrABC 
proteins recognise and cleave damaged DNA, one mechanism of DNA repair that is 
known as Nucleotide Excision Repair (NER) (Truglio et al, 2006). However, in MC58 
nmb1326 is annotated to encode UvrC (UniProt-Consortium, 2012). Therefore, NMB0501 
might be a related protein contributing to DNA repair but may have been sorted out in 
DE9686 in order to dispose unnecessary additional genes. 
 
All four proteins are hypotheticals belonging to the IHT-B or IHT-C. This is concordant 
with a study in which a comparison of a carrier strain of ST-41/44 cc and the invasive 
isolate MC58 (ST-32 cc) showed considerable variation in IHT-B and IHT–C (Joseph et al, 
2010). IHTs most likely have been obtained by horizontal gene transfer between species. 
The IHT-B and IHT-C encode numerous hypothetical proteins that may also be putative 
virulence factors (Tettelin et al, 2000). Both IHTs are variable in their presence within 
diverse mCGH groups which suggests that the islands have been gained and lost multiple 
times, probably due to the recombinant nature and transformability of Neisseria spp. 
(Dunning Hotopp et al, 2006; Feil et al, 2001). 
 
We therefore hypothesise that the invasive isolate DE9686 displays signs of reductive 
microevolutionary events. Microevolution is crucial for the pathogenesis of infectious 
diseases. In contrast to long-term processes termed macroevolution that lead to 
development of new species, microevolution describes a short-term development 
happening within days or weeks leading to new variants of a (sub)species. Both 
processes are important for the development of pathogenic microorganisms and are 
conditioned by horizontal transfer of mobile genetic elements. Plasmids, bacteriophages 
and pathogenicity islands strongly contribute to microevolution. Moreover, insertion 
sequences and transposons play an important role, which is also supported by acquisition 
of point mutations and genetic rearrangements as well as phase variation and antigenic 
variation, especially of OMPs or surface structures such as pili (Morschhauser et al, 
2000). Meningococci are naturally highly competent to take up DNA, and it has been 
reported that microevolution occurs frequently in N. meningitidis, leading to different 
variants which may disappear again within months or years. Especially microevolution of 
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serogroup A meningococci was highlighted since clonally related isolates originating from 
a common ancestor diversified at numerous loci within the last decades (Achtman, 1998; 
Morelli et al, 1997). Furthermore, Vogel et al reported diverseness of two invasive MenC 
strains isolated from a patient compared to carrier isolates isolated from healthy contact 
persons and reference strains of the same clonal complex (Vogel et al, 1998). This case 
study illustrates within-host microevolution of a specific strain during infection without 
further spread of this variant. It also shows the increased invasive potential of certain 
strains due to genetic adaptation to the host. 
Our study emphasises within-host microevolution in serogroup B meningococci. The three 
closely related isolates α16, α528 and DE9686 are most probably descendants from a 
common ancestor. Yet, in contrast to the carrier strains, the invasive isolate DE9686 
seems to have adapted to the human host during passages. Due to gene duplications or 
dispensability of certain genes within the human host, these genes may not have been 
necessary anymore and only represented ‘ballast’ for successful invasion. This might 
have led to genomic reduction over generations as identified in our analysis. 
 
We did not identify genes that are exclusively present in the invasive isolate, but absent 
in both carrier isolates. Therefore, enhanced serum resistance of strain DE9686 cannot 
be explained by exclusive possession of a certain gene encoding a virulence factor that 
mediates serum resistance, e.g. an additional regulator or an OMP like fHBP. We cannot 
rule out that the hypothetical genes may encode OMPs as in silico predictions of protein 
locations are unknown. However, this scenario seems to be less likely since for 
meningococci the benefits of OMP expression are possibly higher than the benefits of 
non-expression. Furthermore, importance of genetic islands for serum resistance is 
questionable as presented in work of Tinsley and colleagues. They analysed eight large 
genetic islands that are present in N. meningitidis but absent in N. gonorrhoeae 
regarding their impact on virulence in vitro and in vivo. Deletion of these regions did not 
result in an alteration of the bacterial resistance to serum (Klee et al, 2000). 
However, for gene content analysis we used microarrays that covered the genomes of 
four meningococcal strains but neither the genome of α16 nor α528 or DE9686. 
Therefore, DE9686 could possess genes that are not covered by the microarray used and 
that may be absent in the carrier strains. This question could be addressed 
bioinformatically by performing an in silico hybridisation of DE9686 with MC58, which 
now would be possible since the DE9686 genome was sequenced in cooperation with Dag 
Harmsen (Vogel et al, 2012b). Furthermore, non-coding small regulatory RNAs (sRNAs) 
could influence gene expression and modulate protein activity by binding to mRNAs and 
proteins, respectively (Storz et al, 2011). Due to their small size, however, they cannot 
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be detected in the genomes of the strains analysed using a mCGH or transcriptome 
microarray.  
 
By employing a screening approach, the work group identified upregulation of Opc as a 
mechanism of serum resistance (Hubert et al, 2012). Furthermore, enhanced expression 
of Opc was also detected in the invasive isolate DE9686. 
In the early 1990s, Opc was recognised as a virulence factor involved in adhesion, 
colonisation and invasion of epithelial and endothelial cells (Sarkari et al, 1994; Virji et 
al, 1993; Virji et al, 1992). Recently, Virji and co-workers identified that Opc binds to the 
extracellular matrix protein and serum factor vitronectin and uses them to anchor to 
integrin receptors of human brain endothelial cells (Sa et al, 2010). Vitronectin in turn is 
known as a negative regulator of the terminal pathway of complement system by 
blocking assembly and insertion of the MAC and hindering pore formation (Milis et al, 
1993).  
This study is the first to demonstrate the link between expression of the adhesin Opc and 
meningococcal serum resistance: Deletion of opc in DE9686 background had a slight 
impact on serum resistance. Serum exposure led to enhanced MAC deposition on the opc 
knockout strain, whereas deposition of C3 was comparable. Using the same set of 
mutants, our Finnish project partners identified considerably increased binding of 
vitronectin in the opc complemented mutant in DE9686 background which overexpressed 
Opc. We therefore summarise that Opc binds the negative complement regulator 
vitronectin which reduces MAC deposition on the bacterial surface which contributes to 
serum resistance of meningococci (Hubert et al, 2012). Therefore, binding of vitronectin 
by Opc does not only conduce to the interaction with integrin receptors to attach to 
endothelial cells, but also to escape complement attack. 
 
Moreover, another target, i.e. NspA, was identified by a comparative proteome analysis 
of the three ST41/44 strains. Expression of NspA was increased in DE9686 compared to 
α16 and α528. Deletion of nspA in an acapsulated, LPS sialylation-deficient DE9686 strain 
resulted in considerably enhanced deposition of MAC on the bacterial surface, comparable 
to complement deposition levels of the acapsulated, LPS sialylation-deficient α16. This is 
consistent with findings of Ram and colleagues who identified NspA as a second protein 
binding fH, a negative regulator of the complement system (Lewis et al, 2010). fH blocks 
the amplification loop of the AP of complement system by hindering the formation of the 
C3 convertase and acting as a cofactor for the C3b-inactivating fI (Ferreira et al, 2010). 
Deletion of nspA leads to increase of C3b deposition, resulting in a boost of the AP, 
leading to enhanced MAC deposition, as seen after serum treatment of our mutants, and 
complement-dependent killing (Lewis et al, 2010). 
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Since NspA levels in the invasive isolate DE9686 were higher than in both carrier isolates, 
we assume that NspA is also most likely the major factor conferring serum resistance in 
our set of strains that lacked capsule, LPS sialylation and fHBP. The view of NspA as a 
mediator of serum resistance is supported by a recent study of Kroll and colleagues in 
which nspA was upregulated after meningococcal growth in human blood for four hours 
(Hedman et al, 2012). Another study showed that meningococcal deletion mutants 
lacking expression of NspA, Fur or the transferrin-binding protein TbpB are sensitive to 
killing in human blood (Echenique-Rivera et al, 2011). 
NspA is widely distributed among meningococcal strains of different serogroups and 
elicits a bactericidal response. It was therefore suggested as a meningococcal vaccine 
candidate (Martin et al, 1997). We are currently investigating mechanisms of gene 
regulation and general differences between carriage and IMD isolates. 
 
Comparative transcriptome analysis of the three strains especially highlighted an 
increased expression of nmb0865, coding for a hypothetical integral membrane protein, 
in the invasive isolate DE9686 compared to α16 and α528. We could show within this 
study that NMB0865 at least to some extend contributes to serum resistance of DE9686, 
as MAC deposition was increased in the nmb0865 deletion mutant which shifted the 
extent of complement deposition towards levels seen in the α16 mutant (acapsulated and 
deficient in LPS sialylation). The protein does not contain any putative conserved domain, 
and only shows similarities to the CrcB protein family conferring camphor resistance. 
Further research on the mechanism of action of NMB0865 and its role in mediating serum 
resistance in meningococci is currently conducted within the work group. 
 
In summary, we analysed a set of genetically closely related strains from carriage and 
disease. We aimed to identify virulence factors that mediate the enhanced serum 
resistance of the invasive isolate, even if dominant effects of capsule LPS sialylation and 
fHBP were excluded. A gene content analysis highlighted signs of reductive 
microevolution in the invasive isolate DE9686 that probably represents better adaptation 
to the human host. By means of transcriptomic and proteomic analyses, we identified 
three proteins that influence serum complement deposition and thus serum resistance of 
DE9686, i.e. NMB0865, Opc and NspA. 
The data support the view that a large number of proteins contribute to serum resistance 
of meningococci. Which repertoire is used under a given situation and whether different 
lineages utilise different components to achieve the same goal needs to be studied in 
detail. 
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 9 ANNEX 
 
9.1 Abbreviations 
 
AP alternative pathway of complement system 
APS ammonium persulfate 
β-ME beta-mercaptoethanol 
bp base pairs 
BSA bovine serum albumine 
C4BP complement component 4 binding protein 
CEACAM carcino-embryonic antigen-related cell adhesion molecule 
cc clonal complex 
cDNA copy DNA, obtained by transcription of RNA 
CE Correia element 
cfu colony forming units 
CP classical pathway of complement system 
DIG digoxygenine 
dH2O distilled water 
DNA desoxyribonucleic acid 
dNTP desoxynucleotide triphosphate 
dsDNA double-stranded DNA 
DTE dithioerythritol 
DTT dithiothreitol 
EDTA ethylenediamine-tetra-acetic acid 
ELISA enzyme-linked immunosorbent assay 
EMSA electrophoretic mobility shift assay 
et al et altera (and others) 
fH factor H 
fHBP factor H binding protein 
fI factor I 
FNR Fumarate and nitrate reduction regulator  
gDNA genomic DNA (chromosomal DNA) 
HBSS Hank's balanced salt solution 
HIS heat-inactivated serum 
IHF integration host factor 
IHT island of horizontally transferred DNA 
IMD invasive meningococcal disease 
kb kilo base pairs 
kDa kilo Dalton 
KDO 3-deoxy-2-keto-D-manno-octulosonic acid 
LNT lacto-N-neotetraose 
 
LP lectin pathway of complement system 
LPS lipopolysaccharide 
M molar (mol/litre) 
mAb monoclonal antibody 
MAC membrane attack complex 
Men[A] meningococci [of serogroup A] 
MLST multilocus sequence typing 
Msf meningococcal surface fibril 
N-CAM neural cell adhesion molecule 
NeuNAc (α2-8)-N-acetylneuraminic acid 
NHS normal human serum; herein: Dunn Lab pooled human complement serum 
N.m. Neisseria meningitidis 
NrrF neisserial regulatory RNA responsive to iron 
NspA neisserial surface protein A 
OD600 optical density measured at an absorption of 600 nm 
o/n over night 
OMV outer membrane vesicle 
Opa/Opc opacity protein A/C 
PBS phosphate-buffered saline 
PCR polymerase chain reaction 
PorA/B porin A/B 
qRT-PCR quantitative real-time PCR 
RNA ribonucleic acid 
rpm rounds per minute 
RpoH RNA polymerase sigma factor 
rRNA ribosomal RNA 
RT room temperature 
SDS-PAGE SDS-polyacrylamide gel electrophoresis 
sg serogroup 
SDS sodium-dodecyl-sulfate 
SNP single nucleotide polymorphism 
SSC saline-sodium-citrate buffer 
SSPE saline-sodium-phosphate-EDTA buffer 
ST sequence type 
STM signature tagged mutagenesis 
TEMED tetramethylethylenediamine 
TIR terminal inverted repeat 
TPEN N,N,N′,N′-tetrakis-(2-pyridyl-methyl)-ethylenediamine 
Tris trishydroxymethylaminomethane 
U units 
 9.2 Publications 
 
 
Parts of this work have been published in: 
 
Pawlik MC, Hubert K, Joseph B, Claus H, Schoen C, Vogel U. The zinc-responsive regulon 
of Neisseria meningitidis comprises 17 genes under control of a Zur element. J Bacteriol. 
2012. 194(23):6594-6603. 
 
Hubert K, Pawlik MC, Claus H, Jarva H, Meri S, Vogel U. Opc expression, LPS immunotype 
switch and pilin conversion contribute to serum resistance of unencapsulated 
meningococci. PLoS ONE. 2012. 7(9): e45132. 
 
 
During my doctoral research I also contributed to the following publications: 
 
Claus H, Jördens MS, Kriz P, Musilek M, Jarva H, Pawlik MC, Meri S, Vogel U. Capsule null 
locus meningococci: typing of antigens used in an investigational multicomponent 
meningococcus serogroup B vaccine. Vaccine. 2012. 5;30(2):155-60. 
 
 
Parts of this work have been presented at the following international 
conferences: 
 
09/2012 XVIIIth International Pathogenic Neisseria Conference (IPNC) – 
Würzburg, Germany 
Poster The Zinc-responsive Regulon of Neisseria meningitidis Comprises 17 Genes 
under Control of a Zur element. Pawlik MC, Hubert K, Joseph B, Claus H, 
Schoen C, Vogel U. 
 
10/2011 6th International Student Symposium of the Graduate School of Life 
Sciences - “BioBang: the Xpanding Space of Life Science” - Würzburg, 
Germany 
Poster Studies on meningococcal gene regulation by the Zinc uptake regulator Zur. 
Pawlik MC, Hubert K, Vogel U.  
 
05/2011 1st Mol Micro Meeting - Würzburg, Germany 
Poster Establishment of genomic approaches to unravel meningococcal serum 
resistance factors. Pawlik MC, Hubert K, Claus H, Vogel U.  
 
04/2011 FEMS-Leopoldina Symposium on "Emerging Topics in Microbial 
Pathogenesis" - Würzburg, Germany 
Poster Establishment of genomic approaches to unravel meningococcal serum 
resistance factors. Pawlik MC, Hubert K, Claus H, Vogel U. 
 
04/2011 Annual Conference of the Association for General and Applied 
Microbiology (VAAM) - Karlsruhe, Germany 
Poster Establishment of genomic approaches to unravel meningococcal serum 
resistance factors. Pawlik MC, Hubert K, Claus H, Vogel U. 
 
 
Parts of this work have been presented at the following international meetings: 
 
11/2011 3rd Meeting of the CoMeVac Consortium - Frankfurt/Main, Germany 
Talk Studies on meningococcal gene regulation by the Zinc uptake regulator Zur. 
Pawlik MC, Hubert K, Vogel U.  
 
11/2010 2nd Meeting of the CoMeVac Consortium - Würzburg, Germany 
Talk Analysis of the adaptive response of meningococci to serum complement 
exposure. Pawlik MC, Hubert K, Claus H, Vogel U.  
 
02/2010 1st Meeting of the CoMeVac Consortium - Paris, France 
Talk Characterization and mutation of ST-32 cc and ST-41/44 cc strains from 
France and Germany. Pawlik MC, Hubert K, Claus H, Vogel U. 
 
 
